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ABSTRACT 
Computer-aided molecular design (CAMD) offers a methodology for rational product design. The CAMD 
procedure consists of pre-design, design and post-design phases. CAMD was used to address two 
bioengineering problems: design of excipients for lyophilized protein formulations and design of ionic 
liquids for use in bioseparations. Protein stability remains a major concern during protein drug 
development. Lyophilization, or freeze-drying, is often sought to improve chemical stability. However, 
lyophilization can result in protein aggregation. Excipients, or additives, are included to stabilize proteins 
in lyophilized formulations. CAMD was used to rationally select or design excipients for lyophilized 
protein formulations. The use of solvents to aid separation is common in chemical processes. Ionic 
liquids offer a class of molecules with tunable properties that can be altered to find optimal solvents for 
a given application. CAMD was used to design ionic liquids for extractive distillation and in situ extractive 
fermentation processes.  
The pre-design phase involves experimental data gathering and problem formulation. When available, 
data was obtained from literature sources. For excipient design, data of percent protein monomer  
remaining post-lyophilization was measured for a variety of protein-excipient combinations. In problem 
formulation, the objective was to minimize the difference between the properties of the designed 
molecule and the target property values. Problem formulations resulted in either mixed-integer linear 
programs (MILPs) or mixed-integer non-linear programs (MINLPs). 
The design phase consists of the forward problem and the reverse problem. In the forward problem, 
linear quantitative structure-property relationships (QSPRs) were developed using connectivity indices. 
Chiral connectivity indices were used for excipient property models to improve fit and incorporate 
three-dimensional structural information. Descriptor selection methods were employed to find models 
that minimized Mallow's Cp statistic, obtaining models with good fit while avoiding overfitting. Cross-
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validation was performed to access predictive capabilities. Model development was also performed to 
develop group contribution models and non-linear QSPRs. A UNIFAC model was developed to predict 
the thermodynamic properties of ionic liquids.  
In the reverse problem of the design phase, molecules were proposed with optimal property values. 
Deterministic methods were used to design ionic liquids entrainers for azeotropic distillation. Tabu 
search, a stochastic optimization method, was applied to both ionic liquid and excipient design to 
provide novel molecular candidates. Tabu search was also compared to a genetic algorithm for CAMD 
applications. Tuning was performed using a test case to determine parameter values for both methods. 
After tuning, both stochastic methods were used with design cases to provide optimal excipient 
stabilizers for lyophilized protein formulations. Results suggested that the genetic algorithm provided a 
faster time to solution while the tabu search provides quality solutions more consistently.  
The post-design phase provides solution analysis and verification. Process simulation was used to 
evaluate the energy requirements of azeotropic separations using designed ionic liquids. Results 
demonstrated that less energy was required than processes using conventional entrainers or ionic 
liquids that were not optimally designed. Molecular simulation was used to guide protein formulation 
design and may prove to be a useful tool in post-design verification. Finally, prediction intervals were 
used for properties predicted from linear QSPRs to quantify the prediction error in the CAMD solutions. 
Overlapping prediction intervals indicate solutions with statistically similar property values. Prediction 
interval analysis showed that tabu search returns many results with statistically similar property values 
in the design of carbohydrate glass formers for lyophilized protein formulations. The best solutions from 
tabu search and the genetic algorithm were shown to be statistically similar for all design cases 
considered. Overall the CAMD method developed here provide a comprehensive framework for the 
design of novel molecules for bioengineering approaches.       
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1.0 INTRODUCTION 
Chemical product design is an important, yet often overlooked, aspect of chemical engineering. 
Traditionally, chemical engineering has focused on process design, yet the aim of any process is to 
manufacture a product of value. The objective of process design is to maximize output and profit while 
minimizing material and energy inputs. Additional factors, such as safety and environmental concerns, 
further constrain the process design. The same design principles can be applied to chemical product 
design, where a molecule requires specific chemical or physical properties for a certain task. Other 
properties can be used as constraints to further ensure the designed product works to the correct 
specifications. Chemical product design has been defined as the process in which needs are determined, 
candidates are generated to meet needs, screening and selection of candidates identifies the best 
candidate and the final candidate is manufactured into a finished product (Cussler and Moggridge 2011). 
The product design problem is often addressed by extensive experimental generate-and-test 
approaches. Such approaches would not be feasible in many process design problems, and thus systems 
engineering and process design developed to identify solutions from a modeling, simulation and 
optimization perspective. Computer-aided molecular design (CAMD) offers a methodology that aims to 
reduce trial-and-error and rationally design and select candidates in chemical product design using 
systems engineering principles. In general, CAMD aims to solve the chemical product design problem by 
determining a molecule or formulation (mixture of molecules) that best matches a set of target 
properties given an assortment of chemical groups (Gani 2004). The advent of engineering approaches 
to biological systems presents many new opportunities for the application and further development of 
computer-aided molecular design.  The work that follows describes the development and use of CAMD 
approaches towards two applications of biological relevance: design of lyophilized protein formulations 
and design of ionic liquid solvents for use in separation of bio-products.  
 
2 
 
1.1 MOTIVATION 
Protein drugs are a fast growing pharmaceutical market. Global spending on biologics, which include 
protein drugs and cell-based therapies, in 2011 was $157Bn and is expected to grow to $200Bn by 2016 
(source: IMS Health, http://www.imshealth.com). In relation to traditional pharmaceutical molecules, 
biologics are gaining market share. Of the top 100 drugs by U.S. sales in the fourth quarter of 2012, 28 
were protein drugs or other biologics (source: IMS Health, http://www.imshealth.com ). Lyophilization, 
or freeze-drying, is a common process used to increase the stability of protein drug products through 
the removal of water. Despite improvements to chemical stability, lyophilization can induce protein 
aggregation. Protein aggregation is undesirable in drug products as it can reduce efficacy, cause 
immunogenicity and/or result in product losses during production. Thus, reduction of protein 
aggregation is a topic of extreme interest and concern in the pharmaceutical industry. The two general 
approaches taken to minimize aggregation are protein engineering and formulation development. The 
work detailed here focuses on use of CAMD for the design of a molecule or set of molecules for inclusion 
in a lyophilized formulation with the aim of minimizing aggregation. 
Another class of molecules receiving increased attention both in research and industry is ionic liquids. 
The number of publications concerning ionic liquids has jumped from less than 100 in 2000 to nearly 
2,500 in 2011 (Ann, Nicholas et al. 2012). Ionic liquids are attractive as environmentally friendly, or 
“green”, solvents due to their extremely low vapor pressure and tunable properties through alteration 
of the cation and anion selected (Marsh, Boxall et al. 2004; Zhao, Xia et al. 2005). Two bio-based 
applications of ionic liquids as solvents are used as the basis for CAMD in this work: ionic liquids as 
entrainers in azeotropic distillation and ionic liquids as extraction media for in situ fermentation 
processes.  
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Distillation is a commonly used unit operation that allows for separation of products based on 
differences in volatility. Azeotropic distillation allows separation of azeotropes through use of an 
entrainer, further increasing the applications of distillation. A major drawback to distillation is the 
energy requirements. Distillation processes are estimated to account for 40% of the entire energy usage 
of the chemical processing industry in North America (U.S. Dept. of Energy 2001). The use of ionic liquids 
as entrainers has shown improvements in energy requirements in comparison to conventional 
entrainers used in azeotropic distillation (Seiler, Jork et al. 2004).  
Fermentation is a common method which utilizes microorganisms for the production of chemicals. 
Substrate/product inhibition and separation of chemical products are two main concerns that reduce 
the efficiency of fermentation processes. By removing the product as it is produced, in situ fermentation 
offers a solution to these concerns. Ionic liquids have been proposed for use as extractive media for in 
situ fermentation processes due to their flexible properties obtained by altering the cation and anion 
used (Gangu, Weatherley et al. 2009). Through CAMD methods, optimal ionic liquids can be identified 
for azeotropic distillation and in situ fermentation resulting in increasingly efficient separation 
processes. 
CAMD provides a methodology for the rational design or selection of molecules for a specific task. 
CAMD methodology consists of a forward and a reverse problem (Venkatasubramanian, Chan et al. 
1994). In the forward problem, property models are developed which relate chemical structure to 
properties of interest. The reverse problem determines a molecular structure which best matches a set 
of target property values and property constraints. The overall design methodology is outlined by Figure 
1.1. 
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Figure 1.1 Computer-aided molecular design methodologyThe forward problem relates molecular 
structure to property values through molecular descriptors. The reverse problem determines the 
molecular descriptor values and hence molecular structure that provides an optimal match to target 
property values.  
 
While much research has been spent on the reverse problem, little effort has been spent on the forward 
problem (Patel, Ng et al. 2009). Many CAMD methods utilize group contribution (GC) property models 
(Gani, Nielsen et al. 1991; Harper and Gani 2000). Group contribution methods describe molecular 
structure as a collection of chemical fragments of groups. The number and type of groups are correlated 
to properties of interest. GC methods generally do not account for the connectivity of the molecule and 
provide a low level of molecular representation (Patel, Ng et al. 2009). The work here largely uses 
connectivity indices to represent molecular structure to provide higher level molecular representation 
and increased accuracy in property modeling. Connectivity indices and other topological indices are 
becoming more widespread in the development of property models for CAMD (Raman and Maranas 
1998; Camarda and Maranas 1999; Siddhaye, Camarda et al. 2000; Lin, Chavali et al. 2005; Eslick, Ye et 
al. 2009; McLeese, Eslick et al. 2010; Roughton, Topp et al. 2012). The following work advances the level 
of molecular representation used in CAMD approaches through the integration of chirality information 
in the calculation of connectivity indices.     
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Descriptor selection is trivial in the development of GC property models as the descriptors needed are 
defined by the types of chemical groups present in the model building set. GC models run the risk of 
over-fitting as a result, potentially leading to poor property prediction. By using connectivity indices, 
descriptor selection techniques become available to ensure the development of models with good fits 
and predictive ability. The work here integrates established statistical techniques for descriptor selection 
with CAMD model development for the first time. Additionally, model cross-validation methods used 
previously in CAMD (Eslick, Ye et al. 2009) are further advanced.   
Given a set of predictive property models, a CAMD solution technique is employed to design or select 
candidate molecules for a given task in the reverse problem. Three main solution approaches have been 
used in CAMD: enumeration techniques, mathematical programming and stochastic optimization (Eljack 
and Eden 2008). Enumeration techniques use a set of chemical groups to generate all chemical 
combinations and then screen the combinations using property targets and constraints. As the number 
of groups and/or the maximum allowable molecule size becomes large, enumeration techniques can 
suffer from combinatorial explosion. Enumeration approaches are also reliant on a predefined chemical 
group set that may preclude the consideration of many novel molecules. Mathematical programming 
poses the CAMD problem as a mixed integer linear program (MILP) or mixed integer nonlinear program 
(MINLP). While solution of a MILP ensures that a globally optimal solution is found, many CAMD 
problems require a MINLP representation. Solution of a MINLP can be computationally expensive and 
does not guarantee that the solution found is the global optimum (Eljack and Eden 2008). Furthermore, 
a global optimum may not be necessary or even meaningful for CAMD approaches due to uncertainties 
in property prediction. CAMD methods which employ stochastic optimization algorithms are iterative 
procedures which aim to find multiple near-optimal or locally optimal solutions. The speed in generation 
of a set of many good candidate molecules makes stochastic optimization approaches attractive for 
CAMD and stochastic approaches are the focus of this work. Genetic algorithm CAMD approaches mimic 
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evolution to refine a population of candidate molecules through a series of generations, until candidates 
are identified that provide the best match to a set of target properties (Venkatasubramanian, Chan et al. 
1994). Tabu search CAMD approaches use a local search to identify candidate molecules while 
maintaining a history of previous solutions (Lin, Chavali et al. 2005). The solution history, stored in tabu 
lists, is used to guide the local search and determine when the search should be expanded to consider 
other, more diverse molecular structures (Lin, Chavali et al. 2005).  While both methods have 
advantages – multiple initial solutions (seed population) in genetic algorithms and memory guided 
search (via tabu lists) in tabu search – the utility of one stochastic method over another for CAMD is not 
established. The work that follows details the development, tuning and comparison of genetic 
algorithms and Tabu search for CAMD to identify the strengths and weaknesses in both approaches. 
Finally, as stochastic methods generate many locally optimal solutions, a comparison method would 
provide a tool to determine the best subset of solutions for further consideration. The work here 
demonstrates a novel application of prediction intervals to provide statistical comparisons of CAMD 
solutions obtained from stochastic solution methods. The prediction interval comparisons are made 
between solutions found using the same method and also between the best solutions found using 
different methods. 
1.2 OVERVIEW 
The following chapter (Section 2) will offer further background into both the lyophilized protein 
formulation and ionic liquid solvent design problems being considered, along with a detailed 
explanation of CAMD methodology and state-of-the-art. In addition to the use of CAMD towards novel 
applications, the work concerned here also presents new approaches for CAMD model development, 
solution and final candidate selection. To design a molecule with target properties, models must exist 
for prediction of the targeted properties. Experimental data is needed for model development. The 
 
7 
 
experimental methods used in the work are detailed in Section 3. Development of reliable property 
models is imperative as the validity of a CAMD solution rests on the predicted properties being accurate. 
The work described in Section 4 details the efforts made to improve property prediction by uniting 
established statistical techniques to model development for CAMD problems. Solution of the CAMD 
problem provides candidate molecules for a given application. The CAMD solution approaches 
presented here are based on optimization frameworks and are detailed in Section 5. Solution of the 
optimization problems are approached through both deterministic and stochastic methods, with the use 
of stochastic methods being emphasized. Additional computational tools have been utilized and are 
detailed in Section 6 (process design) and Section 7 (molecular simulation). Results are presented in 
Section 8 (ionic liquid design) and Section 9 (excipient design). Finally, conclusions and future 
recommendations are given in Section 10.  
For further clarification, nomenclature is given in Appendix A. The procedure used for model 
development is provided in Appendix B. Appendix C provides guidelines for using a previously existing 
CAMD framework while Appendix D provides the source code for a new CAMD framework proposed 
here. Additional interaction parameters for a UNIFAC model developed by this work are available in 
Appendix E. All experimental data obtained by the author are summarized in Appendix F. 
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2.0 BACKGROUND 
CAMD requires a product design problem for solution. Two different problems related to bioengineering 
have been addressed here: design of lyophilized protein formulations to minimize aggregation and 
design of ionic liquids for separation of bio-products. Background on lyophilization and protein 
aggregation is given in Sections 2.1-2.6. Background regarding ionic liquids and their use in separations 
is given in Sections 2.7-2.8. Once a design problem of interest has been identified, property models are 
needed to link key properties for design to molecular structure (the forward problem). Sections 2.9-2.11 
describe model development for both structure-property relationships as well as thermodynamic 
property models. Upon creation of reliable property models, CAMD is used to generate candidates that 
optimally match a given set of target properties (the reverse problem). The CAMD methodology and its 
historical development are detailed in Sections 2.12-2.17. 
LYOPHILIZED PROTEIN FORMULATION DESIGN 
2.1 PROTEINS AS DRUGS 
Proteins are increasingly being considered as therapeutic candidates. Proteins fulfill a multitude of 
biological functions including catalysis, transport and structural support and consequently have been 
indicated in numerous disease states (Leader, Baca et al. 2008). Currently, approved protein drugs are 
available for treatment of a wide range of diseases including diabetes, multiple sclerosis, rheumatoid 
arthritis, cancer and hepatitis (Marshall, Lazar et al. 2003). Compared to traditional small molecule 
pharmaceuticals, protein molecules have increased complexity. 
Proteins are biopolymers comprised of amino acids. The main structure of an amino acid involves an 
amino group and carbonyl group common to all amino acids along with a side group that defines the 
amino acid. There are twenty common amino acids used in the biosynthesis of proteins, which can be 
arranged in classes of non-polar or hydrophobic, polar, acidic and basic amino acids. Two amino acids 
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bond covalently to form a peptide bond between the amide nitrogen of one amino acid and carbonyl 
carbon of another amino acid. The formation of peptide bonds creates the polypeptide backbone which 
is common among all proteins with structural diversity arising from the amino acid side groups. The 
amino acid sequence of the protein is referred to as the primary structure. Proteins do not exist as linear 
molecules but instead fold into a variety of three-dimensional conformations. Structural motifs known 
as -helices and -sheets (pleated sheets) form the secondary structure of a protein. Such motifs are 
formed by hydrogen bonding between the amide hydrogen of one amino acid and the carbonyl oxygen 
of another amino acid. The three-dimensional arrangement of secondary structural elements and 
unfolded regions constitutes the tertiary structure of the protein, which is driven by the amino acid 
sequence (Anfinsen 1972). Minimization of exposed non-polar or hydrophobic surface area and 
formation of intramolecular contacts are two main driving forces in the tertiary structure adopted by a 
protein (Pace, Shirley et al. 1996; Rose, Fleming et al. 2006). Quaternary structure is derived from 
arrangement of single folded polypeptide chains into multi-protein complexes. An overview of the 
structural hierarchy in proteins is given by Figure 2.1. The biological function of proteins is derived from 
protein structure. As a result, preservation of native structure is essential for proper function of 
therapeutic proteins. 
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Figure 2.1 Hierarchy of protein structure Figure adapted from (University of Massachusetts, accessed 1 
June 2013). 
 
When a protein is identified as a therapeutic candidate, a formulation must be developed for 
administration. Due to degradation processes in the body, protein drug products generally require 
injectable routes of administration (intravenous, intramuscular or subcutaneous). Thus the final product 
requires an injectable solution for patient use. Additives, or excipients, are included in the formulation 
to attain desirable properties, including stabilization of the final drug product. Stability is a major 
concern, as many degradation routes exist for proteins. For example, degradation can occur via 
aggregation, deamidation, isomerization, oxidation, glycation, and thioldisulphide exchange (Cleland, 
Langer et al. 1994; Manning, Chou et al. 2010). Degradation not only results in product loss, but also can 
lead to issues in regulatory approval. In most cases, the FDA requires pharmaceutical product 
degradation to be below 10% of the product’s final weight (Cleland, Langer et al. 1994). 
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2.2 LYOPHILIZATION  
For proteins that prove unstable under aqueous conditions, lyophilization is often employed. 
Lyophilization removes water from the formulation by sublimation via a freezing step and then by 
evaporation through primary and secondary drying steps (Cleland, Langer et al. 1994; Costantino and 
Pikal 2004). During the lyophilization process, the protein experiences several temperature and pressure 
changes. By removing water, the mobility of the protein is reduced and stability is improved by 
elimination of many reactions that are facilitated by water. The desired resulting product is an 
amorphous solid with minimal water content (see Figure 2.2). Lyophilization is among the most common 
formulation choices for protein drugs, representing 46% of the biopharmaceuticals approved by the FDA 
through December 2003 (Costantino and Pikal 2004). For administration, lyophilized protein drug 
products are reconstituted and subsequently injected.  
 
Figure 2.2 Vial containing lyophilized protein formulation The resulting formulation is an amorphous 
solid.  
 
Despite improvements to stability, degradation can still occur in lyophilized proteins. Of particular 
interest here is degradation due to protein aggregation, which is an often irreversible self-association 
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resulting in a protein complex (Cleland, Langer et al. 1994; Wang 2005; Wang, Nema et al. 2010). The 
aggregation process can occur due to physical interactions between protein surfaces or can result from 
chemical interactions of the amino acids, forming covalent bonds between proteins (Wang 2005). The 
detection of aggregates is difficult, as the protein complexes may be soluble (Wang 2005). Aggregation 
not only results in product loss and lowered efficacy of the protein drug, but can also lead to severe and 
life threatening immunogenic responses (Rosenberg 2006). One aim of a lyophilized formulation should 
be to minimize aggregation, ensuring the safety and efficacy of the final product. 
2.3 PROTEIN AGGREGATION – MECHANISMS, MEASUREMENT AND PREDICTION 
Protein aggregation is defined as the self-association of monomeric protein leading to the formation of 
multi-protein complexes. Aggregation can be either reversible or irreversible, arising from the formation 
of covalent bonds or through physical interactions (Wang 2005). An example of chemical reaction 
leading to aggregation is the formation of intermolecular disulfide bonds.  Interactions between 
hydrophobic regions of proteins represent a physical pathway that results in aggregation. Protein 
aggregates can either be soluble or insoluble (Wang 2005). Insoluble protein aggregates precipitate out 
of solution. Soluble aggregates are further characterized as visible or sub-visible. An example of visible 
soluble aggregates is provided by Figure 2.3. The formation of visible soluble aggregates results in 
solution turbidity and can be detected through optical methods (Katayama, Nayar et al. 2005). The 
presence of sub-visible aggregates is receiving increasing attention in protein formulation development 
(Carpenter, Randolph et al. 2009).  
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(A)       (B) 
      
Figure 2.3 Solutions containing aggregated protein  (A) The presence of visible aggregates leads to 
turbidity in the solution. (B) Protein aggregates can precipitate out of solution.  
 
The formation of protein aggregates is primarily driving by two factors: colloidal instability and 
conformation instability (Chi, Krishnan et al. 2003). Colloidal instability results in aggregation through 
direct interaction of properly folded proteins. Of special concern for colloidal instability is the exposure 
of hydrophobic surfaces on the protein which may drive aggregation and has been implicated in a 
variety of disease states resulting from protein aggregation (Münch and Bertolotti 2010). The 
mechanism behind colloidal instability is rather straightforward (i.e., direct protein-protein interactions), 
yet the prediction of colloidal instability for any given protein remains a challenge. 
Conformational instability involves a change in native conformation that leads to aggregation. Partial 
unfolding may expose regions of the protein that increase aggregation propensity (Wang 2005).  A 
general pathway for the formation of aggregates is outlined in Figure 2.4. The progression of protein 
from native state to partially unfolded states is driving by the free energy landscape and can result in an 
ensemble of intermediate structures (Gsponer and Vendruscolo 2006). The free energy landscape has 
both entropic and enthalpic contributions. It has been suggested that individual unfolded monomers are 
favorable by increasing entropy while aggregated states are favorable by decreasing enthalpy (Gsponer 
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and Vendruscolo 2006). In many cases, aggregation may be driven through a combination of colloidal 
and conformation instabilities leading to a more complicated set of pathways than that proposed in 
Figure 2.4 (Wang, Nema et al. 2010).  
 
Figure 2.4 Pathway for the formation of aggregates through conformation instability Partial unfolding 
of the native protein lead to aggregation-prone intermediates. The intermediates can aggregate or 
further unfolded. Figure adapted from (Wang 2005). 
  
A variety of experimental techniques exist for the detection and assessment of protein aggregates which 
can be classified as particle-based methods, separation-based methods and indirect methods 
(Engelsman, Garidel et al. 2011). Particle-based methods aim to detect aggregates through identification 
of particles in solution. Separation-based methods aim to separate aggregates from native protein in 
solution through basis of size, following by aggregate detection. Indirect methods often utilize 
spectroscopy methods to detect structural changes that are associated with protein aggregation. 
Overall, experimental techniques either provide qualitative information on protein aggregation or 
quantitative information such as the percentage of protein that is monomeric as opposed to aggregated.  
A summary of some common experimental techniques is provided by Table 2.1. The list provided is by 
means exhaustive and continual work is being performed to both improve existing aggregate detection 
methods as well as develop novel techniques for aggregate detection. 
Native Intermediate Unfolded 
Aggregate 
 
15 
 
Understanding the structural properties of proteins that lead to aggregation is critical to the design of 
safe and effective protein drug products, and an ability to predict aggregation propensity (i.e., the 
likelihood and extent to which a protein will aggregate) with reasonable accuracy would accelerate 
development. Several approaches have been developed to estimate aggregation propensity for a given 
protein, which can classified into two main methods: heuristic-based methods and simulation-based 
methods. 
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Heuristic-based approaches attempt to use prior history on aggregation or causes of aggregation in 
proteins to develop predictors for aggregation propensity. The aim of a heuristic-based approach is to 
relate protein properties to experimental data on protein aggregation, with the end result being a 
predictive model or algorithm that returns aggregation propensity given a measure of protein structure. 
Several algorithms have been developed to predict protein aggregation in solution as a function of 
structural parameters. For example, AGGRESCAN utilizes the intrinsic aggregation propensity of amino 
acids obtained from an experimental aggregation database of mutated β-amyloid peptides (Conchillo-
Sole, de Groot et al. 2007). PASTA predicts the likelihood of amino acid sequences being involved in 
intermolecular β-sheet formation, based on minimization of β-pairing energies (Trovato, Seno et al. 
2007). Zyggregator uses factors such as protein hydrophobicity, electrostatic interactions and 
alternating stretches of polar and non-polar residues to predict aggregation propensity (Tartaglia and 
Vendruscolo 2008). For all of these methods, protein primary structure (amino acid sequence) is used to 
return one or more scoring parameters which are indicative of the propensity of a protein to aggregate. 
For instance, AGGRESCAN returns the number of aggregation prone regions, or “hot spots” in a protein. 
The number of hot spots is then used to qualitatively indicate the likelihood of protein aggregation 
occurring, with a larger number of hot spots corresponding to a higher likelihood. Therefore, a hallmark 
of current methods is qualitative results in the form of aggregation predictors that must be interpreted. 
Simulation-based methods use any of the many available molecular simulation software packages or 
newly-developed tools to investigate interactions between protein molecules or dynamics within a 
single protein molecule. The aim of simulation-based methods is to determine if aggregation is likely to 
happen based on the energetics of protein-protein interactions (Ma and Nussinov 2006). Alternatively, 
simulation-based methods can investigate the dynamics of a single protein molecule to determine if the 
properties of the protein could become amenable to aggregation (Irbäck and Mohanty 2006). For 
example, the spatial aggregation propensity (SAP) algorithm uses molecular simulations to determine 
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the average exposed hydrophobic surface area for a given protein, with larger exposed hydrophobic 
surface areas representing increased aggregation propensity (Chennamsetty, Voynov et al. 2009). In 
general, simulations are more computationally expensive than use of a model or algorithm to predict 
aggregation propensity. Simulations are usually required for every system of interest. Simulation-based 
methods necessitate three-dimensional structure of a protein for determination of aggregation 
propensity and thus require more structural information than the heuristic-based methods described 
previously. Simulation-based approaches offer advantages over current heuristic-based approaches due 
to the ability for qualitative assessments (e.g., free energy calculations of protein-protein interactions) 
and inclusion of formulation conditions via explicit solvent and solute modeling. Recently, hybrid 
approaches have been developed to combine simulation results with heuristic model-based predictions. 
The Developability Index has been constructed for monoclonal antibodies utilizing net charge and SAP 
(Lauer, Agrawal et al. 2012).  Additionally, the osmotic second virial coefficient (B22) has also been used 
to predict protein self-association in aggregation (Chi, Krishnan et al. 2003; Printz, Kalonia et al. 2012), 
though it is based on experimental measurement and not on a priori descriptors of protein structure. 
2.4 APPROACHES TO AGGREGATION MINIMIZATION 
Two basic approaches are taken to minimize protein aggregation in therapeutics: protein engineering 
and formulation development. Protein engineering focuses on modifications to the structure of the 
protein which result in reduced aggregation propensity. Formulation development attempts to minimize 
aggregation through the inclusion of excipients, resulting in a multi-component product. The two 
approaches differ in that protein engineering is focused on the protein molecule itself (active 
compound) while formulation development is concerned with selection of excipient molecules (inactive 
compounds). 
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The basis behind protein engineering is that structure of the protein determines function. Consequently, 
modification of protein structure can offer improvement of certain properties while still maintaining the 
intended therapeutic function. Key properties of interest for protein drugs, and therefore areas for 
desired improvement, include mechanism of action, stability, bioavailability, toxicity or occurrence of 
side effects, ability for production at economically viable scales and dosing/delivery requirements 
(Marshall, Lazar et al. 2003). Table 2.2 provides an overview of the common targets of protein 
engineering approaches. With regards to preventing aggregation, common protein engineering 
strategies include replacement of cysteine residues, replacement of exposed hydrophobic residues, 
charge modification and post-translation modification (Marshall, Lazar et al. 2003). Replacing free 
cysteine residues can prevent aggregation that occurs due to disulfide bond formation and has been 
shown to successfully reduce aggregation for commercially available protein drugs such as Proleukin 
(aldesleukin, produced by Chiron) and Betaseron (interferon beta-1b, produced by Berlex/Chiron) 
(Marshall, Lazar et al. 2003). Yet aggregation can still occur from the scrambling of disulfide bonds 
formed from paired cysteine residues (Wang 2005). Replacement of hydrophobic residues through site-
directed mutagenesis offers an increasingly popular choice for protein engineering, including rational 
protein design. For example, the SAP algorithm has been developed to identify amino acids in antibodies 
with high aggregation propensity as targets for mutagenesis (Chennamsetty, Voynov et al. 2009). SAP 
has also been used with total charge to provide a developability index for monoclonal antibodies (Lauer, 
Agrawal et al. 2012). Protein engineering approaches may improve the stability of lyophilized protein 
drugs or offer sufficient stability improvements such that lyophilization is no longer necessary.  
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Table 2.2 Common protein engineering targets for property improvementTable adapted from 
(Marshall, Lazar et al. 2003).  
Protein Structural Target Desired Improvement 
Exposed hydrophobic residues Solubility 
Binding site Interaction affinity and specificity  
Loops Protease susceptibility 
Core Stability and conformational control 
Linear epitopes Immunogenicity 
Termini Attachment of fusion partners or polyethylene glycol (PEG) 
 
Formulation development assumes a fixed protein molecule and selects excipients to improve the drug 
product properties. Figure 2.5 illustrates the general preformulation and formulation development 
process. Excipients provide a variety of roles in protein drug formulation including solubilizing 
compounds, stabilizers and bulking agents for lyophilized formulations (Costantino and Pikal 2004; 
Strickley 2004). If possible, excipients are added to ensure stability in the aqueous solution, bypassing 
the need for a lyophilized formulation.  For reduction of aggregation, a common strategy is to create 
favorable conditions for the native state of the protein through addition of excipients to prevent 
protein-surface interactions and/or improve conformational stability. Surfactants are employed to 
prevent denaturation and adherence of proteins to the surface of any variety of containers that the 
protein is exposed to during manufacturing and storage, as the surfactants are more likely to bind to the 
surfaces (Chang, Kendrick et al. 1996; Chi, Krishnan et al. 2003). Other excipients, such as sugars, are 
added to improve conformational stability via preferential exclusion (Arakawa and Timasheff 1982). 
According to preferential exclusion, sugars and other weakly interacting excipients are excluded from 
the protein’s surface. The exclusion leads to an increase in free energy that is proportional to the 
protein’s surface area (Arakawa and Timasheff 1982; Timasheff 1998). As a result, a compact form of the 
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protein is energetically more favorable and the native state is preferred to an unfolded or denatured 
state. Excipients that bind with strong affinity to the protein surface can also affect protein stability. 
Excipients that bind to the native state increase conformational stability, while excipients that have an 
affinity for the unfolded state drive denaturation (Chi, Krishnan et al. 2003). Examples of molecules that 
affect protein stability through binding include heme with myoglobin (increased stability) and guanidine 
hydrochloride with proteins in general (decreased stability, denaturation). During formulation 
development, stability concerns may justify the use of lyophilization. 
Several classes of molecules are employed in lyophilized protein formulations including amino acids, 
carbohydrates, polymers and surfactants (Costantino and Pikal 2004). Of special interest are 
carbohydrate excipients, such as sucrose and trehalose, which have been shown repeatedly in literature 
to stabilize lyophilized protein structure (Fung, Darabie et al. 2005; Li, Williams et al. 2008; Sinha, Li et 
al. 2008). Many lyophilized protein formulations utilize simple sugars, disaccharides, oligosaccharides, or 
sugar alcohols as stabilizers (Cleland, Langer et al. 1994). Two main theories have been proposed for 
describing an excipient’s ability to stabilize biomolecules during lyophilization: water replacement and 
vitrification. In the water replacement theory, stabilizing excipients are those that can substitute for 
water in the dried state through hydrogen bonding with the protein (Cleland, Langer et al. 1994). The 
vitrification hypothesis proposes that stabilizing excipients are those that form glasses during 
lyophilization (Crowe, Carpenter et al. 1998). Vitrification is described in more detail in Section 2.4, while 
water-replacement is further addressed in Section 2.5. 
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Figure 2.5 Preformulation and formulation development process diagram Adapted from (Cleland, 
Langer et al. 1994).   
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2.5 VITRIFICATION – GLASS TRANSITIONS IN LYOPHILIZATION 
In general, the glass transition temperature marks the change between a liquid/rubbery state and an 
amorphous solid/glass state. The glass transition temperature can be measured by a variety of methods 
including differential mechanical thermal analysis (DMTA) and differential scanning calorimetry (DSC) 
(Rahman, Al-Marhubi et al. 2007). Due to the different features used by each method, the exact 
transition temperature measured varies by method (Rahman, Al-Marhubi et al. 2007) or even by 
procedure or data interpretation used for a particular method (Roos 1997). Regardless of method, the 
change in features attributed to the glass transition indicate the point or region where -relaxation 
processes are arrested when cooling a liquid/rubber into a glass (Gangasharan and Murthy 1995). The 
transition is not a true glass-transition as defined for polymers; however, the language used to describe 
the transition noted in sugars is borrowed from literature concerned with polymers. In reality, the glass 
transition of sugars is related to mobility and does not describe a thermodynamic event.   
For carbohydrates, -relaxation involves both structural and dielectric changes. The dielectric changes 
involve the rotation of dipoles resulting in polarization while structural changes arise from local spatial 
reorientations of chemical groups on the molecule (Gangasharan and Murthy 1995). The dielectric and 
structural modes are coupled in carbohydrates, mainly due to the presence of hydroxyl (-OH) groups 
(Gangasharan and Murthy 1995).  The hydroxyl groups are polarizable and also constrain structural 
rearrangements through the need to form hydrogen bonds. Every rearrangement that occurs during -
relaxation requires a hydrogen bond to be broken and then subsequently remade.  The glass transition 
temperature then marks the point when cooling a rubber/liquid at which there is not enough random 
kinetic energy present for the necessary vibrations, reorientations and hydrogen bond shuffling resulting 
in the cessation of -relaxation (Meste, Champion et al. 2002). As the molecule size increases, large 
intermolecular and intramolecular cooperation is needed to make and break hydrogen bonds 
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(Gangasharan and Murthy 1995).  As a result, glass transition temperatures are generally higher in 
trisaccharides as compared to disaccharides and higher in disaccharides as compared to 
monosaccharides. Segmental rotation also occurs during -relaxation. For carbohydrates, ring-chain and 
chair-boat transformations increase the number of modes of relaxation (Gangasharan and Murthy 
1995). Such modes generally require more energy and thus monosaccharides tend to have higher glass 
transition temperatures than sugar alcohols that exist solely in chain conformations due to the lack of a 
carbonyl moiety. 
Often in biological or pharmaceutical contexts, water is present in the system. Water acts as a plasticizer 
and effectively lowers the glass transition temperature. The glass transition temperature for a binary 
mixture is often represented by the Gordon-Taylor expression, given by Equation 2.1 (Meste, Champion 
et al. 2002): 
   
              
      
 
      (Equation 2.1) 
Where      and      represent the pure component glass transition temperature of components 1 and 2, 
   and    represent the weight fractions of components 1 and 2 and   is the Gorbon-Taylor constant 
for the mixture of interest. 
A specific temperature may be reached during cooling of carbohydrate-water mixtures, known as the 
maximally freeze-concentrated glass transition temperature (Tg’), where a glass transition of the solute 
occurs. The solute compound is the carbohydrate excipient and the solvent is water. The result is an 
amorphous solid composed of the carbohydrate and water, where the carbohydrate is at the maximal 
freeze concentration (Cg’) (Roos 1997).  The glass transition temperature of the anhydrous solute is used 
for Tg,1 and the glass transition temperature of water (-135°C) is used for Tg,2 (Roos 1993). By 
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rearrangement of Equation 2.1, the solute concentration (weight fraction) of the maximally freeze 
concentrated matrix (Cg’) can be solved for, as shown in Equation 2.2. 
  
  
 (          
 )
(  
           (          
 ))
 
    (Equation 2.2) 
If the solution is not at the proper or maximal concentration, glass formation occurs sub-Tg’ (Meste, 
Champion et al. 2002). The glass transition of the anhydrous carbohydrate (Tg), the glass transition 
temperature of the maximally freeze-concentrated solute (Tg’) and the maximal freeze concentration 
(Cg’) are all parameters of interest when developing lyophilized protein formulations. 
During lyophilization, a concentrated amorphous glass is produced during the freezing step and a mostly 
water free glass is produced during the drying steps (Costantino and Pikal 2004). Initially, as a solution 
with excipients is cooled, a concentrated supercooled liquid or rubbery state is formed. The melting 
point of ice occurs first and represents the point where ice begins to form in the concentrated rubbery 
phase (Roos 1997). Upon further cooling, the concentrated rubbery phase transitions into a 
concentrated glass phase, marked by the glass transition temperature of the maximally concentrated 
solute (Roos 1997). The ice is removed via sublimation as a vacuum is applied to the system (Costantino 
and Pikal 2004). The amount of water remaining in the maximally freeze-concentrated glass matrix can 
be estimated by Equation 2.2 (Roos 1993; Costantino and Pikal 2004). The lyophilized product 
temperature is then raised and residual water in the maximally freeze-concentrated glass matrix is 
removed during the drying steps.  The phase transitions that occur in a lyophilized formulation are 
summarized in Figure 2.6. 
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Figure 2.6 The phase transitions that occur during the lyophilization process Figure adapted from 
(Roughton, Topp et al. 2012).  
 
Roos suggested that the increase of transition temperatures could be “used in product development to 
improve freeze-drying behavior and stability of dehydrated materials” (1997). A lyophilized product 
must reach a temperature below both the glass transition temperature of the maximally concentrated 
solute and the melting point of ice to ensure minimal water content and glass formation, restricting 
protein mobility. By restricting mobility, the protein’s potential to aggregate is reduced.  An appreciable 
temperature difference between the glass transition temperature of the maximally concentrated solute 
and the melting point of ice is also desired, as the freeze-concentrated solution is annealed between 
these temperatures to ensure maximal solute concentration and minimal water content (Roos 1997). 
The glass transition temperature of the anhydrous solute is important for long-term storage stability as 
well, as lyophilized formulations are usually stored at temperatures at least 50°C below their glass 
transition temperature (Costantino and Pikal 2004). The literature has shown glass transitions to be 
dependent on chemical structure (Slade and Levine 1995), providing motivation for structure-property 
model development. An ideal excipient will form a freeze-concentrate with minimal water content and 
will remain a glass during drying and storage, restricting protein mobility and reducing the potential for 
aggregation.  
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2.6 PROTEIN-EXCIPIENT INTERACTIONS IN THE DRIED STATE 
As water is the key factor in the structure that proteins adopt, dehydration or removal of water is 
predicted to have a large effect on protein structure (Kuntz Jr and Kauzmann 1974). Using a poly-L-lysine 
model, dehydration has been shown to result in loss of hydrogen bonds that are present in solution 
(Prestrelski, Tedeschi et al. 1993). To compensate for the loss of hydrogen bonds, intermolecular 
hydrogen bonds are formed and a -sheet conformation is adopted over the native random coil 
conformation (Prestrelski, Tedeschi et al. 1993). A possible approach to stabilization in the dried state is 
to prevent protein conformational adjustments due to the removal of water. The water replacement 
hypothesis attributes protein stabilization to the replacement of protein-water interactions in aqueous 
solution with protein-excipient interactions in the dried state following lyophilization. 
Addition of so-called stabilizer excipients achieves partial or full preservation of protein native structure. 
In particular, carbohydrate excipients have shown success when used as stabilizers. It has been 
proposed that stabilization arises from a direct effect of the excipient on protein conformation 
(Prestrelski, Tedeschi et al. 1993; Manning, Chou et al. 2010). Infrared spectra results have suggested 
that carbohydrates hydrogen bond with proteins in the dried state and may be a requirement for the 
preservation of lyophilized/dried proteins by carbohydrates (Carpenter and Crowe 1989; Prestrelski, 
Tedeschi et al. 1993). The water-replacement hypothesis postulates that hydrogen bonds form between 
the hydroxyl groups of carbohydrates (see Figure 2.7) and the protein backbone, mimicking the 
hydrogen bonding that occurs between water and the protein backbone. Recent hydrogen-deuterium 
exchange mass spectroscopy experiments support the water-replacement hypothesis, with the results 
showing that certain excipients can reduce deuterium exchange in a site-specific manner (Li, Williams et 
al. 2007; Li, Williams et al. 2008). Reduction of deuterium exchange indicates that the protein backbone 
is protected by the inclusion of stabilizing excipients. Such protection could arise from hydrogen bonding 
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between the protein backbone and excipients. Hydrogen bonding is attributed to reduced deuterium 
exchange (Tsutsui and Wintrode 2007).  
 
Figure 2.7 Hydroxyl groups on sucrose Groups are circled. Hydroxyl groups form hydrogen bonds with 
the protein backbone in dried proteins. Such interaction may have a stabilizing effect on protein 
conformation.  
 
An alternative to the water replacement hypothesis has been proposed recently. Known as the water 
entrapment hypothesis, the hypothesis proposes that water molecules are entrapped between the 
protein surface and sugar matrix in lyophilized solids (Hackel, Zinkevich et al. 2012). Thus the water 
needed to maintain the protein conformation is still available to the protein, with stabilizing excipients 
aiding in the maintenance of the water layer.  Evidence from nuclear magnetic resonance spectroscopy 
(NMR) and molecular dynamics (MD) simulations indicate that there is the formation of sugar-water-
protein structures, indicating that water is maintaining the protein conformation and that the sugar is 
maintaining the hydration layer of the protein (Cottone, Ciccotti et al. 2002; Hackel, Zinkevich et al. 
2012). A combination of both the water replacement hypothesis and the water entrapment hypothesis 
is likely as dehydration can prevent the formation of a fully hydrated layer and NMR and MD results 
both indicate that contacts between the protein surface and sugar matrix are formed (Cottone, Ciccotti 
et al. 2002; Hackel, Zinkevich et al. 2012). While water may still play a role in preservation of native 
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protein structure in the dried state, stabilizers clearly play a role in maintaining protein conformation 
including the formation of some direct protein-excipient interactions.  
IONIC LIQUID SOLVENT DESIGN 
2.7 USE OF SEPARATION MEDIA FOR AZEOTROPIC DISTILLATION AND IN SITU FERMENTATION 
Solvents represent chemicals that are used to solubilize molecules of interest and may or may not be 
present in the final chemical product. Of particular concern here is the use of solvents as mass 
separating agents (MSA). An MSA is a chemical that aids in the separation of two or more compounds of 
interest to high levels of purity. In general, an MSA is not a component of the final chemical product and 
is removed and recycled following separation. Two applications for separation media are azeotropic 
distillation and in situ fermentation. 
Numerous binary azeotropes are encountered in chemical systems (Gmehling 1994). An azeotrope is 
defined as a mixture where the liquid composition is equal to the vapor composition, resulting in a lack 
of driving force for further separation to pure or mostly pure compositions. Separation of azeotropic 
mixtures affects many industrial sectors due to the prevalence of such mixtures, yet separation remains 
a challenging task. Azeotropes may be encountered in the solvent recovery stage following the 
downstream separation of pharmaceutical and/or biochemical processes (Barton 2000; Simoni, 
Chapeaux et al. 2010). Separation of azeotropic mixtures also contributes to many of the separation 
tasks in the petrochemical and chemical industries (Trotta and Miracca 1997). An entrainer can 
selectively interact with one of the components in an azeotrope, allowing the azeotrope to be broken 
and the components separated. An basic process diagram for azeotropic distillation is presented in 
Figure 2.8. A common concern with the design and operation of separation processes is the selection of 
the entrainer. 
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Figure 2.8 Block flow diagram of azeotropic distillation process HC refers to the heavy component, LC 
refers to the light component and E refers to the entrainer.  
 
Industrial processes can utilize fermentation, where microorganisms convert sugars to other chemicals, 
to produce chemicals of interest. A major concern in fermentation processes is separation of product 
from the fermentation broth as downstream separation often requires a high energy input. Additionally, 
product yield is often low in fermentation due to product inhibition. In situ product recovery during 
fermentation offers a means to improve fermentation processes by reducing product inhibition and 
enabling more efficient separations (Gangu, Weatherley et al. 2009). Three main in situ product 
recovery processes exist: volatility-based methods, membrane-based methods and solvent-based 
methods (Huang, Ramaswamy et al. 2008). Solvent-based methods provide a pathway to tunable 
separations based on solvent selection. Major considerations when selecting a solvent include toxicity 
towards fermentation microorganism, immiscibility with water and increased solubility of solute 
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(product) in solvent compared to water (Huang, Ramaswamy et al. 2008; Gangu, Weatherley et al. 
2009). Figure 2.9 presents the basic process diagram for in situ extractive fermentation. 
 
Figure 2.9 Block flow diagram of in situ extractive fermentation P refers to the desired product, B 
refers to the fermentation broth and S refers to the solvent used for extraction.  
 
Increasingly, the environmental impact of solvent selection must be minimized (Kerton 2009). 
Additionally, material and energy inputs need to be minimized to improve process economics. Ionic 
liquids represent a class of molecules that possess many desirable solvent properties and are 
increasingly being considered for industrial applications. For separation processes, an optimal ionic 
liquid solvent can be designed to reduce material and energy inputs and ensure feasible separation or 
extraction.  
2.8 IONIC LIQUIDS AS SEPARATION MEDIA 
Ionic liquids (ILs) have become increasingly attractive options in solvent selection, especially for 
separations. Ionic liquids are defined as salts with melting points below 100°C (Marsh, Boxall et al. 
2004). Due to negligible vapor pressure, environmental concerns are reduced in comparison to many 
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conventional solvents (Marsh, Boxall et al. 2004). Ionic liquids can be recycled in separation processes, 
reducing the material demands and improving the economics (Zhao, Xia et al. 2005). As a class of 
chemicals, ionic liquids are soluble with a wide range of organic compounds (Marsh, Boxall et al. 2004). 
Ionic liquids can be composed of many different cation and anion combinations, resulting in different 
thermophysical properties (Zhao, Xia et al. 2005). The properties of an ionic liquid can be tuned for use 
in a particular application by rational design or selection of the cation, anion, and cation alkyl chain 
length. An example of a commonly studied ionic liquid is shown in Figure 2.10. 
 
 
Figure 2.10 The ionic liquid 1,3-dimethylimidazolium dimethylphosphate (MMIm DMP)  
 
Ionic liquids are promising candidates for entrainers due to their adjustable properties and negligible 
vapor pressure. Extractive distillation processes using ionic liquids as entrainers have be proposed and 
designed for common binary azeotropes, showing reduced energy requirements when compared to 
processes using conventional entrainers (Seiler, Jork et al. 2004). Energy requirements may further be 
reduced through correct selection or design of the ionic liquid entrainer.  
Ionic liquids are a class of molecules that have been shown to exhibit immiscibility with water and high 
organic solute solubility, providing viable candidates for solvents used for in situ fermentation and 
product recovery processes (Gangu, Weatherley et al. 2009). Additionally, toxicity towards the 
fermentation organism can be adjusted through cation and anion selection (Matsumoto, Mochiduki et 
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al. 2004; Gangu, Weatherley et al. 2009). Thus the design of an ionic liquid for in situ fermentation 
processes offers several, often competing, targets for required solvent properties. 
FORWARD PROBLEM 
2.9 DESCRIPTORS USED IN STRUCTURE-PROPERTY MODELS 
The impetus for CAMD is the need for a chemical or formulation to fulfill certain characteristics. Ideally, 
product characteristics can be directly linked to chemical properties. Upon identification of key 
properties, property models are required for the design of molecules matching target properties. 
Properties are linked to molecular structure through molecular descriptors by the generation of 
structure-property models in the forward problem of CAMD. 
The representation of molecule via molecular descriptors that capture relevant information is a key step 
in the forward problem. Many different molecular descriptors have been considered for CAMD:  group 
contribution (GC) methods, graph theoretical approaches (including connectivity indices), three-
dimensional descriptors and other so-called “DRAGON” descriptors (Consonni and Todeschini 2000). In 
addition to the descriptor class chosen, the functional form of the structure-property model must also 
be determined. More treatment to model development is given in Section 2.10.  
Group contribution models have often been used for CAMD methods as they are considered to be 
simple, accurate and predictive (Harper, Gani et al. 1999). However, while GC models are commonly 
applied to solvents, reliability can be a concern for classes of molecules that are inherently larger in size 
(Harper, Gani et al. 1999). For example, carbohydrates can be an order of magnitude larger in molecular 
weight than common organic solvents. Additionally, the types of properties that can be predicted by GC 
methods has commonly been limited to thermophysical properties (Harper, Gani et al. 1999). Properties 
that are dependent on three-dimensional molecular structure are not amenable to GC methods. 
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Graph theoretical methods, especially connectivity indices, have been used in quantitative structure-
property relationship (QSPR) models for a variety of systems including polymers (Camarda and Maranas 
1999; Bicerano 2002) and pharmaceutical compounds (Kier, Hall et al. 1975). In graph theoretical 
methods, a molecular structure is interpreted as a graph where atoms are represented by vertices and 
bonds are represented by edges. Therefore, graph-based approaches capture the two-dimensional 
topology of a molecular structure. Apart from bonding configuration, some graph-based descriptors 
(including valence connectivity indices) capture information pertaining to the electronic configuration of 
a molecule. Descriptors derived from graph theoretical approaches can be calculated with low 
computational effort. In general, graph-based descriptors do not capture three-dimensional or 
conformational information. 
Three-dimensional based descriptors have received increase attention in the development of 3-D 
quantitative structure-activity relationships (QSAR) for prediction of interaction energies for a variety of 
biologically relevant systems (Cheng, Shen et al. 2002). Additionally, use of 3-D QSAR models coupled 
with molecular simulation has proven fruitful in guiding computer-aided drug design efforts (Cheng, 
Shen et al. 2002). A variety of 3-D descriptors can be calculated through use of computational packages 
such as DRAGON (Consonni and Todeschini 2000). The advantage of 3-D descriptors is increased 
information about molecular structure which can help discriminate between stereoisomers. However, 3-
D QSARs are usually limited to very defined molecular spaces and requires large computational effort for 
calculation of necessary descriptors (Golbraikh, Bonchev et al. 2001).  Incorporation of chirality 
information in graph-based topological descriptors has been proposed as a bridge between the efficient 
of graph theoretical methods and the detailed structural information provided by 3-D descriptors 
(Golbraikh, Bonchev et al. 2001). 
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2.10 PROPERTY MODEL DEVELOPMENT 
Development of property models requires a function form. The most basic function form is a linear 
model, which can be determined through use of linear regression. Linear regression (or multiple linear 
regression for multiple dependent variables) essentially utilizes optimization to provide a model with 
maximum fit to the provided data. Equation 2.3 gives the general multiple linear regression model form 
(Wasserman 2004).  
     
(Equation 2.3) 
Where Y is an array of independent, or response, variable values, X is a matrix of dependent variable 
values and  is an array of coefficient values. To maximize fit, coefficients for all dependent variables are 
varied to achieve minimization of the residual sum of the squares (RSS). Equation 2.4 is used to calculate 
RSS (Wasserman 2004). 
    ∑( ̂    )
 
 
   
 
(Equation 2.4) 
Where  ̂  is the predicted value for observation i,    is the observed value for observation i and n is the 
number of observations. Determination of the coefficient values is achieved through matrix inversion of 
Equation 2.3, as given by Equation 2.5 (Wasserman 2004). 
  (   )      
 (Equation 2.5) 
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For functional forms utilizing non-linear model forms, the determination of coefficient values is still 
determined through optimization by minimizing either RSS or another suitable indicate of fit. 
While model development, especially for linear models, is relatively straightforward, the selection of 
descriptors used in the model remains a subject of interest and debate. Model selection aims to choose 
descriptors that maximize fit and minimize variance and prediction errors due to overfitting (Wasserman 
2004). Model selection requires a score to be assigned to each model and also requires a method of 
searching for models with the best score (Wasserman 2004). 
Several methods exist for scoring a model. In nearly all cases, the score is based on the lack of fit provide 
by the model and the number of descriptors used to generate the model. As fit will increase (albeit 
usually at a decreasing rate) with the addition of more descriptors, a trade-off between underfitting and 
overfitting is sought. Several common methods for scoring models include Mallow’s Cp statistic, Akaike 
Information Criterion (AIC) and Bayesian Information Criterion (BIC) (Wasserman 2004). Each method 
utilizes slightly different penalties for lack of fit and number of descriptors. For all cases, the model with 
the minimal score is selected. Cross-validation and sensitivity analysis also provide methods of scoring 
and selecting models on the basis of predictive ability and can provide further justification for the 
selection of a model. 
To select a model, a search must be performed for the model with the minimal score. Three methods 
are used to search for models: exhaustive search, forward search and backward search (Wasserman 
2004). Exhaustive search looks at all possible model combinations (number and type of descriptors). 
Therefore, exhaustive search is guaranteed to return the model with the optimal score. For models with 
large data sets and/or descriptor sets, exhaustive search may be too computationally expensive. In such 
cases, forward search or backward search are useful. In forward search, a null model provides the 
starting point. Descriptors are added one by one, selecting the descriptor that provides the lowest score 
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at each step. Once a model size is encountered that cannot provide an improvement in score compared 
to the previous model size, the search is ended and the best model from the previous size is selected. 
Backward search operates in a similar manner with the difference being the initial model is generated 
using all available descriptors. Descriptors are then removed one by one until no further improvement 
can be gained. Backward search is not possible when the number of considered descriptors exceeds the 
number of observations used to develop the model. 
2.11 THERMODYNAMIC PROPERTY MODELING AND PREDICTION 
Thermodynamic property models seek to represent phase equilibria through mathematical means. The 
determination of phase equilibria is paramount in the design of separation processes. Accordingly, 
accurate and predictive models are needed for reliable separation process design. In essence, all phase 
equilibria problems seek to find the solution to Equation 2.6 (Prausnitz, Lichtenthaler et al. 1999). 
  
    
 
 
(Equation 2.6) 
Where  is the chemical potential of species i and and  represent the two phases considered. For the 
work presented here, fluid phases are the phases of interest. For fluid phases, Equation 2.6 can be 
represented in a more useful form for species i, as provided by Equation 2.7 (Prausnitz, Lichtenthaler et 
al. 1999). 
            
  
(Equation 2.7) 
Where    is the fugacity coefficient,    is vapor mole fraction,   is system pressure,    is activity 
coefficient,    is liquid mole fraction and   
  is the fugacity at standard conditions. Of interest to the 
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work here is the determination of the activity coefficient, as provided by activity coefficient models. 
Activity coefficient models provide estimation or prediction of the activity coefficient as a function of 
temperature, pressure and compositon. A variety of activity coefficient models exist with the most 
commonly utilized including Wilson, NRTL and UNIQUAC (Prausnitz, Lichtenthaler et al. 1999). Every 
activity coefficient model is developed with certain assumptions, which can limit applicability. Of 
particular interest for CAMD approaches is the UNIFAC model, a predictive group-contribution based 
extension of UNIQUAC (Fredenslund, Gmehling et al. 1977). The UNIFAC model is given further 
treatment in Section 4.5. 
REVERSE PROBLEM 
2.12 COMPUTER-AIDED MOLECULAR DESIGN (CAMD) OVERVIEW AND PROBLEM FORMULATION 
The reverse problem in CAMD entails the actual design phase, where either known molecular structures 
are selected from a database or novel molecular structures are proposed. In the reverse problem, target 
properties values are set and molecular structures are generated which best match the target 
properties. Property constraints may be employed to guide candidate selection, either during design as 
rigid constraints or after design as screening criteria. The intermediary between structure and property 
are the molecular descriptors used in the property models. As candidates are determined, molecular 
descriptors must be calculated and used in property models to evaluate the suitability of the candidate. 
Thus, a potential limiting factor in CAMD is that molecules can only be designed which are enclosed by 
the chosen descriptor class.  
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Three steps comprise the CAMD procedure (Harper and Gani 2000): 
1. Pre-design step – problem formulation 
2. Design step – model development and solution of problem leading to compound identification 
3. Post-design step – results analysis and screening  
 
Figure 2.11 A general procedure for the solution of the CAMD reverse problem Interplay between the 
main steps of the CAMD methodology is highlighted. Figure adapted from (Gani 2004).  
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The general procedure used for the reverse problem solution and the interplay between the steps of the 
CAMD procedure are illustrated in Figure 2.11. The design step is the dominant step, influencing the 
problem formulation as well as the options for post-design analysis. The methodology concerning the 
actual design step is outlined in Figure 1.1 (see 1.0 Introduction).  
The main concerns with CAMD approaches during the design step are as follows (Gani 2004): 
 How will new molecular structures be generated? 
 How will the molecular structure be represented? 
 What level of structural information is required? 
 How are target properties obtained? 
The problem formulation, solution method used in design and the availability of post-design screening 
methods are impacted by the answers given for the above questions. A general problem formulation is 
given by Equation 2.8 (Camarda and Sunderesan 2005). 
     ∑
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(Equation 2.8) 
Where z is the objective function, which consists of the sum of the absolute differences between 
solution properties (Pm) and target properties (Pm
target) for the set of properties M. Each difference can 
be scaled (via Pm
scale) to place more or less emphasis on the target property, as determined by the 
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molecular properties with the highest priorities. The properties are functions of the molecular structure 
(y), where the structure is provided by the chemical groups (wi) and the adjacency matrix (aijk) of the 
groups. Structural constraints (hc) are employed to ensure solutions are feasible. Molecular structure 
representation may vary according to implementation of CAMD. Additionally, some property models 
may be used as constraints rather than targets. Property models and/or constraints often introduce 
non-linearities, resulting in a mixed-integer non-linear program (MINLP). 
Historically, three main approaches have been used for the solution of CAMD problems (Harper, Gani et 
al. 1999; Eljack and Eden 2008): 
 Enumeration techniques/database search 
 Deterministic optimization/mathematical programming 
 Stochastic optimization/iterative search 
Each approach has seen success in certain applications of CAMD. The approach chosen should be taken 
with consideration towards the advantages and disadvantages of each approach. The three approaches 
are given further attention in the following sections (2.13-2.15). A subset of CAMD involves 
simultaneous product and process design and is detailed in section 2.16. Post-design methods are 
examined in section 2.17. 
2.13 ENUMERATION SOLUTION METHODS 
The first CAMD methods employed relied on enumeration of possible solutions followed by selection of 
molecules that best matched a set of target property values (Gani and Brignole 1983). Enumeration 
solution methods have historically used group contribution property models. The approach of 
enumeration methods is to determine the number and types of functional groups that best satisfy a set 
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of target properties. Given the functional groups determined, molecular structures are identified that 
are comprised of all the functional groups selected.  
A general procedure for CAMD by enumeration follows (Gani, Nielsen et al. 1991): 
1. Preselect the types of groups that will be used to provide solutions. Additionally, the properties 
of interest with set target values must be identified. Rules for the formation of feasible 
compounds from the groups selected must be established. 
2. All chemically feasible molecules are generated. 
3. Solution reduction is performed by property screening. Properties are predicted for the set of 
chemically feasible molecules. Molecules that match the target properties are retained while all 
other solutions are discarded. 
4. Post-design methods such as process simulation are utilized to rank remaining solutions on basis 
of performance index. Screening of secondary properties may also be used to reduce the 
amount of solutions considered. 
Vital to the use of enumeration solution methods is the ability to generate all feasible chemical 
structures. For design cases with large numbers of possible solutions, the generation of all possible 
solutions may prove computationally restrictive. However, for small cases the enumeration approach 
can identify optimal solution. Incorporation of multi-level molecular representation (e.g., higher order 
group contribution methods) provides opportunities for more rigorous property prediction (Harper and 
Gani 2000). 
2.14 DETERMINISTIC SOLUTION METHODS 
Deterministic methods seek to find a global optimum to a mixed-integer linear program (MILP) or 
mixed-integer non-linear program (MINLP) through derivative-based solutions. Use of deterministic 
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methods requires mathematical constraints to effectively limit the search space.  Solution of a MILP is 
almost always performed by branch and bound methods (Edgar, Himmelblau et al. 2001). Often a MINLP 
results from problem formulation. When a MINLP results, the determination of a global optimum is not 
guaranteed. By far, the most commonly used method to solve MINLPs in CAMD utilizes the optimization 
solver DICOPT (http://www.gams.com/dd/docs/solvers/dicopt.pdf), which is available in the 
optimization software GAMS (http://www.gams.com/). 
DICOPT solves MINLPs through the use of outer approximation, which is an iterative process that solves 
two sub-problems each iteration (Duran and Grossmann 1986; Floudas 1995). The first sub-problem is 
the solution of a non-linear program (NLP), which is formed by fixing the integer values of the original 
MINLP problem. Optimization is then performed over the continuous variables, with the provided 
solution being a lower bound to the original MINLP problem (Edgar, Himmelblau et al. 2001). The next 
sub-problem is the solution of a MILP. The continuous variable portion of the objective function is 
replaced with a constant. The constant is constrained to maintain equivalence to the original MINLP 
formulation. Solution of the MILP sub-problem optimizes over both the integer and continuous 
variables, with the provided solution being an upper bound to the original MINLP problem (Edgar, 
Himmelblau et al. 2001). If the problem is convex, the upper and lower bounds will converge to the 
optimal solution for the original MINLP problem in a finite number of iterations (Duran and Grossmann 
1986; Floudas 1995). In addition to outer approximation, other approaches have also been considered 
for solution of MINLPs in CAMD problems, but are not given further treatment here (Sahinidis and 
Tawarmalani 2000; Karunanithi, Achenie et al. 2006). 
2.15 STOCHASTIC SOLUTION METHODS 
Stochastic methods employ iterative processes to determine locally optimal solutions. Depending on the 
method, different rules or moves are used to proceed from one solution to another. Stochastic methods 
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do not require derivatives for solution and are not guaranteed to return the global optimum. Two 
stochastic approaches have featured prominently in CAMD: genetic algorithms and tabu search. They 
are summarized in Table 2.3. In addition to genetic algorithms and tabu search, simulated annealing has 
also been used to solve CAMD problem (Ourique and Silva Telles 1998). 
Table 2.3 Overview of stochastic approaches commonly used in CAMD 
Method Characteristics Advantages Disadvantages 
Genetic 
Algorithm 
(GA) 
Mimics evolution by 
improving a population of 
solutions incrementally over 
several generations 
 Many solutions 
evaluated at 
each generation 
 
 Random moves 
can help to 
escape local 
minima 
 No guarantee that 
moves will be 
significant enough to 
escape local minima 
 
 Storage of many 
current solutions 
may be memory 
intensive 
Tabu 
Search 
Use of previous solutions 
stored in a tabu list to guide 
search for new solutions  
 Random moves 
can help to 
escape local 
minima 
 
 History of 
previous 
solutions further 
helps avoid local 
minima traps 
 May disregard good 
solutions as tabu 
 
 Storage of past 
solutions may be 
memory intensive 
 
Genetic algorithms are search methods that simulate natural progression through evolution (Holland 
1975). Given an initial set of solutions, or seed population, adaptive and reproductive strategies are used 
to advance the solutions (Holland 1975). The classical genetic algorithm is not well suited for 
combinatorial solution spaces, leading to the development of special data structures on an application 
by application basis (B c  199 ). One such application is CAMD, where molecular groups are 
represented by genes, a molecule represents a chromosome and a set of molecules represents the 
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population  (Venkatasubramanian, Chan et al. 1994). Moves mimicking adaptation and reproduction are 
used to alter the population in each iteration or generation. Moves mimicking adaption can be thought 
of as local moves, while reproductive-inspired moves are global moves. The suitability of solutions is 
determined by their fitness, which in turn determines the likelihood of a solution to become a parent 
(Venkatasubramanian, Chan et al. 1994). Parents are used to generate the population for the next 
generation. The search continues until a predetermined number of generations is reached. The search is 
then terminated, returning the solution with the highest fitness.  
Tabu search is a heuristic approach which guides a local search through use of previous solution history 
(Glover 1989; Lin, Chavali et al. 2005). Tabu search relies on recently visited solutions, which are stored 
in a tabu list. Local moves are made to change a previous solution to a new solution. If a new solution is 
too similar to a solution stored in the tabu list, it is deemed tabu and discarded (Glover 1989; Lin, 
Chavali et al. 2005). Similarity is determined by the tabu criterion. In this manner, the search for 
solutions is a constrained search (Glover 1989). The search space is more effectively scanned and local 
minima can be escaped to search for better solutions. If a tabu solution is the best solution yet 
encountered, the tabu criterion can be overridden via aspiration (Glover 1989). After a predetermined 
number of non-improving iterations, the search is terminated and the best solution is returned (Glover 
1989). 
2.16 INTEGRATED PRODUCT-PROCESS DESIGN 
Product and process design employ similar solution methods and are both utilized to improve chemical 
production processes. Consequently the simultaneous design of both product and process has been 
pursued for various applications, especially for separation design (Eden, Jørgensen et al. 2004; 
Roughton, Christian et al. 2012). For separation design, the designed product is often a solvent for use in 
achieving the desired separation. The desired process performance is used to determine molecule 
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property targets and constraints. The properties are in turn used to determine optimal chemical 
structures. In effect, integrated process design involves solving two reverse problems (see Figure 2.12). 
The final solution contains the design variables for the process as well as the molecules that satisfy the 
necessary property targets. By coupling molecular design with process design, process performance can 
be expected to improve as optimal solvents are identified and used in the necessary separations. 
 
 
Figure 2.12 Overview of integrated product and process design Each design process generates 
parameters that are used to constrain the other design problem. Adapted from (Eden, Jørgensen et al. 
2004).  
 
2.17 POST-DESIGN METHODS 
Post-design methods are used in CAMD to further screen the candidates generated in the design phase. 
The simplest post-design method is the use of secondary properties to screen the candidates. Such 
properties may require higher-dimensional  structural information than is utilized during the design 
phase due to computational limitations (Harper and Gani 2000). A more detailed analysis of candidates 
is provided by the use of molecular modeling. A three-dimensional model is generated for a given 
candidate through the use of energy minimization. The end result is a 3-D molecular structure that can 
be used to obtain values for properties that require 3-D structural information (Harper, Gani et al. 1999). 
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An common example is toxicity towards various organisms, which is often predicted via a 3-D QSAR 
(Akamatsu 2002). Experimental verification is needed for final candidate selection and is beginning to be 
implemented in CAMD frameworks (Conte, Gani et al. 2011; Conte, Gani et al. 2012). 
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3.0 EXPERIMENTAL METHODS 
The following chapter describes in detail the experimental plan used in the work as well as all relevant 
experimental methods that were used to generate data for the forward problem. Methods that were 
performed by the author include the experimental procedure used for generation of the data. The 
theory behind hydrogen-deuterium exchange mass spectroscopy is detailed as experimental data 
obtained from the method is used in conjunction with simulations to investigate protein-excipient 
interactions (See Section 7.0). Refer to the references cited for detailed information concerning the 
experimental setup and procedure. 
3.1 EXPERIMENTAL OVERVIEW 
The experiments done by the author were performed to evaluate the effect of excipient selection on 
aggregation following lyophilization. The following methods were performed by the author and all data 
pertaining to the methods were generated by the author for the data set used to generate models 
describing post-lyophilization protein loss as a function of excipient structure: ultraviolet-visible light 
spectrophotometry, size-exclusion chromatography, sodium-dodecyl-sulfate polyacrylamide gel 
electrophoresis and powder x-ray diffraction. Figure 3.1 displays the overall experimental approach. 
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Figure 3.1 Overview of experimental procedure used by author The aim of the experiments was to 
characterize aggregation following lyophilization for several different excipient and protein choices.  
 
Additional experimental results were obtained from literature for use in modeling building for the 
forward problem. The corresponding references contain information concerning the experimental setup 
and procedure. Material procurement, sample preparation and lyophilization for the experiments done 
by the author follow. 
3.1.1 Materials 
The following proteins were considered in the study: -amylase, bovine serum albumin (BSA), 
ovalbumin, ribonuclease A (RNAse A) and soybean trypsin inhibitor. All proteins were acquired from 
Sigma-Aldrich (St. Louis, MO) except trypsin inhibitor, which was obtained from Worthington 
Biochemical Corporation (Lakewood, NJ). Table 3.1 lists key biophysical properties for each protein. 
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Table 3.1 Biophysical descriptors for the proteins considered 
Protein 
PDB 
code 
MW 
(kDa) 
pI 
ASAa 
(Å2) 
fASA
b 
% α 
helix 
% β 
sheet 
# SS 
bonds 
# free 
thiols 
Tm 
(°C) 
Ovalbumin 1ova 44.3 5.19 34237 0.63 30.8 31.3 1 4 76c 
RNase A 5rsa 16.5 8.93 4052 0.60 21 33 4 0 62.5d 
α-amylase 1bli 58 6.33 10480 0.60 26.2 25.6 0 0 102e 
BSA 3v03 66 5.82 35921 0.68 67 0 17 1 59f 
Trypsin 
inhibitor 
1avu 20.1 4.95 4986 0.60 1.4 97.2 2 0 65g 
a – ASA=apolar surface area 
b – fASA = apolar surface area / total surface area 
Melting temperature (Tm) values were obtained from literature: c (Tani, Shirai et al. 1997), d (TAKAHASHI, IRIE et al. 1969),         
e (Duy and Fitter 2005), f (Arakawa and Kita 2000), g (Roychaudhuri, Sarath et al. 2003) 
 
A broad range of readily available molecules for use as excipients were considered, which can be broken 
into the two main classes of amino acids and carbohydrates. The following amino acids and amino acid 
derivatives were considered: N-acetylglycine, N-ethylglycine, glycine-alanine (glu-ala), glycine-glycine 
(gly-gly), glycine-leucine (gly-leu) and glycine-serine (gly-ser). The following carbohydrates and 
carbohydrate derivatives were considered: mannitol, sorbitol, maltitol, glucose, mannose, fructose, 
psicose, 2-deoxyglucose, 2-deoxyribose, xylose, rhamnose, -methylglucopyranoside, trehalose, 
maltose, palatinose, melibiose, raffinose, N-methylglucamine, N-acetylglucosamine and N-
acetylneuraminic acid. All chemicals were acquired from Sigma-Aldrich. While all of the molecules used 
may not have suitable properties for protein formulation, the entire set provides a broad sampling of 
molecular structures which is desirable for model development purposes. 
3.1.2 Sample Preparation 
Protein solutions were prepared by dissolving protein in 20 mM potassium phosphate pH 7.4 buffer to a 
concentration of 2 mg/mL. The protein solution was then dialyzed using Biotech cellulose ester dialysis 
tubing (MWCO 8,000-10,000 Da, Spectrum Laboratories, Rancho Dominguez, CA) against a 20 mM 
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potassium phosphate pH 7.4 buffer at 4°C. Following dialysis, the protein solutions were passed through 
a 20 m syringe filter (Gelman Nylon Acrodisc 13, Sigma-Aldrich). Dialyzed and filtered solutions were 
stored at 4°C for use within 24 hours. 
In a similar manner, excipient solutions were prepared by dissolving excipient in 20 mM potassium 
phosphate pH 7.4 buffer to a concentration of 2 mg/mL.  The excipient solutions were passed through a 
20 m syringe filter and stored at 4°C. 
Formulations were prepared for each protein-excipient pair by mixing equal volumes of protein solution 
and excipient solution to yield a solution with 1 mg/mL protein and 1 mg/mL excipient (1:1 excipient to 
protein weight ratio). Immediately following preparation of a formulation, 400 L of the solution was 
added to a lyophilization vial (Worthington Biochemical Corporation). Vials were prepared in triplicate 
for each protein-excipient pair. After the solution was transferred to the vial, the samples were 
immediately lyophilized. Additional samples of non-lyophilized control solutions were prepared in 
triplicate for each protein-excipient pair using the same procedure. 
3.1.3 Lyophilization 
Each formulation (protein-excipient pair) was lyophilized in triplicate through use of a VirTis adVantage 
Plus lyophilizer (SP Industries, Inc., Gardiner, NY). The following lyophilization cycle was used for all 
samples: shelves were pre-cooled to -2°C (15 minutes), sample freezing at -40°C (50 minutes) was 
performed, primary drying under vacuum (70 mTorr) occurred at -35°C for 10 hours, -20°C for 8 hours,   
-5°C for 6 hours, with secondary drying (100 mTorr) at 10°C for 6 hours, 25°C for 6 hours and 4°C for 30 
minutes (Sophocleous, Zhang et al. 2012). After completion of the lyophilization cycle, samples were 
held at 4°C for no more than 2 hours before reconstitution and subsequent analysis. No attempt was 
made to optimize the lyophilization cycle based on the formulation properties, such as the glass 
transition temperature of the maximally freeze-concentrated solute (Tg’). 
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3.2 ULTRAVIOLET-VISIBLE LIGHT SPECTROPHOTOMETRY (UV-VIS) 
3.2.1 Theory 
UV-Vis is a technique that measures absorbance of light by a molecule at any given wavelength. The 
absorption of light is accompanied by a transition in the molecule from lower energy state to a higher 
energy state, via energy provided by the photon of light (Van Holde, Johnson et al. 2006). The transitions 
typically associated with ultraviolet and visible light absorption are electronic transitions of the valence 
shell electrons, where electrons are excited from an occupied or ground state orbital to an unoccupied 
or excited state orbital (Van Holde, Johnson et al. 2006). Absorption occurs if the energy of the photon 
at a particular wavelength is equal to the difference in energy between the ground state and the excited 
state. The energy absorbed from the photon is usually lost as heat. By comparing the emission of light 
through a sample and a control, differences observed are used to construct the absorption spectra of 
the sample. Chromophores are chemical groups that absorb light at particular wavelengths and thus 
have characteristic absorption spectra (Van Holde, Johnson et al. 2006). 
Proteins contain several chromophores: peptide bond, aromatic residues (phenylalanine, tryptophan 
and tyrosine), prosthetic groups and metal cations (see Figure 3.2). Absorbance due to the peptide bond 
is the strongest observed and occurs around a wavelength of 185-195 nm, depending on the protein’s 
secondary structure (Martin, Sinko et al. 2011). Absorbance from the range of 250-300 nm corresponds 
to absorbance by the aromatic residues in the protein. Prosthetic groups and metal cations may have 
absorbance at varying wavelengths according to the species of interest. Absorbance past 300 nm is 
associated with light scattering (Martin, Sinko et al. 2011). A typical UV-vis spectrum for a protein is 
shown in Figure 3.3. 
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Figure 3.2 Chromophores commonly present in proteins 
 
Absorbance (A) allows calculation of concentration of a species through Beer’s law (Equation 3.1): 
      
(Equation 3.1) 
where   is concentration,   is path length and  is the extinction coefficient. The value of  for proteins is 
estimated from the amino acid sequence (Martin, Sinko et al. 2011). In practice the pure absorbance is 
not usually measured but rather the optical density (O.D.), which is defined as the absorbance plus any 
other extinction processes such as light scattering. 
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Figure 3.3 Typical UV-Vis spectra for a protein The large peak is due to absorbance by the peptide bond. 
The smaller peak arises from absorbance by the aromatic amino acid residues (phenylalanine, 
tryptophan and tyrosine).  
 
Information about protein structure can be obtained through a derivative analysis of the UV-vis spectra, 
focusing on the absorbance due to the aromatic residues (Martin, Sinko et al. 2011). The calculation of 
aggregation index (AI) compares the O.D. values at two different wavelengths (i.e., 280 nm and 350 nm) 
to check for the presence of larger particles or aggregates (Equation 3.2). AI is affected by light 
scattering of particles and increases with larger aggregates (Katayama, Nayar et al. 2005).  
       
     
           
 
 (Equation 3.2) 
 
3.2.2 Experimental Procedure 
UV-visible spectra were obtained for all lyophilized and non-lyophilized samples using an Agilent 8453 
UV-Vis spectrophotometer. For each spectrum, 400 L of sample solution was added to a low volume 
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cuvette. Wavelengths were collected from 200-600 nm using an integration time of 10 seconds and an 
interval of 1 nm. The aggregation index (AI) was calculated for each sample given the optical density 
values at 280 and 350 nm (see Equation 3.2).   
 
3.3 SIZE-EXCLUSION CHROMATOGRAPHY (SEC) 
3.3.1 Theory 
SEC is used to separate molecules on the basis of size and shape (see Figure 3.4). A sample containing 
molecular species of varying sizes is injected upstream of the column. The sample flows through the 
system through use of a mobile phase, which is pumped at a constant rate. The mobile phase often 
contains a buffer to maintain the pH of the sample. The column used in SEC is packed with a porous 
matrix which provides the separation ability. Gel beads comprise the matrix or fixed phase of the 
column, resulting in a cross-linked network of pores (Rosenberg 2005). Separation of molecules is based 
on the size of the pores in the beads, with larger molecules being unable to enter the pores and thus 
eluting at a faster time. Both molecular weight (size) and the three-dimensional conformation (shape) of 
the molecule contribute to a protein’s ability to enter a pore. Adsorption of protein to the column 
matrix is a concern in SEC, preventing protein from eluting in a timely manner if at all. For analysis of 
protein samples, high salt concentrations are used in the mobile phase to curtail protein adsorption to 
the column matrix (Arakawa, Ejima et al. 2010). 
SEC is often coupled with UV-vis spectrophotometry through inclusion of an inline UV detector following 
the SEC column. Determination of UV absorption immediately following elution form the column allows 
for quantitative measurement of the amount of molecules eluting at a given time. UV absorption values 
are either taken at a few specific wavelengths (e.g., 280 nm for proteins) or an entire absorption 
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spectrum can be obtained. Sample volume should be kept minimal to ensure high signal resolution and 
avoid peak broadening (Rosenberg 2005).  
 
Figure 3.4 Overview of size-exclusion chromatography (SEC) Molecules are separated by the column 
based on size, with smaller molecules experiencing a more tortuous path and hence longer times to 
elution. As molecules elute, they are detected using UV absorption. Some molecules may be too large to 
pass through the column and are retained.  
 
The use of SEC in analysis of protein aggregates is common due to the advantages offered by the fast 
analysis time, ability to be performed at high-throughput, the quantitative information on the 
abundance of monomeric and multimeric protein species and the high precision that is obtainable in the 
results (Carpenter, Randolph et al. 2010). However, a need for orthogonal methods for aggregation 
analysis has been established due to numerous concerns including the inability of large aggregates to 
pass through the frit and enter the column, adsorption of aggregates on the column walls and the 
dissociation of aggregates in the column prior to elution (Carpenter, Randolph et al. 2010).  
 
Flow 
Molecules are too large 
 to pass through column 
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3.3.2 Experimental Procedure 
Quantitative aggregation analysis was performed using size exclusion chromatography (SEC) for both 
reconstituted lyophilized and non-lyophilized control samples. SEC was performed using an Agilent 1200 
Series LC system (Agilent Technologies, Santa Clara, CA) with a TSKgel G3000SWxI column (Tosh 
Bioscience LLC, King of Prussia, PA). A mobile phase of 50 mM potassium phosphate pH 7.0 buffer with 
200 mM NaCl was used. The flow rate was set to 0.5 mL/min and UV signals were collected at 215 nm 
and 280 nm. Using the 280 nm signal, peak area was calculated for each chromatogram. The peak area 
was used to determine the percent monomer remaining after lyophilization, assuming that the peak 
area for the non-lyophilized control corresponded to 100% monomer. 
          
                     
                        
 
(Equation 3.3) 
 
3.4 SODIUM-DODECYL-SULFATE POLYACRYLAMIDE GEL ELECTROPHORESIS (SDS-PAGE) 
3.4.1 Theory 
Electrophoresis separates molecules on the basis of size and charge. Molecules are separated in a cross-
linked gel network in polyacrylamide gel electrophoresis (PAGE). Pore size is controlled by concentration 
of polyacrylamide with higher concentrations of polyacrylamide leading to smaller pore sizes (Rosenberg 
2005). Commonly, gels are comprised of a stacking gel with low polyacrylamide content where the 
sample is injected and the resolving gel with higher polyacrylamide content where separation occurs 
(Rosenberg 2005). 
Sodium-dodecyl-sulfate (SDS) is a detergent which is used to denature the protein prior to 
electrophoresis. SDS also causes protein to carry an overall net negative charge. Additionally, proteins 
may be treated with reducing agents to eliminate disulfide bonds. After injection of samples, an electric 
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field is applied to the gel which causes the protein to migrate through the gel. The speed of migration is 
proportionally to the molecular weight of the protein (Rosenberg 2005). Following electrophoresis, 
protein is deposited in bands throughout the gel according to its molecular weight. A reference ladder of 
known proteins can be used to provide molecular weight references for comparison. Figure 3.5 provides 
a representative gel following SDS-PAGE. 
 
 
Figure 3.5 Representative gel following SDS-PAGE  The leftmost lane shows a reference ladder. The 
protein used is RNAse A.  
 
Staining following SDS-PAGE allows for visual detection of protein within the gel. SDS-PAGE can be used 
to qualitatively detect the presence of species of different molecular weight, including aggregates. 
Alternatively, quantitative methods such as radio-labeling and autoradiography allow the quantification 
of different protein species or protein size distribution following SDS-PAGE (Rosenberg 2005). 
3.4.2 Experimental Procedure 
Qualitative aggregation analysis was performed using SDS-PAGE for both reconstituted lyophilized and 
non-lyophilized control samples. Samples were divided and mixed with either non-reducing or reducing 
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(containing -mercaptoethanol) loading buffer containing bromophenol blue for staining. Samples were 
vortexed for 10 min and then heated for 5 min at 95°C. Samples were allowed to cool and were then 
loaded into 10% or 12% polyacrylamide gels. Precision Plus Protein Dual Xtra Standards (Bio-Rad, 
Hercules, CA) were used as a reference ladder. SDS-PAGE was performed using a Mini-PROTEAN Tetra 
cell electrophoresis instrument attached to a PowerPac Basic power supply (Bio-Rad). After completion 
of electrophoresis, the gels were removed and stained with Coomassie Brilliant Blue R-250 staining 
solution for 30 min and then destained for approximately 24 hrs on a rocking platform (VWR 
International, Radnor, PA).  
3.5 POWDER X-RAY DIFFRACTION (PXRD) 
3.5.1 Theory 
Powder x-ray diffraction emits x-rays at a powdered solid sample and measures the resulting 
diffraction pattern. X-rays are sent from a source (e.g., x-ray tube) and collide with the sample at a 
specified incident angle (). As the x-rays collide with atoms in the solid, the x-rays are scattered. 
An x-ray detector is used to detect any x-rays that are deflected at an angle of twice the incident 
angle (in reference to the x-ray beam sent from the source), referred to as 2. The detection of x-
rays is represented as the intensity. The incident angle is changed repeatedly to allow detection of 
diffraction patterns across a range of 2 values. A typical PXRD setup is shown in Figure 3.6. 
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Figure 3.6 Diagram of typical powder x-ray diffraction setup X-rays are sent from the source (x-ray 
tube) and are reflected back to the detector at an angle referred to as the incident angle (). 2 is equal 
to two times . Figure adapted from (Speakman).  
 
Arrangement of the atoms in a sample produces a characteristic diffraction pattern. Bragg’s law 
describes the conditions that must be satisfied for diffraction to occur at a given incident angle (): 
            
(Equation 3.4) 
Where l is the wavelength of the x-ray and is fixed and dhkl is a characteristic vector defined by the 
crystal geometry. A crystal has repeating units of atomic structure, referred to as unit cells 
(Shackelford 2009). The unit cell represents the maximal symmetric unit in the material and has a 
characteristic shape and size that determines dhkl (Speakman ; Shackelford 2009). The unit cell in a 
crystal has atomic planes which are attributed to the diffraction peaks observed in a sample. As 
the unit cell is repeated, diffraction at the angle incident to the plane occurs frequently resulting in 
a sharp peak with high intensity in the observed diffraction pattern. 
2 
X-ray  
tube 
Sample 
Detector 
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While pxrd has several applications, the focus here is the use of pxrd to determine whether a sample is 
crystalline or amorphous. On a qualitative basis, a sample can be classified as either largely amorphous 
or largely crystalline based on the overall diffraction pattern observed. Amorphous solids have no long 
range order and thus show no diffraction pattern, instead displaying what is referred to as an 
“amorphous halo” (see Figure 3.7). Crystalline solids are highly ordered and only show diffraction at 
certain wavelengths based on the crystal structure. The resulting diffraction pattern is characterized by a 
few sharp peaks of high intensity (see Figure 3.7). The discernible visual differences in the diffraction 
patterns often allows for a general qualitative classification of either largely amorphous or largely 
crystalline. Quantitatively, pxrd can be used to calculate the percent crystallinity of a sample by dividing 
the intensity of a peak observed in a given sample by the intensity of the peak in a pure crystalline 
control (Clas, Faizer et al. 1995). For multiple peaks, the intensities are summed for both the sample and 
the pure crystalline control and then the ratio is determined. Low percent crystallinity corresponds to a 
sample that is largely amorphous. For small molecule drug development, the exact percent crystallinity 
is often of interest as it relates to bioavailability (Clas, Faizer et al. 1995). However for the experiments 
conducted here, the main concern was whether any given formulation was largely amorphous following 
lyophilization for which a qualitative approach was sufficient. 
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Figure 3.7 Representative x-ray diffraction patterns (A) amorphous material and (B) crystalline material 
showing intensity (<I>) versus 2. Figure adapted from (Speakman).  
 
3.5.2 Experimental Procedure 
Samples for PXRD analysis were prepared similarly to the method stated previously except protein and 
excipient solutions were made to concentrations of 10 mg/mL, yielding formulation concentrations of 5 
mg/mL protein and 5 mg/mL excipient (1:1 excipient to protein weight ratio). The same sample volume 
of 400 L was transferred to the lyophilization vials for each protein-excipient pair. Samples were 
lyophilized using the previously mentioned lyophilization cycle. Following lyophilization, confirmation 
that the samples were amorphous was performed by collecting X-ray diffractograms using a Scintag X2 
- diffractometer (Scintag Inc., Cupertino, CA) equipped with a Cu K anode operating at a wavelength 
of 1.5406 Å.  
Due to the large amount of formulations considered, a smaller subset was selected for PXRD analysis. 
JMP statistical software (SAS, www.jmp.com ) was used to randomly select a minimal number of 
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formulations for analysis such that each protein was selected at least once, each excipient was selected 
at least once and each sugar alcohol excipient was selected at least twice.  20 formulations were 
selected and from the set of 20, 6 were randomly selected to be done in replicate. Only carbohydrate 
excipients were considered. 
3.6 HYDROGEN-DEUTERIUM EXCHANGE MASS SPECTROSCOPY (HX-MS) 
3.6.1 Theory 
Hydrogens bonded to the amide nitrogen (See Figure 3.8) in the protein backbone can exchange with 
deuteriums when exposed to deuterated water (D2O). The reaction can be catalyzed either acid (D3O
+) 
or base (OD-). The exchange rate of the amide hydrogens can occur over a wide range of time, with 
some exchanging in milliseconds and others in days.  
 
Figure 3.8 A peptide bond, which forms between amino acids to construct the protein backbone The 
hydrogen bonded to the amide nitrogen is highlighted in red. The hydrogen participates in exchange 
with deuterium during HX experiments.  
 
The exchange rate is highly dependent on the degree of solvent protection and hydrogen bonding. 
Buried residues or residues with an amide hydrogen that participating in hydrogen bonding are resistant 
to exchange, where surface residue freely exchange hydrogen for deuterium (Tsutsui and Wintrode 
2007). Hydrogen exchange is also impacted by the flexibility of the protein’s conformation, both locally 
and overall. Fluctuations in the protein’s structure allow solvent penetration and subsequent exchange. 
The exchange rate is given by Equation 3.5 (Tsutsui and Wintrode 2007): 
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(Equation 3.5) 
 
Where    is the rate of conformational changes that result in unfolding,     is the rate of 
conformational changes that result in folding,    is the chemical rate of exchange between a hydrogen 
and a deuterium and      is the observed rate of exchange. The overall observed exchange can be 
divided into two regimes: the EX1 regime (   >>    ) and the EX2 regime (    >>   ). In EX1, the 
protein exhibits multiple conformations and slowly interconverts between conformations, allow 
exchange to occur (Tsutsui and Wintrode 2007). The observed exchange rate depends only on the rate 
of unfolding. The EX1 regime is often induced through use of denaturants. More frequently the EX2 
regime is observed, where local conformational changes exposing amide hydrogens may occur multiple 
times before exchange can occur (Tsutsui and Wintrode 2007). The observed rate is therefore mostly 
dependent on the equilibrium of local unfolded and folded states. In regions where local unfolding 
occurs more frequently, more exchange will occur. The observation of local exchange rates gives an 
indication of the stability of the region.  
Exchange at individual residues can be determined with Nuclear Magnetic Resonance (NMR), but the 
approach is limited due to the large protein amounts needed, the size of the protein is restricted, and 
the difficult and time consuming assessment of peaks (Tsutsui and Wintrode 2007). In 1990, mass 
spectroscopy was shown to be a viable tool for the study conformational changes in proteins 
(Chowdhury, Katta et al. 1990). Mass spectroscopy and proteolysis have since been coupled with 
hydrogen/deuterium exchange to provide a medium resolution tool (5-10 residues) for probing the 
structural changes of proteins (Katta, Chait et al. 1991; Tsutsui and Wintrode 2007). An overview of the 
HX-MS experimental procedure is given in Figure 3.9. 
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Figure 3.9 General experimental procedure for HX-MS experiments performed in aqueous solution  
Figure adapted from (Tsutsui and Wintrode 2007).  
 
3.6.2 Use in Lyophilized Solids 
HX-MS has been extended to lyophilized solids as a method to elucidate protein structure and 
formulation effects (Li, Williams et al. 2007; Li, Williams et al. 2007; Li, Williams et al. 2008). Some 
modification to the procedure outlined in Figure 3.9 is required to adapt the process to lyophilized 
solids. Following equilibration in aqueous solution, the protein is lyophilized to produce an amorphous 
solid. Exchange with deuterium is then carried out by exposing the solid to deuterated water vapor. 
Following exchange, the lyophilized protein is reconstituted with quenching and peptic digestion 
following as performed for aqueous samples.  
The results given by HX-MS with lyophilized solids provides site-specific information on interactions 
between protein and the solid environment (Li, Williams et al. 2007). Factors influencing in the solid 
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state include relative humidity during exchange, inclusion of salts and inclusion of stabilizing excipients 
(Li, Williams et al. 2007; Li, Williams et al. 2007). HX-MS with lyophilized proteins provides a quantitative 
and site-specific tool for the study of protein-excipient interactions in amorphous solids. 
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4.0 PROPERTY MODEL DEVELOPMENT: THE FORWARD PROBLEM 
CAMD requires accurate and predictive property models for design or selection of candidate molecules. 
For development of property models, molecular descriptors are needed for correlation between 
molecular structure and properties of interest. For example, an overview of the experimental procedure 
and model development steps in the design of lyophilized protein formulation is given by Figure 4.1 with 
the steps relevant to property model development highlighted. 
The property models considered here are classified either as quantitative structure-property 
relationships (QSPRs), group contribution (GC) methods or thermodynamic property models. The 
property models developed here are given in Table 4.1, along with the corresponding descriptor type 
and model type. Additional property models available in literature were used where applicable. 
The types of molecular descriptors used are discussed in Section 4.1. Development of linear QSPRs is 
described in Section 4.2 and development of non-linear QSPRs is described in Section 4.3. Group 
contribution methods are detailed in Section 4.4. Finally, the development of a UNIFAC thermodynamic 
property model for ionic liquids (UNIFAC-IL) is outlined in Section 4.5. 
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Figure 4.1 Procedure for experimental data acquisition and model development for rational 
lyophilized formulation development The part of the process that describes the model development 
process is detailed in Section 4.0. The experimental procedure is described in Section 3.0. Figure 
adapted from (Roughton, Iyer et al. 2013).  
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Table 4.1 Summary of property models developed for both lyophilized protein formulation design and 
ionic liquid design for use in separations of bio-products 
LYOPHILIZED PROTEIN FORMULATION DESIGN 
Property Descriptors Used Model Type 
Anhydrous glass transition         
temperature (Tg) 
Connectivity indices Linear QSPR 
Freeze-concentrated glass transition 
temperature (Tg’) 
Connectivity indices Linear QSPR 
Maximal concentration in freeze-
concentrated matrix (Cg’) 
Connectivity indices Linear QSPR 
Gordon-Taylor constant (k) Connectivity indices Linear QSPR 
Percent monomer remaining after 
lyophilization (%Monomer; on a 
formulation-by-formulation basis) 
Protein-based descriptors Linear QSPR 
Percent monomer remaining after 
lyophilization (%Monomer; on a 
protein-by-protein basis) 
Chiral connectivity indices 
 
Linear QSPR 
Percent monomer remaining after 
lyophilization (%Monomer; as a 
function of protein and excipient 
choice) 
Chiral connectivity indices 
Protein-based descriptors 
Non-linear QSPR 
IONIC LIQUID DESIGN 
Property Descriptors Used Model Type 
Hildebrand solubility parameter () Group contribution Group contribution method 
Thermal decomposition temperature 
(Td) 
Group contribution Group contribution method 
Partition Coefficient for NDHD (Kx) Connectivity indices Linear QSPR 
Toxicity towards E. coli (EC50) Connectivity indices Linear QSPR 
Activity coefficients () Group contribution UNIFAC thermodynamic model 
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4.1 CALCULATION OF MOLECULAR DESCRIPTORS 
Three classes of molecular descriptors were considered. Group contribution is described in Section 
4.1.1, connectivity indices are discussed in Section 4.1.2 and protein-based descriptors are detailed in 
Section 4.1.3. 
4.1.1 Group Contribution 
Group contribution methods identify common molecular groups, which are then used to build the 
molecule of interest. Group contribution (GC) methods have been utilized successfully to predict many 
physical properties of organic compounds, including boiling point and freezing point (Joback and Reid 
1987). GC approaches have seen success in the prediction of vapor-liquid equilibria (VLE) (Gani, 
Tzouvaras et al. 1989). The UNIFAC method uses group contributions to predict activity coefficients for 
mixtures, which are subsequently used to predict VLE (Fredenslund, Gmehling et al. 1977). 
 
 
Figure 4.2 Example group contributions for (A) ethanol, (B) acetone and (C) benzene Groups used are 
the main groups used in UNIFAC.  
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In general, groups are determined by the author of the method and can vary from method to method. 
An example of the groups present in several molecules as defined by UNIFAC is given by Figure 4.2. As 
every chemical group needs to be accounted for, descriptor selection methods (cf. Section 4.2.4) cannot 
be utilized in the development of GC methods. The motivation behind group contributions is that results 
from a limited experimental data set can be applied to other systems with different molecule structures, 
but the same basic molecular groups. One major limitation of GC methods is that they cannot account 
for groups that are not present in the model-building set. GC methods assume that the number of a 
certain group present and the location of groups within a molecule do not affect the observed property 
of the molecule (Prausnitz, Lichtenthaler et al. 1999). This assumption is incorrect; improvement can 
come with the definition of more groups or higher-order groups, albeit with the need for more model 
parameters (Prausnitz, Lichtenthaler et al. 1999; Harper and Gani 2000). Predictions from GC methods 
offer a first approximation for properties (Prausnitz, Lichtenthaler et al. 1999) and are thus useful for 
property screening purposes (Gani, Nielsen et al. 1991). 
4.1.2 Connectivity Indices 
Topological descriptors are a class of molecular descriptors which identify individual atoms and their 
bonding configuration in a molecule. Connectivity indices are a type of topological descriptors first 
proposed by Randic (1975). Later work extended the use of connectivity indices to pharmaceutical 
product property prediction (Kier and Hall 1986) and polymer property prediction (Bicerano 2002). The 
use of connectivity indices have been proposed to describe missing groups for GC models (Gani, Harper 
et al. 2005; Satyanarayana, Abildskov et al. 2009). 
Connectivity indices were chosen as the class of excipient descriptors to be used in model development. 
Connectivity indices were also used for some ionic liquid property models where group contribution did 
not perform with acceptable accuracy. Connectivity indices have utility due to the ability to calculate 
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indices and to store bonding information for any molecular structure proposed, regardless of the 
molecular groups present. Additionally, connectivity indices have seen success in the prediction of 
properties for pharmaceutically relevant systems (Kier, Hall et al. 1975), including carbohydrate 
excipients (Roughton, Topp et al. 2012).  
Connectivity indices (n) describe the two-dimensional atomic and bonding features of a molecule while 
valence connectivity indices (n v) describe the electronic configuration. For calculation of connectivity 
indices, the molecule is represented as a hydrogen-suppressed graph where vertices represent non-
hydrogen atoms and edges represent bonds. The vertex degree i for any vertex i is equal to the number 
of vertices connected to the vertex by an edge and represents the number of non-hydrogen atoms that 
form bonds with the given non-hydrogen atom. The calculation of an n-th order connectivity index is 
giving by Equation 4.1. 
   ∑ (∏
 
  
   
   
)
 
     
   
 
    (Equation 4.1) 
Where Ns is the number of subgraphs of size n. Vertices (atoms) are the subgraph considered for a 
zeroth-order connectivity index,  edges (bonds) are the subgraph considered for a first-order 
connectivity index, paths of two edge-lengths (two bond paths) are the subgraph for a second-order 
connectivity index and so on. For a valence connectivity index, Equation 4.2 is used to determine the 
valence vertex degree i
v and then Equation 3 is used for calculation, replacing i with i
v. 
  
  
     
      
 
(Equation 4.2) 
Where Z is the atomic number, Zv is the number of valence electrons and NH is the number of connected 
hydrogen atoms. Average simple or valence connectivity index values () for a given order are calculated 
 
73 
 
by dividing the simple or valence connectivity index value by the number of subgraphs of the order 
being considered. 
 
Figure 4.3 Comparison of the chiral structures of stereoisomers (A) glucose and (B) mannose The 
hydrogen suppressed graphs derived from glucose and mannose are given for (C) simple connectivity 
index calculations and (D) valence connectivity index calculations. (C) and (D) are representative of the 
topologies of both (A) and (B).  
  
Due to the excipient molecules considered, three-dimensional structure is important. For example, 
glucose and mannose are stereoisomers which have the same two-dimensional representation but 
differ in three-dimensional configuration (see Figure 4.3). By using only simple connectivity indices, the 
two molecules are indistinguishable yet may contribute different to the stability of a given protein in a 
lyophilized formulation. To overcome these limitations, chiral-corrected connectivity indices were 
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considered. For any chiral molecule, the vertex degree i is replaced with either (i + c) for S-
configuration or (i – c) for R-configuration, with c representing the chirality correction factor (Golbraikh, 
Bonchev et al. 2001). In this work, c = 2 has been chosen. Connectivity indices are then calculated as 
described previously, using the chirality-corrected vertex degree values. By accounting for the differing 
chiral atoms, some three-dimensional or conformational information is captured without the need for 
three-dimensional structure determination. 
4.1.3 Protein-Based Descriptors 
Both biophysical properties and predictive descriptors of aggregation propensity were considered for 
protein descriptors. The biophysical descriptors capture basic structural information and innate stability 
information (via Tm) (Takahasi, Irie et al. 1969; Tani, Shirai et al. 1997; Arakawa and Kita 2000; 
Roychaudhuri, Sarath et al. 2003; Duy and Fitter 2005). The biophysical descriptors used along with 
values for each protein are given in Table 4.2. 
Table 4.2 Biophysical descriptors for the proteins considered 
Protein 
PDB 
code 
MW 
(kDa) 
pI 
ASAa 
(Å2) 
fASA
b 
% α 
helix 
% β 
sheet 
# SS 
bonds 
# free 
thiols 
Tm 
(°C) 
Ovalbumin 1ova 44.3 5.19 34237 0.63 30.8 31.3 1 4 76c 
RNAse A 5rsa 16.5 8.93 4052 0.60 21 33 4 0 62.5d 
α-amylase 1bli 58 6.33 10480 0.60 26.2 25.6 0 0 102e 
BSA 3v03 66 5.82 35921 0.68 67 0 17 1 59f 
Trypsin 
inhibitor 
1avu 20.1 4.95 4986 0.60 1.4 97.2 2 0 65g 
a – ASA=apolar surface area 
b – fASA = apolar surface area / total surface area 
Melting temperature (Tm) values were obtained from literature: c (Tani, Shirai et al. 1997), d (TAKAHASHI, IRIE et al. 1969),         
e (Duy and Fitter 2005), f (Arakawa and Kita 2000), g (Roychaudhuri, Sarath et al. 2003) 
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Descriptors calculated from two primary sequence-based methods for the prediction of aggregation 
propensity were also considered: AGGRESCAN (Conchillo-Sole, de Groot et al. 2007) and PASTA (Trovato, 
Chiti et al. 2006; Trovato, Seno et al. 2007). Both methods require only the amino acid sequence and 
offer web-based servers for calculation of all relevant variables (AGGRESCAN: bioinf.uab.es/aggrescan/ 
and PASTA: http://biocomp.bio.unipd.it/pasta/). AGGRESCAN predicts aggregation propensity by 
determining “hot spots” or short amino acid sequences that are likely to be aggregation-prone. PASTA 
predicts aggregation propensity by determining sequences that are likely to induce aggregation through 
the formation of intermolecular -strands. Both methods are primarily concerned with amyloid fibril 
formation. Explanation of the descriptors calculated or derived from these methods is given in Table 4.3. 
Table 4.3 Descriptors obtained and derived from aggregation propensity prediction methods 
AGGRESCAN Descriptor Name Definition 
a3vSA Sequence average amino acid aggregation propensity  
nHS Number of aggregation hot spots 
NnHS nHS normalized by number of residues in protein 
AAT Area of aggregation profile above hot spot threshold 
THSA Total area of aggregation profile comprising hot spots 
TA Total area of aggregation profile 
AATr AAT normalized by number of residues in protein 
THSAr THSA normalized by number of residues in protein 
Na4vSS Sliding window average of amino acid propensity values divided 
by number of amino acids in protein 
PASTA Descriptor Name  
Emin Minimum energy of PASTA pairings 
Eavg Average energy of PASTA pairings 
Lmax Average amino acid pair length of PASTA pairings 
Lavg Maximum amino acid pair length of PASTA pairings 
(E/L)min Minimum ratio of energy to length of PASTA pairings 
(E/L)avg Average ratio of energy to length of PASTA pairings 
# of Peaks Number of peaks in PASTA aggregation profile 
  
 
4.1.4 Principal Component Analysis 
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Principal component analysis (PCA) is a data-reduction technique which replaces an original set of 
variables with a smaller number of principal components, which are calculated through linear 
combinations of the original variables (Maindonald and Braun 2010). Through development of principal 
components, the majority of variance in the data set is captured with a minimal number of variables. In 
this work, PCA was used to visualize the excipient descriptor space. Such visualization is used for the 
discussion of results. PCA was performed using the DAAG package in R (Maindonald and Braun 2010). 
4.2 DEVELOPMENT OF LINEAR QSPRS 
Development of linear QSPRs is comprised of four steps: 
1. Identification of key properties and procurement of experimental property values 
2. Calculation of descriptors and descriptor selection 
3. Linear regression 
4. Cross-validation 
The steps are further detailed in the following sections. 
4.2.1 Glass Transition Properties 
QSPRs were developed for the glass transition temperature of the anhydrous solute, glass transition 
temperature of the maximally concentrated solute, melting point of ice and Gordon-Taylor constant for 
carbohydrates. The experimental data were collected from published literature(Roos 1993). Discussion 
on glass transitions and their importance in lyophilized protein formulations is given in detail in Section 
2.5. 
 
 
4.2.2 Percent Monomer Remaining Following Lyophilization 
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The quantitative measure of aggregation used for property modeling was percent monomer remaining 
following lyophilization. Measurement and calculation of percent monomer is detailed in Section 3.3. 
Linear QSPRs for percent monomer were developed either as a function of protein structure 
(formulation-by-formulation basis) or as a function of excipient structure (protein-by-protein basis). 
Additionally, a non-linear QSPRs for percent monomer was developed as a function of both protein and 
excipient structure (see section 4.3). Protein-based descriptors were used to represent protein structure 
and chiral-corrected connectivity indices were used to represent excipient structure. 
 
4.2.3 Properties for in situ NDHD recovery 
The example case used for in situ product recovery during fermentation is the production of (1R,2S)-1,2-
naphthalene dihydrodiol (NDHD) by Escherichia coli. NDHD is an important intermediate product that 
can be used in synthesis of pharmaceutical intermediates or in synthesis of polymers (Raschke, Meier et 
al. 2001). The reaction producing NDHD that is performed by E. coli is given in Figure 4.4 (Jerina, Daly et 
al. 1971). 
 
Figure 4.4 Oxidation of naphthalene to (1R,2S)-1,2-naphthalene dihydrodiol (NDHD) The reaction is 
catalyzed by the enzyme naphthalene dioxygenase (NDO), which is present in E. coli. The reaction 
requires oxygen (O2) and nicotinamide adenine dinucleotide phosphate (NADPH). Adapted from (Jerina, 
Daly et al. 1971).  
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The key properties of interest when designing an ionic liquid to extract NDHD during fermentation are 
the partition coefficient of NDHD between ionic liquid and water (Kx) and the toxicity of the ionic liquid 
towards E. coli (EC50). Group contribution models proved unable to successfully correlated the 
properties of interest to molecular structures; accordingly, connectivity index QSPRs were used. The 
partition coefficient of NDHD between ionic liquid and water is given by ratio between the mole fraction 
of NDHD in ionic liquid (xIL) over the mole fraction of NDHD in water (xaq), given by Equation 4.3. 
   
   
   
 
(Equation 4.3) 
Toxicity is measured by the half maximal effective concentration (EC50) value, which represents the 
concentration that is effective in killing half of a given community of organisms. For the system 
considered here, EC50 represents the overall toxicity of the ionic liquid towards E. coli. Lower values of 
EC50 represent a more toxic ionic liquid. Experimental values were obtained for partition coefficient 
values of 10 ionic liquids and toxicity values of 12 ionic liquids (Scurto 2012). 
4.2.4 Descriptor selection 
Linear property models were developed relating percent monomer remaining after lyophilization to 
excipient structure on a protein-by-protein basis. Descriptor selection was performed to prevent over-
fitting through use of Mallow’s Cp statistic (see Equation 4.4). Conceptually, Mallow’s Cp statistic is equal 
to the lack of fit plus a penalty for the number of descriptors chosen (Wasserman 2004).  
   ∑(    ̂ )
 
 
   
      
(Equation 4.4) 
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Where    is the observed or experimental value,  ̂  is the predicted value, m is the number of data 
points, p is the number of parameters or descriptors and    is the estimate of the residual variance. The 
value given by    is an unbiased estimate of the variance (Wasserman 2004), shown below: 
   (
 
   
)∑(    ̂ )
 
 
   
 
     (Equation 4.5) 
When comparing models, the model with the minimal value of Cp represents the model that best 
correlates the data without over-fitting. For a given model size (number of descriptors), an exhaustive 
search was performed to select the descriptors that minimized Cp. All model sizes were then compared 
and the model size with the minimal Cp statistic was selected as the final model. Figure 4.5 gives a 
graphical example of the use of Cp in descriptor selection. For linear correlations, the selection results 
given by Cp are equivalent to AIC (Akakie Information Criterion) (Wasserman 2004). Accordingly, 
descriptor selection results may refer to either AIC or Cp, depending on the software package used for 
selection. Descriptor selection was performed using the Leaps package in R (Lumley 2004; Dalgaard 
2008). The general procedure used in R for descriptor selection along with sample code is given in 
Appendix B. 
 
Figure 4.5 Values for Mallow’s Cp statistic versus model size (number of connectivity indices used) The 
lowest value is observed when six connectivity indices are used, indicating the size of the model that 
should be used. Figure adapted from (Roughton, Topp et al. 2012).  
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4.2.5 Cross-Validation 
Once a final model was selected, leave-one-out cross-validation (LOOCV) was performed to evaluate the 
predictive ability of the model.  In LOOCV, one by one, each observation is left out of the data set and 
then the selected descriptors are again correlated to the data set. The resulting model is then used to 
predict the left-out data point. The process is repeated for each fold. Upon completion, the predictions 
are used to calculate the predicted residual sum of the square errors (PRESS) through use of Equation 
4.6 (Quan 1988). 
 
      ∑(    ̂〈 〉)
 
 
   
 
(Equation 4.6) 
where  ̂〈 〉 is the predicted value for the left-out observation and m is the total number of observations. 
The PRESS value is then used to calculate the cross-validation coefficient Q2 (see Equation 4.7).  
     
     
∑ (    ̅) 
 
   
 
(Equation 4.7) 
where  ̅ is the average value for all data points. Q2 has a maximal value of the model’s R2 value, which 
represents a perfect predictive ability (Quan 1988). When comparing models, smaller R2-Q2 values 
represent better predictive power. In general, Q2 can be calculated for K-fold cross-validation by 
expanding upon Equation 4.6 to yield Equation 4.8. In K-fold cross-validation, K number of folds are 
generated from the original data set. The number of data left-out should be equal for each fold. As K 
decreases, the predictive power of the model is further strained as fewer observations are used to build 
the model. 
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      ∑∑(    ̂〈 〉)
 
 
   
 
   
 
(Equation 4.8) 
where k is the number of folds and n is the number of observations left-out in each fold. The general 
procedure used in R for cross-validation along with sample code is given in Appendix B. 
4.3 DEVELOPMENT OF NON-LINEAR QSPRS 
A non-linear QSPR was used to describe percent monomer remaining after lyophilization as a function of 
both protein and excipient choice. More details concerning percent monomer remaining after 
lyophilization can be found in Section 4.2.2. Development of non-linear QSPRs offer an added layer of 
complexity in comparison to linear QSPR development as a functional form must first be selected, where 
the functional form is assumed in linear QSPR development. Additionally, certain assumptions in the 
development of linear correlations do not hold for non-linear correlations. 
4.3.1 Selection of Functional Forms 
Several functional forms for a model describing protein stability following lyophilization as a function of 
excipient choice and protein choice were considered. Attempts to build a linear model of sufficient 
correlative quality were unsuccessful (results not shown). Non-linear models were considered to better 
correlate the descriptors to the %Monomer values. The final form used is given below: 
          (∑    ) (∑    ) 
(Equation 4.9) 
where  represents excipient descriptors,  represents protein descriptors, and a, b, and c are 
adjustable parameters.   
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The form used for Equation 4.9 was motivated by the enthalpic contribution to the Flory-Huggins model, 
given by Equation 4.10. The Flory-Huggins model has been used previously to describe protein-sugar 
interactions in lyophilized solids (Katayama, Carpenter et al. 2009; Wang, Tchessalov et al. 2009). 
Equation 4.9 emulates the Flory-Huggins interaction parameter (12) through the multiplication of 
excipient structural descriptors and protein structural descriptors. The success of the Flory-Huggins 
functional form of the universal model suggests that direct protein-excipient interactions play a 
significant role in stabilization of the protein during lyophilization for the formulations considered. 
              
(Equation 4.10) 
4.3.2 Parameter Fitting 
A non-linear model was considered for the correlation between percent monomer remaining after 
lyophilization and both excipient and protein descriptors, referred to as the universal model. Parameter 
fitting was performed by minimization of the residual sum of the squares (RSS) between the model and 
experimental data. The minimization was performed as a mixed-integer non-linear program (MINLP), 
resulting in parameter values that were not guaranteed to be globally optimal. However, the 
formulation of the problem as a MINLP is necessary as a non-linear property model is used for the 
universal model. The Excel solver was utilized in solution of the MINLP. 
4.3.3 Parameter Sensitivity 
A parameter sensitivity analysis was used to select descriptors. Given the functional form, all descriptors 
were included. The parameters for each descriptor were determined such that the residual sum of the 
squares (RSS) between the model and experimental data was minimized (see Section 4.3.2). Sensitivity 
(Sx) was then calculated descriptor by descriptor through use of Equation 4.11. 
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(Equation 4.11) 
Where RSS1.1*x represents the sum of the square errors after increasing the parameter value for a given 
descriptor (x) by a factor of 1.1. When Sx is equal to or near one, the descriptor in question had no 
discernible effect on the model outcome. Larger sensitivities suggest a stronger importance on model 
outcome for the descriptor of interest. Sensitivity values were used to guide two rounds of descriptor 
selection. In the first round of descriptor reduction, descriptors with sensitivities approximately equal to 
one were excluded. In the second round of descriptor reduction, the remaining descriptor with the 
lowest sensitivity was excluded from the model and parameter fitting through minimization of RSS was 
redone for the remaining descriptors. If the model performance statistics changed by less than an order 
of magnitude, the descriptor remained excluded; otherwise the descriptor was retained in the final 
model. The procedure was repeated for the descriptor with the next lowest sensitivity value until all 
descriptors had been considered.  
4.3.4 Statistical Verification 
The model performance statistics of interest were the percent average absolute deviation (%AAD) and 
the reduced chi-squared value. The statistics were used for the non-linear model over R2 and Q2 as R2-
based methods are poor indicators of non-linear model performance (Spiess and Neumeyer 2010). 
Furthermore, calculation of R2 assumes that the total sum of squares is equal to the explained sum of 
squares plus the residual sum of squares (TSS = ESS + RSS). The assumption is valid for linear regression 
but does not hold for non-linear regression. The %AAD gives the average deviation between the 
experimental and the predicted values given by the model (see Equation 4.12). %AAD was used to 
evaluate the accuracy of the model. 
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(Equation 4.12) 
The predictive power of the model was evaluated using reduced chi-squared. The reduced chi-squared 
statistic accounts for model variance as well as the number of parameters chosen (see Equation 4.13). 
For each data point, the difference between experimental and predicted is normalized by the 
uncertainty of the experimental measurement (). A value of one indicates that the model provides a 
good fit for the data, as the model variance is equal to the experimental variance (Spiess and Neumeyer 
2010). Order of magnitude differences in reduced chi-squared value suggest that either measurement 
errors are over-estimated (reduced chi-squared < 0.1) or a combination of under-estimated 
measurement errors and incorrect choice of functional form for the model (reduced chi-squared > 10) 
(Spiess and Neumeyer 2010).  
reduced chi-squared  
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(Equation 4.13) 
4.4 GROUP CONTRIBUTION METHODS 
For design of IL-based separation processes, group contribution (GC) models for heat capacity (Gardas 
and Coutinho 2008) and density (Valderrama and Robles 2007) were required. A solubility parameter GC 
model was developed for use as a design target and ionic liquid selection criteria. Additionally, a thermal 
decomposition temperature GC model was developed for use in selection of ionic liquid candidates.  
4.4.1 Hildebrand Solubility Parameter 
The Hildebrand solubility parameter is used to predict whether compounds will be miscible (Barton 
1991). Compounds with similar solubility parameter values are more likely to form a miscible solution. 
Solubility is a key parameter for selecting an entrainer, allowing the solubility parameter to be used as a 
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tool for designing or selecting possible candidates.  The cohesive energy density of a compound i (   ) is 
determined by its molar volume (  ) and enthalpy of vaporization (     ). The Hildebrand solubility 
parameter (  ) is defined as the square root of the cohesive energy density, as shown in Equation 4.14. 
      
 
 ⁄  (
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(Equation 4.14) 
For mixtures, a geometric mean is used to determine the mixture cohesive energy density (Prausnitz, 
Lichtenthaler et al. 1999). The mixture cohesive energy density is then used to determine the volume 
average solubility parameter for the mixture ( ̅), as given by Equation 4.15. 
 ̅  ∑    
 
 
 
   
(Equation 4.15) 
Where the volume fraction for a component in the mixture (  ) is determined from the mole fraction 
(  ) and molar volume (  ), as shown by Equation 4.16. 
   
    
∑     
 
 
 
   
(Equation 4.16) 
In the presented work, a GC model was developed for Hildebrand solubility parameter of ionic liquids. 
Several functional forms were considered (Roughton, White et al. 2011), but a linear GC model was 
determined to be appropriate given the small data set. Known solubility parameter values were used to 
calculate the volume average solubility parameter for azeotropic mixtures of interest.  
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4.4.2 Thermal Decomposition Temperature 
An important consideration of the design or selection of an ionic liquid for a separations process is the 
thermal decomposition temperature. Temperatures under 500°C have been reported to lead to thermal 
decomposition of the alkyl chain substituents of the cation as well as the anion itself (Ohtani, Ishimura 
et al. 2008). Higher temperatures (>500°C) can result in thermal decomposition of the imidazolium ring 
in cations (Ohtani, Ishimura et al. 2008). Imidazolium-based cations generally exhibit higher thermal 
stability than other cation types, such as tetraalkyl ammonium-based cations (Ngo, LeCompte et al. 
2000). Operating temperatures for any process utilizing ionic liquids must be well below the thermal 
degradation onset temperature of the ionic liquids.  
4.4.3 Group Contribution Model Development 
Group contribution models were developed to predict solubility parameters and thermal decomposition 
temperature for ionic liquids to provide a screening tool for selection of ionic liquids for use as 
entrainers. Additionally, group contributions form the basis of the activity coefficient predictions from 
the UNIFAC model (see Section 4.5). The ionic liquids were characterized as alkyl chain groups, cation 
groups, and anion groups. The groups used to develop ionic liquid GC models are given by Table 4.4. 
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Table 4.4 Ionic liquid groups used for GC model development Groups are classified either as alkyl chain 
groups, cation groups or anion groups. The X represents a point of connection with another group. 
Hildebrand solubility parameter and Td = thermal decomposition temperature.  
Alkyl Chain Groups 
Name Structure Models 
CH3 
 
, Td, 
UNIFAC 
CH2 
 
, Td, 
UNIFAC 
O (ether) 
 
 
Isobutyl 
 
Td
Ethylbenzyl 
 
Td
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Cation Groups 
Name Structure Models 
Imidazolium [Im] 
 
, Td, 
UNIFAC 
Pyridinium [Py] 
 
, 
UNIFAC 
Pyrrolidinium [Pyr] 
 
 
Ammonium [N] 
 
, Td, 
UNIFAC 
Phosphonium [P] 
 
 
Sulfonium [S] 
 
 
 
 
 
 
89 
 
Anion Groups 
Name Structure Models 
Dimethylphosphate [DMP] 
 
, 
UNIFAC 
Diethylphosphate [DEP] 
 
 
Tetrafluoroborate [BF4] 
 
, Td, 
UNIFAC 
Hexafluorophosphate [PF6] 
 
, Td, 
UNIFAC 
Trifluoroacetate [CF3COO] 
 
, Td, 
UNIFAC 
Trifluoromethanesulfonate 
[CF3SO3] 
 
, Td, 
UNIFAC 
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Bis(trifluoromethylsulfonyl) 
amide [Tf2N] 
 
, Td, 
UNIFAC 
2-(2-methoxyethoxy)ethyl 
sulfate [CH3(OC2H4)2SO4] 
 
, 
UNIFAC 
2-(methoxy)ethyl sulfate 
[CH3OC2H4SO4] 
 
UNIFAC 
2-(ethoxy)ethyl sulfate 
[C2H5OC2H4SO4] 
 
UNIFAC 
Methyl sulfate [CH3SO4] 
 
UNIFAC 
Ethyl sulfate [C2H5SO4] 
 
UNIFAC 
Octyl sulfate [C8H17SO4] 
 
 
Thiocyanate [SCN] 
 
, 
UNIFAC 
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Tosylate [TOS] 
 
 
Chloride [Cl] 
 
, Td, 
UNIFAC 
Bromide [Br] 
 
Td, 
UNIFAC 
Iodide [I] 
 
UNIFAC 
 
Linear models were proposed to predict the solubility parameter and thermal decomposition 
temperature. The function form for prediction of property P is given by Equation 4.17, where    
describes the number of groups of type i,    is the contribution of group i to the overall property value, 
and b is a constant. The contributions from the alkyl chain groups, cation groups, and anion groups are 
summed to give the predicted property value. The function forms used in the UNIFAC model differ and 
are explained in Section 4.5. 
         
                 
         
        
  
  ∑      
           
∑      
      
∑      
     
  
  
      (Equation 4.17) 
Experimental values of ionic liquid solubility parameters were obtained from literature (Marciniak 2010). 
The solubility parameter value can change with temperature, so the model was developed to predict the 
solubility parameter at 298.15 K. Even though a temperature dependence exists, solubility parameter 
often scales linearly for all compounds (Barton 1991). Thus, the GC model developed can be utilized to 
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design or select an ionic liquid for a given azeotrope at any given temperature assuming that the 
difference between the solubility parameter values will be similar at different temperatures. 
Experimental values of thermal decomposition temperature were also obtained from literature (D. 
Holbrey and R. Seddon 1999; Ngo, LeCompte et al. 2000; Visser Ann, Reichert et al. 2002; Awad, Gilman 
et al. 2004; Fredlake, Crosthwaite et al. 2004; Wooster, Johanson et al. 2006; Luo, Huang et al. 2008). 
For both property models, the contributions for each group were determined such that the %AARD 
(percent average absolute relative deviation) between experimental and predicted solubility parameters 
was minimized. The problem was formulated as a linear program (LP) and solved using the CPLEX solver 
in the GAMS optimization software package. The objective function is given by Equation 4.18. 
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 (Equation 4.18) 
To make the problem formulation linear, the absolute value term was transformed into the sum of two 
error terms for each data point (  
    
 ) and additional constraints were added. The resulting 
formulation is given by Equation 4.19. 
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(Equation 4.19) 
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4.5 UNIFAC-IL MODEL DEVELOPMENT 
Design of separations requires the determination of thermodynamic parameters for all components 
involved in the separation. For the design of extractive distillation processes, the activity coefficient is 
needed for the light components, heavy components and the entrainers. A UNIFAC model was 
developed to predict ionic liquid activity coefficients (UNIFAC-IL).  Known UNIFAC parameters were used 
for light and heavy components. 
4.5.1 Theory 
Modeling or prediction of VLE is a key tool needed for the design of separation processes. For the 
examples considered, the pressure was near or at atmosphere and the vapor phase was considered 
ideal. The Poynting correction was neglected and the saturated fugacity coefficients were assumed to be 
unity, also due to low pressure. Due to the extremely low vapor pressure exhibited by ionic liquids, the 
saturation pressure (  
   ) for the ionic liquids was assumed to be zero. As a result, no ionic liquid was 
assumed to be present in the vapor phase. Factoring in the assumptions, total pressure for a ternary 
system containing an ionic liquid is given by Equation 4.20, where components (1) and (2) are not ionic 
liquids. 
        
          
    
              (Equation 4.20) 
Given a known total pressure, the vapor compositions for component (1) or (2) are given by Equation 
4.21. 
   
      
   
 
 
       (Equation 4.21) 
 
94 
 
The UNIFAC model is a method used to predict activity coefficient values (  ). The original UNIFAC model 
has been used in this work, as data was insufficient to use the modified UNIFAC model. The original 
model uses a group contribution concept to calculate activity coefficients of a mixture, which are then 
used to predict VLE (Fredenslund, Gmehling et al. 1977; Lei, Zhang et al. 2009). The activity coefficients 
are calculated from a combinatorial and a residual contribution, as shown by Equation 4.22.  
         
      
  
   
(Equation 4.22) 
The combinatorial contribution, shown in Equation 4.23, is due to the size and shape of the molecule – 
that is the entropic features.   
 
    
               (  
  
  
   (
  
  
)) 
(Equation 4.23) 
Vi and Fi are parameters that are calculated from pure component parameters ri and qi, which represent 
the van der Waals volume and molecular surface area respectively. The molar composition of species i is 
given by xi. The calculation for Vi and Fi are given by Equation 4.24. 
   
  
∑      
 
   
  
∑      
 
(Equation 4.24) 
The pure component parameters ri and qi are the sum of group volume and surface area parameters Rk 
and Qk. Rk and Qk are UNIFAC model parameters and are usually derived from the rules of Bondi (Bondi 
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1964). Calculation of the parameters is given by Equation 4.25, with vk
(i) representing the number of 
groups of type k present in molecule i. 
   ∑  
( )
  
 
 
   ∑  
( )
  
 
 
(Equation 4.25) 
The residual contribution, shown in Equation 4.26, accounts for the interactions between groups – that 
is the enthalpic contribution. 
    
  ∑  
( )
 
[         
( )
] 
(Equation 4.26) 
The group residual activity coefficient is given by k (see Equation 4.27), where k 
(i) represents residual 
activity coefficient of group k in a reference solution containing only molecules of type i.  
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] 
(Equation 4.27) 
m is a volume contribution parameter and is dependent on Xm, which is the fraction of group m in the 
given mixture. Calculation of m and Xm is given by Equation 4.28. 
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(Equation 4.28) 
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The interaction parameter nm (see Equation 4.29) is a function of the group interaction parameter anm 
and temperature (T). The group interaction parameter anm is a fitted UNIFAC model parameter with the 
property that anm ≠ amn. 
       ( 
   
 
) 
(Equation 4.29) 
4.5.2 Determination of Groups and Group Parameters 
The ionic liquids were characterized by the same groups as used for the solubility parameter: alkyl chain 
groups, cation groups, and anion groups. Previous attempts to develop a UNIFAC model for ionic liquids 
characterized a cation and anion pair as one group (Lei, Zhang et al. 2009). The UNIFAC-IL model 
presented here treats cations and anion as separate groups, increasing the number of ionic liquid 
combinations and allowing for prediction of thermodynamic behavior with ionic liquids not used in the 
model development data set (Roughton, Christian et al. 2012). The UNIFAC-IL model proposed can 
predict VLE for systems containing ionic liquids that have yet to be synthesized.  
The combinatorial contribution is based on entropic effects and is calculated from group volume and 
surface area parameters. Parameters were determined for the new ionic groups using the following 
procedure: 
1. The rules of Bondi for estimation of molecular volume and surface area were used (Bondi 1964). 
2. For groups that were undefined by the rules of Bondi, values from previous UNIFAC groups were 
used. For example, the volume and surface area parameters for a di-substituted pyridine group 
were assumed to be roughly equal to the volume and surface area parameters for a di-
substituted pyridinium group. 
3. Values for groups still undefined were found in literature using correlations or molecular 
simulation to determine volume and surface area parameters (Lei, Zhang et al. 2009). 
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4.5.3 Determination of Interaction Parameters 
A wide range of experimental data on activity coefficients of various solutes at infinite dilution in ionic 
liquids was collected from previously published work (Heintz, Kulikov et al. 2001; Heintz, Kulikov et al. 
2002; Krummen, Wasserscheid et al. 2002; Letcher, Soko et al. 2003; Letcher, Soko et al. 2003; Eike, 
Brennecke et al. 2004; Kato and Gmehling 2004; Vasiltsova, Verevkin et al. 2004; Heintz, Casás et al. 
2005; Heintz and Verevkin 2005; Kato and Gmehling 2005; Kato and Gmehling 2005; Letcher, Domans a 
et al.  005   etcher, Marcinia  et al.  005  Vasiltsova, Verev in et al.  005  Heintz, Vasiltsova et al.  00   
Heintz, Verev in et al.  00   Doma s a and Marcinia   007  Ge,  ang et al.  007  Domans a and 
Marcinia   00   Doma s a and Marcinia   00   Ge and Wang 2008; Ge, Wang et al. 2008; Shimoyama, 
Hirayama et al. 2008; Yang, Wu et al. 2008). The experimental values were used to obtain UNIFAC group 
binary interaction parameters between the ionic liquid groups and solute groups through regression, 
using the Thermodynamic Modeling Library (TML) within the ICAS software suite (Gani, Hytoft et al. 
1997). The objective function, given by Equation 4.30, was minimized using the VA05AD solver method. 
The method is a compromise between the Newton-Raphson, Steepest Descent and Marquardt 
algorithms for minimizing a sum of squares (HSL 2011). 
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(Equation 4.30) 
Only the unknown interaction parameters between the new ionic liquid groups and existing UNIFAC 
groups were determined. For interactions between existing UNIFAC groups, the current revised UNIFAC 
interaction parameters were used (Wittig, Lohmann et al. 2002). The interaction parameters between 
ionic liquid groups were assumed to be zero, due to the strong interaction and weak dissociation 
between ion pairs (Lei, Zhang et al. 2009) and also to allow more flexibility in the design of the ionic 
liquid.  
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5.0 MOLECULAR DESIGN METHODS: THE REVERSE PROBLEM 
Two main approaches were taken to address the reverse problem of CAMD: deterministic and 
stochastic. Deterministic design was applied to solution of ionic liquid entrainers and is detailed in 
Section 5.1. Tabu search, a stochastic method, was utilized for the design of ionic liquid extractants and 
carbohydrate glass-formers, as described in Section 5.2. Additionally, two stochastic methods (tabu 
search and genetic algorithms) were developed, tuned and compared for the design of carbohydrate 
excipients in lyophilized protein formulations. Development is detailed in Section 5.3, tuning is explained 
in Section 5.4 and the methods of solution comparison are given in Section 5.5.  
5.1 DETERMINISTIC DESIGN OF IONIC LIQUID ENTRAINERS 
Given an azeotropic mixture of interest, a CAMD problem was formulated to design an ionic liquid 
entrainer. The solubility parameter is used as the target property. First, the design stage in the CAMD 
problem selects all ionic liquids that have solubility parameters in a range between the azeotrope 
mixture's solubility parameter and the entrained component's solubility parameter. From the initial 
design step, several ionic liquid candidates can be generated. Next, the candidates are screened based 
on other desirable properties such as melting temperature, thermal decomposition temperature, and 
toxicity. The candidates remaining are then screened using the UNIFAC-IL model to determine how 
much IL is needed to break the desired azeotrope. The candidates requiring minimal ionic liquid 
concentrations are then finally screened based on distillation column energy requirements as 
determined by simulation (see Section 6.0).  
For the examples provided in this work, the property models for the screening of secondary properties 
are not yet available. To provide an illustrative example of the proposed methodology, the initial 
number of design candidates was limited. Only two candidates for each azeotropic mixture were 
selected based on the extremes of the range of solubility parameters that are considered. One ionic 
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liquid was selected based on its match to the azeotropic mixture’s solubility parameter and another was 
selected based on its match to the component that is desired to be entrained. Then, the candidates are 
screened by comparing the amount of ionic liquid needed to break the azeotrope. For the examples 
given, the best possible ionic liquid is not guaranteed to be selected as the entire range of design 
candidates was not considered.   
The optimization problem was formulated as a mixed-integer linear program (MILP) and solved using 
the CPLEX solver in GAMS (CPLEX solution manual, http://www.gams.com/dd/docs/solvers/cplex.pdf). 
Due to the simplicity of the design problem, use of a deterministic method was feasible and chosen to 
ensure global optimality of the solution. The objective function was used to minimize the difference 
between the target solubility parameter (       ) and the predicted solubility parameter of the designed 
ionic liquid (     ). For the examples given, the target is either set to the volume average solubility 
parameter of the mixture at the azeotrope or the solubility parameter of the entrained component. To 
make the problem formulation linear, the absolute value term was transformed into the sum of two 
error terms for each data point (  
    
 ) and additional constraints were added (Ferguson). The 
resulting objective function and constraints are given by Equation 5.1. 
            
    s.t. 
                   
                   
  
    
    
   
(Equation 5.1) 
To ensure a feasible ionic liquid was designed, several structural constraints were added. Many common 
ionic liquids have methyl, ethyl, butyl, hexyl, and octyl alkyl groups on the cation. To determine the 
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number of CH2 groups and ensure that the number matched with common ionic liquids, the following 
constraints were introduced: 
                (   )     (   )     (   )     (   )     (   ) 
      
(Equation 5.2) 
∑ ( )   
 
   
 
   
(Equation 5.3) 
where  ( ) is a binary variable declaring the existence of an alkyl chain. Due to the limited property 
models, only ionic liquids with one alkyl chain on the cation were designed. If desired, Equation 5.3 
could be edited to allow for more than one alkyl chain. To ensure that only one cation and one anion 
were used in the design of the ionic liquid, constraints are given by Equation 5.4. 
∑       ( )   
 
   
 
  
∑       ( )   
 
   
 
  
(Equation 5.4) 
where        ( ) and       ( ) are binary variables declaring the existence of cation i and anion k, 
respectively. The variables n and m represent the number of cation groups and anion groups available 
for design. Once an ionic liquid candidate was chosen, the UNIFAC-IL model was used to verify that the 
azeotrope was broken by the ionic liquid and to ensure that only one liquid phase was present.  
 
101 
 
5.2 USE OF TABU SEARCH IN DESIGN OF IONIC LIQUID EXTRACTANTS AND CARBOHYDRATE GLASS-
FORMERS 
An existing molecular design framework was utilized for the design of ionic liquid extractants and 
carbohydrate glass-formers (Eslick 2009; Eslick, Ye et al. 2009; McLeese, Eslick et al. 2010). Tabu search 
was used to provide locally optimal solutions. The design targets for the two design problems are given 
in Table 5.1. 
Table 5.1 Property targets for molecular design using tabu search The tabu search was performed via a 
modified version of Polymer Designer Pro (Eslick, Ye et al. 2009).  
Ionic Liquid Extractant  
Property Target 
Partition coefficient (Kx) 50 
Toxicity (lnEC50) 4.0 
Carbohydrate Glass-Former  
Property Target 
Glass Transition Temperature of the Anhydrous Solute (Tg) 100°C 
Glass Transition Temperature of the Maximally Freeze-Concentrated Solute (Tg’) -30°C 
Melting Temperature of Ice (Tm’) -25°C 
Concentration of the Maximally Freeze-Concentrated Solute (Cg’) 0.85 
 
The existing molecular design framework was contained in a software package named Polymer Designer 
(PD), written in C++ (Eslick 2009). For each design case, groups were changed to represent groups that 
existed in the data set used to develop the corresponding property models. Design was limited to the 
cation for the ionic liquid extactant case, with the anion set at tris(perfluoroalkyl)trifluorophosphate 
(FAP). The groups used for both design problems are catalogued in Appendix C, along with general 
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guidelines for the use of PD. Additionally, the necessary property models were added to the program. 
The tabu Search algorithm used in PD follows a procedure similar to the tabu Search algorithm 
described in Section 5.3.3.   
While useful for optimal structure determination, several factors necessitated the development of a 
separate software package for design of carbohydrate excipients for lyophilized protein formulations. 
The primary reason was the desire for comparison between tabu Search and genetic algorithms for use 
in CAMD. A molecular representation that would be useful for both stochastic methods was necessary 
for fair comparison. PD was developed with concern for cross-linked polymer systems and thus some 
elements of the code were unnecessary for the design problems considered and added time to solution. 
Additionally, tuning required easily editable parameter values. Any editing done to the source code or 
group database for PD requires the program to be deleted and the code to be recompiled. The steps 
needed for editing and recompiling the PD code are detailed in Appendix C. As the solution methods 
needed to be ran many times for tuning purposes with different parameter values, ultimately the 
existing framework proved too cumbersome. Development of a framework more suited to the desired 
tasks is given in the following section. 
5.3 DEVELOPMENT OF STOCHASTIC DESIGN METHODS FOR CARBOHYDRATE EXCIPIENTS IN 
LYOPHILIZED PROTEIN FORMULATIONS 
A CAMD framework for the design of carbohydrate excipients was developed for use with either tabu 
search or a genetic algorithm. The framework was implemented in Visual Basic for Applications (VBA), 
with Microsoft Excel used as the database for groups used in design. The overall framework is 
diagramed in Figure 5.1. 
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5.3.1 Molecular Representation 
For implementation of the design phase, a representation is needed for the molecular structure that 
allows calculation of relevant descriptors and properties. The molecular representation also needs to 
allow for easy structural modifications to determine new solutions. For the work detailed here, the 
lowest level of molecular representation is given by an array of group numbers. Each number 
corresponds to a database entry which contains the group adjacency matrix, the vertex degree I for 
each non-hydrogen atom in the group, the valence vertex degree i
v for each non-hydrogen atom in the 
group and the number of hydrogens bonded to each non-hydrogen atom in the group. For the design of 
carbohydrate excipients, 9 building block groups were identified from the set of molecules used to 
generate the experimental %Monomer values. From the building blocks groups selected, chiral sub-
groups were identified with 89 total groups available for use (see Table 5.2). Terminal groups were fixed 
as hydroxyl groups. 
 
Figure 5.1 CAMD framework developed to design carbohydrate excipients using either tabu search or 
a genetic algorithm The CAMD module contains the functions needed to build the adjacency matrix 
from the array of groups present in the molecule. See Table 5.3 for more details.   
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Table 5.2 Building block groups and chiral subgroups available for design of new excipient candidates  
Chiral carbons are identified with “*”. Connections to the next group are identified by “X”.  
 
Building Block Group Chemical Formula Group Structure 
Number of Chiral 
Sub-Groups 
1 CH2 
 
N/A 
2 CH2O 
 
2 
3 O 
 
N/A 
4 CO 
 
N/A 
5 C3H6O2 
 
4 
6 C4H6O3 
 
16 
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7 C5H8O4 
 
16 
8 C5H8O3 
 
16 
9 C5H8O4 
 
32 
 
  
By factoring in chirality, there is an order of magnitude increase in the number of groups available for 
selection during the generation of new candidate structures. The increase in the number of groups 
available for selection has a marked impact on the number of possible molecular structure 
combinations, resulting in a combinatorial problem. Figure 5.2 demonstrates how the number of 
possible combinations increases exponentially as the number of groups available for selection increases. 
For the design problem considered, the maximum number of groups selected is set at six as all 
molecules used in the data set can be described by six or fewer of the groups given in Table 5.2. With a 
maximum molecule size of six groups and 89 groups available for selection, 8.66x108 combinations and 
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5.03x1011 permutations exist. Given the number of possible solutions, a rational and effective method is 
needed to quickly identify only the most promising candidates. The stochastic methods utilized in the 
CAMD framework proposed offer a means to eliminate the combinatorial contribution to the design 
problem. 
 
Figure 5.2 Number of possible combinations of groups that would provide solutions to a CAMD 
problem  The number of combinations are a function of the maximum number of groups selected and 
the number of distinct groups available for selection The vertical axis uses a logarithmic scale. 
  
The low-level group representation is used in the stochastic methods, where groups are changed 
according to the rules for each algorithm (see Sections 5.3.3 and 5.3.4 for more details). For property 
calculation, a higher level of detail is needed. The groups are used to construct an adjacency matrix for 
the molecule. Lists containing the vertex degree (I) for each non-hydrogen atom in the molecule, the 
valence vertex degree (i
v) for each non-hydrogen atom in the molecule and the number of hydrogens 
bonded to each non-hydrogen atom in the molecule are also generated. The functions and subroutines 
used to build the molecular representations are detailed in Table 5.3. The source code for the functions 
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and subroutines is given in Appendix D. From the adjacency matrix and the lists, connectivity indices can 
be calculated. 
  
 
108 
 
Table 5.3 Description of VBA functions and subroutines used for molecular representation Source code 
can be found in Appendix D.  
 
Function Name Argument(s) Resulting Value 
atoms Number of group  Number of atoms in group 
name Number of group 
String containing name of 
worksheet in excel database 
containing group structural 
information 
terminus 
Number of group, number of atom in molecule 
that represents the left-hand terminal atom in 
group 
Number of the atom in the 
molecule that represents the 
right-hand terminal atom in 
group 
Subroutine Name Argument(s) Result of Procedure 
BuildMolecule 
Array containing groups in molecule, array 
containing the vertex degree (I) for each non-
hydrogen atom in the molecule, array containing 
the valence vertex degree (i
v) for each non-
hydrogen atom in the molecule, array containing 
the number of hydrogens bonded to each non-
hydrogen atom in the molecule, array containing 
adjacency matrix 
Adds hydroxyl terminals to 
both the first and last group 
in the molecule. Updates 
adjacency matrix and lists of 
other structural values for 
molecule represented by the 
array containing the groups in 
the molecule 
GetConnectivity 
Array containing the vertex degree (I) for each 
non-hydrogen atom in the molecule, array 
containing the valence vertex degree (i
v) for 
each non-hydrogen atom in the molecule, array 
containing the number of hydrogens bonded to 
each non-hydrogen atom in the molecule, array 
containing adjacency matrix, number of non-
hydrogen atoms in the molecule, array 
containing simple connectivity indices (),array 
containing valence connectivity indices (v), 
array containing average simple connectivity 
indices (),array containing average valence 
connectivity indices (v) 
Updates chiral connectivity 
index values for molecule 
represented by the adjacency 
matrix and lists of other 
structural values 
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5.3.2 Calculation of Chiral Connectivity Indices and Objective Function 
A depth-first search algorithm is used to determine the existence of paths in the adjacency matrix 
ranging from lengths of zero to five (West 2001). The path length information is then used calculate the 
chiral connectivity indices. Both the path search and connectivity index calculation are performed in the 
GetConnectivity subroutine (see Table 5.3 and Appendix D).  The calculated chiral connectivity indices 
are used for property prediction, which is in turn used to calculate the objective function value. The 
objective function is a characteristic CAMD type which describes the sum of the normalized absolute 
differences between target properties and predicted properties (See Section 2.12 and Equation 2.8).  
The objective function used has been modified by the inclusion of a penalty score and is given by 
Equation 5.5. The penalty score is used to disallow final solutions from containing certain group 
combinations that are unfavorable. In particular, the formation of peroxide bonds (O-O) and bonding of 
two ring groups together are prevented through use of the penalty scores. Peroxides are undesired as 
the bond is unstable. A bond between two rings in not wanted as such a bond is not observed in 
carbohydrates. The penalty score is large enough to make objective function values for solutions 
containing such structural features to be much larger in comparison to solutions without said features. 
The penalty function along with the rules for adding and removing groups in each of the stochastic 
design methods (explained further in Sections 5.3.3 and 5.3.4) eliminates the need for explicit structural 
constraints. Additionally, the definition of groups eliminates the need to store the presence of double or 
triple bonds in the adjacency matrix. 
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(Equation 5.5) 
5.3.3 Tabu Search Algorithm 
The tabu search algorithm utilizes solution history to generate locally optimal solutions to the molecular 
design problem. In the following implementation, solutions are given as arrays of groups representing 
the molecular structure. The tabu search algorithm developed is given in Figure 5.3. The tabu search 
begins with a random initial solution which is generated by calling the InitialSolution subroutine (see 
Table 5.4 and Appendix D). The connectivity indices are calculated for the initial solution and used to 
determine the objective function. The solution is set as the current solution and then stored as the initial 
entry in the tabu list. The information stored in the tabu list is comprised of the array of groups 
comprising the molecule and the 0 value for checking to see if a solution is tabu. 
The first iteration then begins by determining the number of neighbors to the current solution. The 
number chosen is a random integer with a value between one and the set maximum number of 
members to evaluate. A neighboring structure is generated through use of the Make_Neighbor function, 
which takes the current solution’s array of groups as an argument and returns a neighboring solution’s 
array of groups (see Appendix D). The Make_Neighbor function randomly selects one of four types of 
local moves to be made to generate the neighboring solution. The types of moves are explained with 
examples in Table 5.4.  
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Figure 5.3 Tabu search algorithm as implemented in the CAMD framework 
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Table 5.4 Moves used to generate neighbors to current solution in tabu search Moves are classified 
either as local or global. Letters are analogous to the group numbers used to represent the molecule in 
the algorithm. The highlighted letter(s) represents the group(s) selected by the move operation.  
 
Local Moves 
Name Description Example 
Swap 
Selects two random groups and switches 
their position in the molecule. 
A-B-C-D  A-D-C-B 
Insert 
Selects two random groups and inserts a 
random group between their positions in 
the molecule.  
A-B-C-D  A-B-A-C-D 
Delete 
Selects one random group and removes 
the group from the molecule. 
A-B-C-D  A-B-D 
Replace 
Selects one random group and replaces the 
group with a new, randomly generated 
group. 
A-B-C-D  A-B-A-D 
Global Moves 
Name Description Example 
InitialSolution 
Completely rebuilds a new solution, 
selecting random groups to comprise the 
molecule. 
A-B-C-D  C-A-A 
 
Following the generation of neighbors, each is checked against the tabu list. A solution is considered 
tabu if it violates the tabu criterion, which is given by Equation 5.6. A solution must pass tabu testing for 
all members on the tabu list to be accepted. If the solution is accepted, the solution becomes the first 
entry in the tabu list and the indices for all other entries in the tabu list are increased by one. Once the 
index of an entry exceeds the maximum size of the tabu list, the entry is removed from the tabu list. 
Therefore stored solutions leave memory on a first-in-first-out basis. The tabu list provides short-term 
solution memory. 
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 |                 
(Equation 5.6) 
If the solution violates the tabu criterion, the solution’s objective function is chec ed against the best 
known solution. If the new tabu solution has a superior objective function to the best solution found so 
far, the new solution is retained despite its tabu status. The process of allowing violation of tabu criteria 
for good solutions is referred to as aspiration (Glover 1989).  If all of the neighbors are deemed tabu, 
then a global move is used to direct the local search to new region of the solution space. The global 
move used is creation of a new random solution (see Table 5.4). The best non-tabu solution or best 
solution allowed by aspiration is chosen as the current solution. If the new current solution is better 
than any previously encountered solution, the solution is stored as the best solution. Storage of the best 
solution yet encountered provides long-term solution memory. The procedure continues until the 
maximum number of non-improving iterations is reached, where a solution obtained by a non-
improving iteration does not have a better objective function value than the best obtained solution. 
Upon completion, the solution encountered with the best objective function value is returned. 
5.3.4 Genetic Algorithm 
The genetic algorithm mimics evolution to provided locally optimal solutions to the CAMD problem. The 
data structure used for molecular structure is identical to the representation used in the tabu search. 
For the genetic algorithm, the groups are analogous to genes. Each molecule, or member of the 
population, is comprised of a set of genes. Genetic operations (i.e., moves) are used to alter the genes of 
members of the population. Through succession iterations, or generations, optimal genomes are 
determined. The procedure used by the genetic algorithm is detailed in Figure 5.4, with source code 
provided in Appendix D.   
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The search for solutions begins with random generation of members of the population through use of 
the InitialSolution subroutine (see Table 5.4 and Appendix D). The size of the population determines the 
number of solutions that are evaluated and generated during each generation. The fitness is determined 
for each member of the population, where the fitness is given as the inverse of the objective function 
(e.g., when the objective function is minimized, the fitness is maximized).  The fitness is used to 
calculate the probability (as a %) that a member will become a parent for the next generation through 
use of Equation 5.7. A parent is a member which undergoes a move to create a new member. 
           ( )       (
   ( )
∑    ( )    
) 
(Equation 5.7) 
Where Fit(j) represents the fitness of the j-th member of the population of size n. Once the probability is 
determined for a member, a roulette selection is used to determine whether the member will be a 
parent. A random integer between zero and the maximum allowable probability is chosen. If the integer 
is less than the probability calculated for the member, the member is chosen as a parent. Due to the 
semi-random selection, any number of members may become parents but members with higher fitness 
values are more likely to become parents. If no parents are chosen, then two parents are randomly 
selected from the population. The fitness of the selected parents is checked against the fitness of the 
best encountered solution. If the fitness exceeds the best known, the parent is retained in the next 
generation through a rule known as elitist policy (Venkatasubramanian, Chan et al. 1995). 
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Figure 5.4 Genetic algorithm as implemented in the CAMD framework 
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Table 5.5 Moves used to generate offspring to selected parents in the genetic algorithm Moves require 
either one parent or two parents. Letters are analogous to the genes or group numbers used to 
represent the molecule in the algorithm. The highlighted letter(s) represents the gene(s) selected by the 
move operation. Bold font is used in the two parent moves to distinguish groups belonging to the 
second parent.  
One Parent Moves 
Name Description Example 
Hop 
Selects two random genes and switches their 
position in the molecule. 
A-B-C-D  A-D-C-B 
Insert 
Selects two random genes and inserts a random 
gene between their positions in the molecule.  
A-B-C-D  A-B-A-C-D 
Delete 
Selects one random gene and removes the gene 
from the molecule. 
A-B-C-D  A-B-D 
Mutate 
Selects one random gene and replaces the gene 
with a new, randomly generated gene. 
A-B-C-D  A-B-A-D 
Two Parent Moves 
Name Description Example 
Blend 
Combines two parent molecules end to end to 
create one offspring molecule. 
A-B + C-D  A-B-C-D 
Crossover 
Selects a random gene in each parent molecule 
to use as a crossover point, generating two 
offspring molecules. 
A-B-C-D + A-B-C-D   
A-C-D + A-B-B-C-D 
 
New members for the next generation are produced by randomly selecting two parents from the list of 
parents generated through the roulette selection. The parents’ structures (given as group arrays) are 
used as arguments in the Make_Offspring function (see Appendix D). The Make_Offspring randomly 
selects either a one parent move or a two parent move to generate a new member for the next 
generation (see Table 5.5). Each move is analogous to known genetic operations that occur in genomes 
of organisms. Comparison shows that all one parent moves have matching local moves in the tabu 
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search algorithm (see Table 5.4). Following the generation of all new members of the population, the 
next generation begins. The genetic algorithm proceeds for a set number of maximum generations, 
returning the member with the highest fitness from the last generation.  
5.4 TUNING OF STOCHASTIC DESIGN METHODS FOR CARBOHYDRATE EXCIPIENTS IN LYOPHILIZED 
PROTEIN FORMULATIONS 
The objective of tuning is to produce a stochastic design method that efficiently produces high quality 
solutions. Efficiency is measured by the time to solution and quality is measured by the solution’s 
objective function value. Each design method contains several key parameters whose values affect the 
solution search. Tuning provided the rationale behind the values used for the parameter values in each 
design method. During tuning, a parameter was changed while all other values were kept constant. For 
each adjusted parameter value, 100 runs were performed with the objective values and times to 
solution captured for each run. The process was repeated for each parameter of interest. 
From the observations, parameter values were chosen to yield a high percentage of high quality 
solutions (designed molecules with property values within 5% of the target property values) while 
minimizing the time to solution. The parameters tuned for each method are detailed in the following 
subsections. The parameters are not exhaustive for the two stochastic methods considered, but do 
represent the key parameters for the methods as developed here. Different implementations of tabu 
search and genetic algorithms may use slightly different parameters to guide the search for new 
solutions than the parameters presented here. The parameters used here were chosen to allow the best 
comparison possible between the two methods for CAMD applications. 
A simple test case with a known global optimum was used as the test case for tuning. Each algorithm 
was used to generate solutions with a target molecular weight of 342 g/mol. For tuning, penalty 
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functions were not employed in the objective function. The only other difference between the tuning 
and final design runs is the property model that is used, which does not affect the search process and 
only affects the objective function calculated for a given molecular structure. Thus it is expected that the 
tuning results would hold for any other CAMD design case where only the property model is altered. 
5.4.1 Tabu Search Algorithm 
For the tabu search algorithm, four parameters were used for tuning: 
 Maximum number of non-improving iterations – determines how long the search will be 
performed. 
 Maximum number of neighbors evaluated per iteration – determines how many new solutions 
to consider at each iteration. 
 Size of tabu list – determines how many previous solutions are stored in memory. Also effects 
the time spent checking to see if a solution is tabu.  
 Tabu criterion – determines how likely a solution is to be considered tabu.  
The base parameter values are presented in Table 5.6.  
Table 5.6 Parameter values used for the base case during tuning of the tabu search Parameters were 
altered on at a time to observe the effects of the parameter value on solution quality and time to 
solution.  
Parameter Base Value 
Maximum number of non-improving iterations 10 
Maximum number of neighbors evaluated per iteration 2 
Size of tabu list 10 
Tabu criterion 0.5 
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5.4.2 Genetic Algorithm 
For the genetic algorithm, three parameters were used for tuning. The base parameter values are 
presented in Table 5.7: 
 Maximum number of generations – determines how long the search will be performed. 
 Population size – determines how many solutions are considered at each iteration/generation. 
 Maximum allowable probability that member is chosen as parent – determines how likely a 
solution is to be used as a parent to generate new solutions for the next iteration/generation. As 
the value decreases, it becomes more likely that any given solution will be selected as a parent. 
Table 5.7 Parameter values used for the base case during tuning of the genetic algorithm Parameters 
were altered on at a time to observe the effects of the parameter value on solution quality and time to 
solution.  
Parameter Base Value 
Maximum number of generations 10 
Population size 10 
Maximum allowable probability 100 
 
5.5 COMPARISON OF STOCHASTIC DESIGN METHODS FOR CARBOHYDRATE EXCIPIENTS IN 
LYOPHILIZED PROTEIN FORMULATIONS 
From the design methods, many excipient candidates are designed. The value of the objective function 
represents the indicator of solution quality, with the minimal value representing the optimal solution. 
Comparison of objective function values between the candidates generated by tabu Search and the 
genetic algorithm allows for identification of the method that provides the best overall solution as well 
as the method that most consistently provides good solutions (as defined by the percentage of designed 
molecules with property values within 5% of the target property values). However, solely relying on the 
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objective function value may be misleading as many candidates could have statistically similar property 
values to best solution and thus be solutions of equal quality. 
A QSPR’s use lies in predicting a property for a new molecule of interest, represented by the molecular 
descriptors. The resulting predicted value has some error term involved. A novel approach to design 
solution comparison using prediction intervals was utilized. Prediction intervals allow for the error from 
the fitted model as well as any error in a future observation to be quantified (Wasserman 2004). A 
confidence interval only accounts for error in the correlation, so a prediction interval is always larger 
than a confidence interval. A 1 -  prediction interval for a predicted property of interest   is given by 
Equation 5.8. 
      ⁄ √ ̂
 (  
 (   )      ) 
    Equation 5.8 
where    ⁄  is the student’s t-test value for the given degrees of freedom,    is the vector of descriptors 
used in the prediction,   
  is the transposed vector of descriptors used in the prediction,   is the matrix 
of descriptors used to build the correlation,    is the transposed matrix of descriptors used to build the 
correlation, and  ̂  is the unbiased estimator of the model variance. 
Given the connectivity indices for a designed carbohydrate excipient, new property values were 
predicted. Using the connectivity index values, R was used to calculate prediction intervals at a 95% level 
(The R Project for Statistical Computing, www.r-project.org). The procedure used in R for calculation of 
prediction intervals along with sample code is given in Appendix B. The prediction intervals were 
included to provide a reasonable range for the expected properties of the designed excipient molecule. 
The prediction intervals were also used to determine if two solutions from the optimal design phase 
were statistically different once the solutions were found using either tabu search or a genetic 
algorithm. When comparing the predicted properties of two designed molecules, overlapping prediction 
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intervals indicate that the solutions are not statistically different. The use of prediction intervals to 
compare solutions represents a novel approach to evaluating solutions generated in computer-aided 
molecular design. 
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6.0 SIMULTANEOUS PRODUCT AND PROCESS DESIGN 
CAMD was linked with separation process design for the simultaneous design of an ionic liquid entrainer 
and azeotropic separation process. Key to the IL-based separation process is the extractive distillation 
column, where the azeotrope is broken. Once a candidate was designed and confirmed to break an 
azeotrope of interest using the UNIFAC-IL model, design of the separation process was performed. The 
extractive distillation column was designed using the driving force method, as detailed in Section 6.1. 
After design of the column, simulations were used to design the ionic liquid recovery unit and to 
determine overall heat duty for the process. The simulation procedure is given in Section 6.2. The overall 
feedback between product and process design is outlined in Figure 6.1. Details concerning the molecular 
design component can be found in Section 5.1. 
 
Figure 6.1 Overall methodology for simultaneous design of ionic liquid entrainers and IL-based 
separation processes Figure is adapted from (Roughton, Christian et al. 2012).  
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6.1 DRIVING FORCE BASED DESIGN 
For separation of a given azeotrope, an extractive distillation column was designed using the driving 
force method. The driving force is defined as the difference between the vapor and liquid composition 
of the light key component (Bek-Pedersen, Gani et al. 2000).  The driving force is used to evaluate the 
feasibility of a proposed separation process, ensuring that the driving force is never zero (Bek-Pedersen, 
Gani et al. 2000). By designing the separation process based upon the maximum driving force, near 
optimal distillation columns can be designed with respect to energy requirements (Gani and Bek-
Pedersen 2000).  
The UNIFAC-IL model was used to generate the driving force for each ternary system consisting of the 
binary azeotrope plus an ionic liquid. The two components comprising the azeotropic mixture were 
defined as the key binary mixture. Product purities of the azeotrope components (on an ionic liquid free 
basis) were specified at ASTM purity standards. The driving force was plotted against the light key 
component mole fraction and the location (Dx) and value (Dy) of the maximum driving force was 
determined for varying ionic liquid compositions. The number of stages (N) were determined by finding 
the minimum number of stages necessary to achieve the desired product specifications, as determined 
by rigorous simulation (detailed in section 2.3.2). As the location of the maximum driving force was 
determined on an ionic liquid free basis, the location was modified using Equation 6.1. The driving force 
profile is only an estimate for the systems considered, as the ionic liquid concentration may vary 
throughout the column. The feed stage location (NF) was determined using Equation 6.2 (Gani and Bek-
Pedersen 2000) with a modification due to one stage being used as the entrainer feed stage. 
   (     )                
  
(Equation 6.1) 
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   (    )(   ) 
   
(Equation 6.2) 
The original driving force method was proposed for systems with one feed. The proposed distillation 
column consists of a main feed for the azeotropic mixture and an ionic liquid feed at the top of the 
tower. For moderate to high ionic liquid concentrations, scaling of the feed tray location may be 
necessary. The scaling factor (SF) is given by Equation 6.3, where       is the specification for the light 
key distillate mole fraction and      is the specification for the heavy key bottoms mole fraction (Bek-
Pedersen, Gani et al. 2000). Calculation of      and      is performed taking into account the ionic 
liquid present in the column. When SF ≤ 0.01 and    < 0.7, scaling is necessary and Equation 6.4 is used 
to determine the site where the feed stage should be relocated in the column. In the initial 
implementation of driving force based design, the feed stage will always move up the column between a 
minimum of 10% of the total number of trays when scaling is required. By scaling the feed tray location 
through use of Equation 6.4, a more accurate location is determined then by relocating either by 5% or 
10% as proposed by Bek-Pedersen et al. (Bek-Pedersen, Gani et al. 2000). By using the scaled feed tray 
location when the stated conditions are met, a near-optimal column design is achieved with respect to 
overall energy consumption for a column with a main feed and a separate ionic liquid feed.  
   
      
      
 
     
(Equation 6.3) 
            [        (  )] 
   
(Equation 6.4) 
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6.2 AZEOTROPE SEPARATION PROCESS SIMULATION 
ChemCAD (www.chemstations.com) was used for rigorous simulation of the extractive distillation 
processes. The overall process selected for separation of the azeotropic mixtures and  regeneration of 
the ionic liquid has been used successfully in design and simulation of ionic liquid-based separation 
processes (Seiler, Jork et al. 2004). The process, shown in Figure 6.2, consists of a distillation column, 
flash drum, and stripper. The distillation column is used to separate the light key component (1) from 
the heavy key component (2) and the ionic liquid (3). The flash drum and stripper are used to separate 
component (2) and any remaining component (1) from the ionic liquid. The proposed process is 
desirable as it minimizes energy inputs and the stripper uses only air to regenerate the ionic liquid 
entrainer. 
 
Figure 6.2 Proposed ionic liquid-based azeotropic separation process A distillation column is used to 
separate the light (1) and heavy (2) components, which the ionic liquid (3) entraining the heavy 
component. The heavy component is then separated from the ionic liquid by flash distillation and 
stripping.  
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Fixed parameters for the process were chosen to match previous simulation work (Seiler et al., 2004) for 
comparison of results. For both the acetone-methanol and ethanol-water azeotropes, a total feed rate 
of 200 kmol per hour was used. Ionic liquid feed rate, column size, and feed tray location were altered 
to minimize energy consumption of the column. The distillate specifications were set to ASTM standards 
for purity. The azeotropic mixture was fed as a saturated liquid. The ionic liquid was fed at the same 
temperature as the feed. First approximation of the feed stage location was obtained using the driving 
force method as outlined in the previous section. The location was then moved above and below the 
initial stage to ensure that energy use was minimized. The procedure was repeated for varying flow 
rates of ionic liquid until a column configuration and entrainer flow rate that minimized overall energy 
consumption was identified.  The values of the free variables for the entire distillation and entrainer 
regeneration process were determined by the ChemCAD solver such that overall energy requirements 
were minimized, while also satisfying constraints on column size, air flow rate and final product purity of 
the ionic liquid entrainer leaving the column (specified as 99.9% pure on a molar basis). The fixed 
parameters and free process variables are outlined in Table 6.1 for both azeotropic systems.  
Prediction of heat capacity was needed for the ionic liquids in order to accurately calculate the energy 
requirements of the proposed separation processes. Group contribution models from literature were 
used to predict the isobaric heat capacities of the ionic liquids used in the simulations (Gardas and 
Coutinho 2008; Ren, Zhao et al. 2011). Column simulation was performed for both the optimal and non-
optimal ionic liquid entrainers (selected for comparison purposes). The entire process, including 
entrainer regeneration, was performed only for the best ionic liquid candidates. Energy requirements 
for the ethanol-water separation were compared to results found for an ionic liquid known to 
experimentally break the given azeotropes but not designed with CAMD methods (henceforth referred 
to as an experimentally-selected ionic liquid) and also for a conventional entrainer (Seiler, Jork et al. 
2004). 
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Table 6.1 Fixed parameters and free variables for ionic liquid-based extractive distillation processes  
 
Fixed Parameters    
  Acetone-Methanol Ethanol -Water 
Distillation Column    
 Operating pressure [atm] 1.00 1.00 
Column Feed    
 Flow rate [kmol/hr] 200 200 
 x1 0.5 0.7 
 x2 0.5 0.3 
Distillate    
 Flow rate [kmol/hr] 100 140 
 x1 0.995 0.998 
Flash Tank    
 Operating pressure [atm] 0.10 0.10 
Stripper    
 xIL (bottom) 0.999 0.999 
 Air temperature [K] 298.15 298.15 
Free Variables    
Distillation Column    
 Number of stages   
 Feed stage   
 Reflux ratio   
Flash Tank    
 Temperature   
Stripper    
 Number of stages   
 Air flow rate   
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7.0 MOLECULAR SIMULATION FOR DESIGN AND POST-DESIGN STAGES  
Stabilizing additives, or excipients, are often included in lyophilized formulations to reduce aggregation. 
Nonionic surfactants have been shown to bind with weak affinity to proteins (McNally and Hastedt 
2008). Such binding could interact with hydrophobic regions on the protein and limit access to 
aggregation prone “hot spots”.  Nonionic surfactants such as Tween 80 have been shown to decrease 
aggregation in lyophilized protein formulations (Kerwin 2008). However, difficulties can arrise during the 
lyophilization process due to the low glass transition temperatures exhibited by surfactants (McNally 
and Hastedt 2008). A successful formulation using surfactants requires the presence of glass formers, 
such as sugars or polymers. 
Sugar molecules have also been shown to exhibit site-specific effects on proteins during lyophilization 
through use of hydrogen-deuterium exchange mass spectroscopy (Li, Williams et al. 2008), indicating 
that interaction between sugars and proteins occur in the lyophilized state. Such interactions can be 
exploited to provide better coverage of aggregation prone “hot spots” on the protein. By selecting 
excipients that interact preferably with aggregation prone regions, a lyophilized formulation can be 
developed to reduce aggregation.  
In following section, a simulation-guided design approach is utilized to select a sugar and surfactant pair 
that optimally provides the most interaction with an aggregation prone region on the protein 
calmodulin (Protein ID #1CLL, Protein Data Bank via http://www.rcsb.org/pdb/home/home.do). By 
choosing a formulation with maximal protein-excipient interactions, the potential for aggregation is 
reduced. While surfactants may interact more than sugars on a per molecule basis, a sugar was included 
to ensure that a stable glass could be formed. The use of molecular docking simulations to aid in post-
design screening is also proposed. 
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7.1 USE OF AUTODOCK FOR BLIND DOCKING SIMULATIONS 
Molecular simulation results were generated for use in guiding formulation design. The tool used for 
molecular simulation was AutoDock (http://autodock.scripps.edu/), which utilizes blind docking to 
determine regions of protein-ligand interaction with no a priori knowledge of binding site (Huey, Morris 
et al. 2007). AutoDock employs a grid-based approach along with a semiempirical free energy force field 
to identify interaction sites with minimal free energy (Huey, Morris et al. 2007). AutoDock leaves the 
protein as a rigid molecule and only adjusts the ligand conformation. The ligand conformation is 
described by rotation, translation and torsional degrees of freedom (Goodsell, Morris et al. 1996). 
Search for conformations is guided by one of three stochastic optimization methods chosen by the user: 
Monte Carlo simulated annealing, traditional genetic algorithm and Lamarkian genetic algorithm 
(Morris, Goodsell et al. 1998). As all solution methods are stochastic, the conformations returned are 
local optima. The work presented here employs the simulated annealing method. Blind docking has 
proved successful in detecting binding sites on proteins for small molecule drug-like compounds 
(Hetényi and van der Spoel 2006) and peptides (Hetényi and van der Spoel 2002), which encompass the 
size of descriptors considered here.  
7.2 DETERMINATION OF PROTEIN-EXCIPIENT INTERACTIONS 
To predict the amino acids of calmodulin most likely to interact with a given excipient, blind docking 
simulations were performed using AutoDock. Each simulation provided ten docking conformations that 
provided the lowest free energy of the conformations encountered. Five simulations were done for each 
excipient with calmodulin, providing fifty docking conformations total for each excipient. Each 
conformation was analyzed to determine which resides were in contact, through hydrogen bonding, 
with the excipient molecule. An important limitation to note is that the blind docking simulations do not 
consider that the protein is lyophilized but rather employ an implicit solvation model. It follows that the 
approach used for estimating protein-excipient interactions does not take into account any dynamics 
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that may result from the lyophilization process. The approach only provides a first-approximation of 
protein-excipeint interactions that may be present. Docking free energy calculations are therefore not 
instructive to the approach taken and are not utilized. 
The computational results from Autodock were qualitatively compared to experimental hydrogen-
deuterium exchange (HDX) mass spectroscopy experiments using lyophilized formulations of calmodulin 
and either trehalose, sucrose, raffinose, or mannitol (Li, Williams et al. 2008). Regions of the protein that 
are able to freely exchange hydrogen for deuterium are exposed and are not protected by protein-
excipient interactions. Experimentally, the extent of protein-excipient interactions is inversely related to 
deuterium uptake. For comparison between experimental and simulation results, it is expected that 
regions of high protein-excipient interaction identified by simulation should correspond with regions of 
low deuterium uptake experimentally. 
7.3 OPTIMAL SELECTION OF EXCIPIENTS 
Contact information provided by the docking simulations was used to optimally select excipients that 
have the highest number of interactions with aggregation prone “hot spots”. The hot spots were 
predicted using Aggrescan (Conchillo-Sole, de Groot et al. 2007). For each hot spot, a sugar and a 
surfactant molecule were chosen to maximize protein-excipient interactions. For selection purposes, 
whichever excipient had the most interactions with a particular residue was chosen as the best 
candidate. It was assumed that the molecule with the most interactions with a residue would have the 
dominant effect and thus contribute the most to the protection of the residue of interest. At each 
residue in the hot spot, the best sugar candidate and the best surfactant candidate were compared. 
Whichever excipient had the most interactions was selected and the process was repeated for the entire 
hot spot sequence. The sugar-surfactant pair that provided the maximum number of interactions was 
selected as the optimal drug formulation. The formulation of the optimization problem is given in 
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Equation 7.1. The problem is formulated as a MINLP and was solved using the DICOPT solver in GAMS 
(GAMS documentation, http://www.gams.com/).  
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(Equation 7.1) 
 
where i is a residue location, n is the number of residues in the hot spot of interest, j is a specific sugar, 
and k is a specific surfactant. The scorej(i) and scorek(i) are input as parameters based on the results 
from molecular docking. The scores are integer values, but are not explicitly defined as such in GAMS. 
The constraints ensure that the highest interaction score between a sugar and a surfactant is chosen for 
each residue. The constraints provide an interaction score that is summarized below, without the need 
for disjunctive programming: 
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7.4 DOCKING SIMULATION RESULTS 
Docking simulations providing fifty conformations were performed individually for mannitol, trehalose, 
sucrose, raffinose, octyl glucoside, tween 40, and tween 80 with the protein calmodulin. The results for 
the sugars were compared to experimental HDX results. Overall, the docking results compared favorably 
with the HDX results. Regions of high interactions in the docking simulations corresponded to regions 
that were protected from hydrogen/deuterium exchange. The histogram of interactions versus residue 
location is provided in Figure 7.1 for trehalose. Residues that interacted frequently with trehalose match 
well with the shaded regions indicating protection from hydrogen/deuterium exchange.  
Figure 7.2 provides a visual comparison of the regions with high interaction and the regions protected 
from exchange for the trehalose-calmodulin system. From the comparison of the computational and 
experimental results, the docking simulations provide a reasonable prediction of the residues involved in 
protein-excipient interactions and provide a useful tool for selecting excipients for lyophilized protein 
formulations.  
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Figure 7.1 Frequency of amino acid residues of calmodulin in contact with trehalose Results are given 
for 50 docking conformations. The shaded regions indicate amino acids that were protected by 
trehalose in the lyophilized state, as determined by HDX experiments (Li, Williams et al. 2008). Figure 
adapted from (Roughton, Pokphanh et al. 2012). 
  
 
Figure 7.2 Trehalose interaction regions mapped to the surface of calmodulin Blue regions indicate 
residues that interacted with trehalose in more than three conformations. Red regions indicate regions 
that were protected by trehalose in the lyophilized state, as determined by HDX experiments. Purple 
regions are theintersect of the computationally predicted high interaction regions and the 
experimentally determined protected regions. Figure adapted from (Roughton, Pokphanh et al. 2012).  
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7.5 FORMULATION SELECTION FOR MAXIMIZING PROTEIN-EXCIPIENT INTERACTIONS  
Using the docking simulation results and the previously described optimization problem formulation, 
sugar-surfactant pairs were selected for each hot spot region on calmodulin. The hot spots were 
predicted using Aggrescan (Conchillo-Sole, de Groot et al. 2007). Due to the proximity of hot spots 4 and 
5, a formulation was also selected for the combined region. The results are given in Table 7.1. The 
interaction scores provided correspond to the number of interactions exhibited in the docking 
simulations. 
Table 7.1 Sugar-surfactant formulations selected for maximum interaction with hot spot regions Table 
adapted from (Roughton, Pokphanh et al. 2012).  
Hot 
Spot 
Amino 
Acids Sugar Surfactant 
Combined 
Interaction 
Score 
Sugar 
Interaction 
Score 
Surfactant 
Interaction 
Score 
1 15-19 Trehalose Tween 40 24 10 24 
2 33-38 Mannitol Tween 40 13 10 7 
3 67-73 Sucrose Tween 40 17 9 15 
4 99-103 Raffinose Octyl Glucoside 10 7 8 
5 106-111 Raffinose Tween 80 17 11 13 
6 141-145 Raffinose Octyl Glucoside 26 15 26 
4 & 5 99-111 Raffinose Octyl Glucoside 29 18 22 
 
 
The results show that the excipients providing maximal interactions vary from hot spot to hot spot. All 
available excipients were selected at least once. The addition of a sugar provided no additional 
interactions for the formulations selected for hot spots 1 and 6 and thus was not beneficial from a 
protein-excipient interaction standpoint. A sugar would be necessary to ensure a stable glass was 
formed during the lyophilization.  
The procedure outlined above could be used for any number of excipients and proteins to predict 
formulations with maximal protein-excipient interactions. By maximizing protein-excipient interactions, 
the aggregation propensity is reduced and a safer, more effective drug product is produced. The fact 
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that the sugar-surfactant pair providing maximal interactions differed between hotspots highlights the 
complexity of selecting beneficial excipients for a lyophilized protein formulation. 
While the proposed approach may have some application in the design phase of CAMD (as outlined 
above), a potentially more useful application is for post-design review. Following design, promising 
candidates could be further screened using a molecular docking approach to identify candidates with 
benficial protein-excipient interactions. Molecular docking provides a faster screening procedure than 
HDX experiments, which would be especially useful for large candidate lists. Following screening by 
molecular docking, HDX experiments can provide final verification and selection of design candidates. It 
is noted that additional protein-excipient systems have been explored using the molecular simulation 
approach outlined by Anthony I. Pokphanh and Haider S. Tarar at the University of Kansas. The data they 
have collected is not included in the presented work, but also provides good comparison to 
corresponding experimental HDX studies. 
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8.0 RESULTS FOR IONIC LIQUID DESIGN 
The following section contains the modeling and molecular design results for the two ionic liquid design 
examples considered: sections 8.1-8.3 are concerned with entrainer design and sections 8.4-8.5 are 
concerned with extractant design for in situ fermentation.  
The group contribution model for ionic liquid solubility parameter is presented in Section 8.1. The 
acetone-methanol and ethanol-water azeotropes were chosen for evaluation of the CAMD methodology 
for design of ionic liquid entrainers. In addition, the 1-propanol-water, 2-propanol-water, and ethyl 
acetate-ethanol azeotropes were used for evaluation of the UNIFAC-IL predictions in Section 8.2. The 
molecular design results for the ionic liquid entrainer case are presented in Section 8.3 and the 
separation process design results are given in Section 8.4. 
The connectivity index models for both the partition coefficient of NDHD in ionic liquid and ionic liquid 
toxicity are presented in Section 8.5. Design results for ionic liquid extractant design obtained through 
tabu search are discussed in Section 8.6. 
8.1 HILDEBRAND SOLUBILITY PARAMETER GROUP CONTRIBUTION MODEL 
Experimental values for 24 different ionic liquids was used for the development of the  Hildebrand 
solubility parameter GC model (Marciniak 2010). In addition to 3 terms for the alkyl chain groups, 5 
cation and 12 anion groups were used to describe the ionic liquids in the data set. The total number of 
independent variables in the model are 21 (including a constant term), giving 3 degrees of freedom. The 
degrees of freedom are relatively low, which is a consequence of the use of group contribution models 
with small data sets. The developed model (see Equation 4.17) provides a good fit of experimental data 
with a value of 0.34 %AARD between the predicted and experimental solubility parameter values. The 
maximum relative deviation observed was 0.305. The results are shown in Figure 8.1. 
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Figure 8.1 Comparison between experimental and predicted solubility parameter values Predictions 
were made using the group contribution model shown in Table 8.1. Experimental ionic liquid solubility 
values are obtained from (Marciniak 2010). Figure adapted from (Roughton, Christian et al. 2012).  
 
The contributions for each group are given in Table 8.1 Increasing the alkyl chain length decreases the 
overall solubility parameter value, as the value for CH2 groups is negative. Ionic liquids with pyridinium 
cations are usually more hydrophobic than those with imidazolium cations (Papaiconomou, Salminen et 
al. 2007), reflected in the model by the smaller contribution for the pyridinium cation compared to the 
imidazolium cation. In general, the many of the anion contributions are larger in magnitude than the 
commonly encountered imidazolium, pyridinium, and pyrrolidonium cation contributions. For the design 
examples, only imidazolium and pyridinium cations were used as cation choices to ensure that the 
UNIFAC-IL model could be used to predict VLE. The minimum solubility parameter value predicted by 
the model using the design problem’s cation restrictions was 17.8 MPa1/2 for 1-octyl-4-methylpyridinium 
chloride. The maximum solubility parameter value predicted was 32.6 MPa1/2 for 1,3-
dimethylimidazolium tetrafluoroborate.  
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Table 8.1 Group contribution values for ionic liquid Hildebrand solubility parameter model See Table 
4.4 for descriptions of groups. Table is adapted from (Roughton, Christian et al. 2012).  
Ionic Liquid Group Contribution (MPa
1/2
) 
Cation groups    
 Imidazolium (Im) 1.427 
 Pyridinium (Py) 1.355 
 Pyrrolidonium (Pyr) 1.765 
 Phosphonium (P) -13.633 
 Sulfonium (S)  -16.101 
Anion groups   
 Trifluoroacetate (CF3COO) 1.720 
 Thiocyanide (SCN) 1.342 
 Trifluormethane sulfonate (CF3SO3) -0.629 
 2-(2-methoxyethoxy)ethyl sulfate (MDEGSO4) 1.603 
 Octyl sulfate (OcSO4) -0.367 
 Tosylate (TOS) -0.065 
 Bis(trifluoromethylsulfonyl)imide (Tf2N) -2.485 
 Dimethyl phosphate (DMP) 2.918 
 Diethyl phosphate (DEP) 2.120 
 Tetrafluoroborate (BF4) 8.403 
 Hexafluorophosphate (PF6) 6.319 
 Chloride (Cl) -4.000 
Alkyl chain groups   
 CH3 9.094 
 CH2 -0.322 
 CH2O 0.496 
Intercept (constant) 4.547 
 
8.2 UNIFAC-IL MODEL 
8.2.1 UNIFAC-IL Parameters 
Using the previous described procedure, group volume and surface area parameters were defined for all 
ionic liquid groups used in the UNIFAC-IL model. The results are given in Table 8.2. The subgroups for the 
cation are chosen based on the smallest alkyl group present in the cation. For example, 1,3-
dimethylimidazolium is represented by a [MIm] and a CH3 group. 1-octyl-4-methylpyridinium is 
represented by a [MPy] group, a CH3 group, and seven CH2 groups. Group parameters for existing 
UNIFAC groups were not changed.  
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Table 8.2 Volume (Rk) and surface area (Qk) parameters for the UNIFAC-IL model The [MIm] and [MPy] 
subgroups are for the imidazolium and pyridinium cations that contain a methyl group. Table adapted 
from (Roughton, Christian et al. 2012).  
 
Group Subgroup Rk Qk 
[Im] [Im] 1.9471 0.8660 
 [MIm] 2.8482 1.7140 
[Py] [Py] 2.6670 1.5530 
 [MPy] 3.5681 2.4010 
[N] [CH3N] 1.1865 0.9400 
(quad- [C2H5N] 1.8609 1.4800 
substituted) [C3H7N] 2.5353 2.0200 
 [C4H9N] 3.2097 2.5600 
[DMP] [DMP] 3.4127 3.2820 
[BF4] [BF4] 1.7856 1.4940 
[PF6] [PF6] 7.0615 6.5787 
[Tf2N] [Tf2N] 5.7738 4.9320 
[CF3COO] [CF3COO] 3.1773 3.2200 
[CF3SO4] [CF3SO4] 4.0870 3.9160 
[CH3SO4] [CH3SO4] 3.4832 3.7280 
[CH3CH2SO4] [CH3CH2SO4] 4.1576 4.1760 
[CH3OC2H4SO4] [CH3OC2H4SO4] 5.0759 5.3560 
[C2H5OC2H4SO4] [C2H5OC2H4SO4] 5.7503 5.8040 
[CH3(OC2H4)2SO4] [CH3(OC2H4)2SO4] 6.6686 6.9840 
[Br] [Br] 0.9492 0.8320 
[Cl] [Cl] 0.7660 0.7200 
[I] [I] 1.2640 0.9920 
[SCN] [SCN] 1.9446 1.1752 
 
Binary interaction parameters were determined for all ionic groups for which data was available. The 
parameters used to describe the final design candidates in examples provided are given in Table 8.3. The 
entire UNIFAC-IL interaction parameter matrix is available (see Appendix E). Due to lack of measured 
data, not all groups used in the solubility parameter GC model are present in the UNIFAC-IL model and 
the converse is also true.  
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Table 8.3 UNIFAC-IL binary interaction parameters for the groups used for the final design candidates 
in the acetone-methanol and ethanol-water examples The lightly shaded region corresponds to 
UNIFAC groups with previously determined interaction parameters, which are not included here 
(Fredenslund, Gmehling et al. 1977). The full list of UNIFAC-IL binary interaction parameters is 
provided in Appendix E. Table is adapted from (Roughton, Christian et al. 2012).  
 
 CH2 OH CH3OH H2O CH2CO [Im] [Py] [CF3SO3] [DMP] 
CH2 
Previous UNIFAC Groups 
65.08 -24.94 694.19 879.73 
OH -199.99 -147.61 91.85 -33.36 
CH3OH 380.03 841.54 -335.72 -182.43 
H2O -914.38 -666.90 -211.41 -650.60 
CH2CO -266.87 -143.22 443.95 320.25 
[Im] 134.11 737.69 0.05 0.00 438.53 0.00 0.00 0.00 0.00 
[Py] 1269.62 1789.95 -224.11 -0.01 507.94 0.00 0.00 0.00 0.00 
[CF3SO3] -285.94 220.70 350.14 0.00 -191.88 0.00 0.00 0.00 0.00 
[DMP] -326.80 64.06 -211.21 1209.55 -42.56 0.00 0.00 0.00 0.00 
 
8.2.2 UNIFAC-IL Performance for Azeotropic Systems 
To determine the performance of the UNIFAC-IL model for predicting the VLE of ternary systems with 
binary azeotropic mixtures and ionic liquids, UNIFAC-IL predictions were compared to experimental data 
for several systems. While the UNIFAC-IL model could be used for other applications, due to the scope 
of the work only the performance of the model for several common azeotropes was evaluated: acetone-
methanol, 1-propanol-water, 2-propanol-water, ethyl acetate-ethanol, and ethanol-water. Experimental 
ternary VLE data of the listed binary azeotropes with the ionic liquids 1-ethyl-3-methyl trifluoromethane 
sulfonate ([emim][triflate]) and/or 1,3-dimethylimidazolium dimethylphosphate ([mmim][dmp]) were 
used for comparison to UNIFAC-IL predictions (Orchillés, Miguel et al. 2006; Orchillés, Miguel et al. 2007; 
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Orchill s, Miguel et al. 2008; Orchill s, Miguel et al. 2010; Wang, Wang et al. 2010). Figures 8.2-8.7 show 
the comparison between the UNIFAC-IL predictions and experimental data, where component (1) is the 
light component and is listed first in the figure caption.  
 
Figure 8.2 Acetone-methanol-[emim][triflate] x-y diagram at 100 kPa 6.0 mol% ionic liquid is present. 
The dashed line indicates the UNIFAC-IL prediction and the open circles represent experimental data 
(Orchillés, Miguel et al. 2006). 6.84 %AARD was observed between the experimental and predicted 
vapor fractions. Figure adapted from (Roughton, Christian et al. 2012). 
  
 
Figure 8.3 1-propanol-water-[emim][triflate] x-y diagram at 100 kPa 6.0 mol% ionic liquid is present. 
The dashed line indicates the UNIFAC-IL prediction and the open circles represent experimental data 
(Orchill s, Miguel et al. 2008). 10.84 %AARD was observed between the experimental and predicted 
vapor fractions. Figure adapted from (Roughton, Christian et al. 2012). 
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Figure 8.4 Ethyl acetate-ethanol-[emim][triflate] x-y diagram at 100 kPa 6.0 mol% ionic liquid is 
present. The dashed line indicates the UNIFAC-IL prediction and the open circles represent experimental 
data (Orchillés, Miguel et al. 2007). 7.93 %AARD was observed between the experimental and predicted 
vapor fractions. Figure adapted from (Roughton, Christian et al. 2012). 
  
 
Figure 8.5 Ethanol-water-[emim][triflate] x-y diagram at 100 kPa 6.0 mol% ionic liquid is present. The 
dashed line indicates the UNIFAC-IL prediction and the open circles represent experimental data 
(Orchill s, Miguel et al. 2010). 6.45 %AARD was observed between the experimental and predicted 
vapor fractions. Figure adapted from (Roughton, Christian et al. 2012). 
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Figure 8.6 1-propanol-water-[mmim][dmp] P-T diagram x1 = 0.6669 and x2 = 0.2472. The solid line 
indicates the UNIFAC-IL prediction and the open circles represent experimental data (Wang, Wang et al. 
2010). 1.10 %AARD was observed between the experimental and predicted total pressures. Figure 
adapted from (Roughton, Christian et al. 2012).  
 
 
Figure 8.7 2-propanol- water-[mmim][dmp] P-T diagram x1 = 0.6669 and x2 = 0.2472. The solid line 
indicates the UNIFAC-IL prediction and the open circles represent experimental data (Wang, Wang et al. 
2010). 1.34 %AARD was observed between the experimental and predicted total pressures. Figure 
adapted from (Roughton, Christian et al. 2012).  
 
Overall, the UNIFAC-IL model shows good prediction of the experimentally observed VLE. As the 
experimental data used for model evaluation was not used to regress the UNIFAC-IL parameters, 
0
20
40
60
80
100
120
140
320 330 340 350 360 370 380
P
 [
kP
a]
 
T [K] 
0
20
40
60
80
100
120
140
300 310 320 330 340 350 360 370
P
 [
kP
a]
 
T [K] 
 
144 
 
agreement between the model and experiments was not assured. The largest AARD between the 
experimental and predicted vapor composition values is observed for the 1-propanol-water-
[emim][triflate] system with a value of 10.84%. The UNIFAC-IL predictions of azeotrope existence and 
location agree very well with the experimental data. Qualitatively, the shapes of the x-y curves are 
similar when comparing the UNIFAC-IL predictions and the experimental data. The P-T predictions 
showed very good agreement with experimental data, with the largest AARD value of 1.34% observed 
for the 2-propanol- water-[mmim][dmp] system. While the comparison to experimental data is limited, 
the results indicate that the UNIFAC-IL model will provide reasonable predictions for the azeotropes 
considered for simultaneous ionic liquid and separation process design. The two ionic liquids present in 
the experimental data are similar (or the same for [mmim][dmp]) to the designed ionic liquids for both 
azeotrope examples, suggesting that the UNIFAC-IL predictions for the designed ionic liquids will be 
reasonably accurate.  
8.3 CAMD RESULTS FOR IONIC LIQUID ENTRAINERS 
Ionic liquid entrainers were designed for use with both the acetone-methanol and ethanol-water 
azeotropes. Candidates were found that either best matched the volume average solubility parameter 
value of each azeotropic mixture or the solubility parameter of the desired entrained component. The 
cation choices were limited to imidazolium and pyridinium to ensure that the designed ionic liquid could 
be used with the UNFAC-IL model. With the groups determined by CAMD, the groups were then 
constructed to make a feasible ionic liquid. The design candidates for the acetone-methanol azeotrope 
were 1-octyl-4-methylpyridinium trifluoromethane sulfonate ([ompy][triflate]) with a solubility 
parameter value of 21.2 MPa1/2 and 1-butyl-3-methylimidazolium hexafluorophosphate ([bmim][PF6]) 
with a solubility parameter value of 29.5 MPa1/2. 1,3-dimethylimidazolium dimethylphosphate 
([mmim][dmp]) with a solubility parameter value of 27.1 MPa1/2 and 1,3-dimethylimidazolium 
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tetrafluoroborate ([mmim][BF4]) with a solubility parameter value of 32.6 MPa
1/2 were the design 
candidates for the ethanol-water azeotrope.  
The UNIFAC-IL model was used to ensure that the azeotropes were broken by the designed ionic liquids 
and that the correct component was entrained by the ionic liquid. Existence of only one liquid phase was 
confirmed by the UNIFAC-IL model. The UNIFAC-IL model was also used to predict the minimum amount 
of ionic liquid needed to break the azeotrope at 101.325 kPa. The ionic liquid 1-ethyl-3-methyl 
trifluoromethane sulfonate ([emim][triflate]) has been shown experimentally to break both the acetone-
methanol and ethanol-water azeotropes (Orchillés, Miguel et al. 2006; Orchill s, Miguel et al. 2010). 
Based on the predicted solubility parameter, [emim][triflate] would not be designed using the CAMD 
procedure for both azeotropes. The UNIFAC-IL model was used to predict the minimum amount of 
[emim][triflate] needed to break both azeotropes at 101.325 kPa. VLE calculations were used to 
calculate vapor compositions of components for each liquid composition for increasing ionic liquid 
concentrations from no ionic liquid present to the concentration where the azeotrope is just broken, 
defined as the minimum ionic liquid concentration needed to break the azeotrope. The ionic liquid 
composition was increased by 0.01 mol% and calculations were performed at each composition. The 
minimum ionic liquid concentrations required were used to screen the design candidates. For acetone-
methanol, slightly more [emim][triflate] on a mole fraction basis was needed to break the azeotropes 
when compared to the designed ionic liquid [ompy][triflate]. The designed ionic liquid [bmim][PF6] 
required a much higher concentration to break the acetone-methanol azeotrope when compared to the 
other design candidate and was eliminated from further consideration. Approximately the same amount 
of the design candidates [mmim][dmp] and [mmim][BF4] were needed to break the ethanol-water 
azeotrope, so both ionic liquids were keep as entrainer candidates. The experimentally selected ionic 
liquid [emim][triflate] broke the ethanol-water azeotrope at a similar concentration to that of the design 
candidates. The results are summarized in Table 5. To illustrate the performance of the designed ionic 
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liquid candidates and the experimentally selected ionic liquid, Figures 8.8 and 8.9 show the x-y diagrams 
for the acetone-methanol and ethanol-water systems with 10 mol% of each considered ionic liquid 
added. The candidate [ompy][triflate] shows much higher vapor mole fractions than the candidate 
[bmim][PF6] at any given liquid mole fraction, indicating that [ompy][triflate] generates noticeably 
higher driving forces (y1 – x1) for separation. The driving forces generated by [ompy][triflate] are also 
slightly higher than the driving forces generated by the experimentally selected ionic liquid 
[emim][triflate]. For the ethanol-water system, both the candidate ionic liquids and the experimentally 
selected ionic liquid showed similar driving forces. 
 
Figure 8.8 x-y diagram showing the performance of several ionic liquid entrainers on the acetone-
methanol azeotrope at 101.325 kPa The concentration of all ionic liquid entrainers is set a 10 mol%. The 
45 degree line is included to indicate where y1 = x1. Figure adapted from (Roughton, Christian et al. 
2012).  
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Figure 8.9 x-y diagram showing the performance of several ionic liquid entrainers on the ethanol-
water azeotrope at 101.325 kPa The concentration of all ionic liquid entrainers is set a 10 mol%. The 45 
degree line is included to indicate where y1 = x1. Figure adapted from (Roughton, Christian et al. 2012).  
 
By designing the ionic liquid entrainer based on solubility parameter targets and screening based on the 
amount needed to break the azeotrope, ionic liquid candidates were identified that required minimal 
concentrations to break a given azeotrope. By requiring less ionic liquid, material inputs are reduced and 
energy requirements are reduced as less ionic liquid needs to be recovered. The ionic liquid 
[emim][triflate] appears to be a good candidate for breaking the ethanol-water azeotrope but does not 
have a predicted solubility parameter value that lies within the range of solubility parameter values that 
would be considered for the initial design step in the CAMD procedure. Although [emim][triflate] would 
not be chosen through the design process, the designed candidates both break the ethanol-water 
azeotrope with the same or similar minimum concentration. Design of ionic liquids for the example 
systems provided ionic liquid candidates that could break the azeotropes with concentrations less than 
or equal to the concentration of the experimentally selected ionic liquid [emim][triflate].  
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8.4 DESIGN OF IONIC LIQUID-BASED AZEOTROPIC SEPARATION PROCESSES 
Using the outlined procedure and specifications, distillation columns for the azeotrope mixtures were 
designed using both designed ionic liquid candidates and an experimentally selected ionic liquid. At a 
given ionic liquid flow rate, the minimum amount of stages needed to achieve the specified separation 
was determined. The driving force method with the proposed modified scaling was used an initial guess 
for the feed stage. The feed stage was then moved up and down to find the optimal feed stage in terms 
of energy requirements. In all cases, the optimal feed stage was at or near the feed stage proposed by 
the driving force method. The results for the ethanol-water-[mmim][dmp] system are given by Figure 
8.10. The results indicate that use of the driving force method with the new proposed scaling can be 
used to design optimal or near-optimal distillation columns with a main feed and separate ionic liquid 
feed. The driving force method was originally proposed for a distillation column with only one feed. By 
comparing the columns with optimal feed stages at different ionic liquid flow rates, the flow rate and 
column configuration yielding the minimum stages and energy requirements was obtained for each 
system. The results for the ethanol-water-[mmim][dmp] system are given by Figure 8.11. 
From the simulation results, optimal distillation columns in regards to minimal stages required and 
energy inputs were obtained for the methanol-acetone and ethanol-water systems using either 
designed entrainer candidates or an experimentally selected ionic liquid entrainer. The results are 
summarized in Table 8.5.  
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Figure 8.10 Reboiler heat duty as a function of feed stage location for separation of the ethanol-water 
azeotrope using various amounts of [mmim][dmp] as an entrainer The scaled feed stage location 
calculated by the driving force method is circled in the figure for each ionic liquid feed rate. The lines are 
drawn to guide the eyes. Figure adapted from (Roughton, Christian et al. 2012).  
 
Figure 8.11 Reboiler heat duty as a function of ionic liquid flow rate for separation of the ethanol-
water azeotrope using [mmim][dmp] as an entrainer Each point indicates the optimal column 
configuration in terms of energy requirements for the specified ionic liquid flow rate. The line is drawn 
to guide the eyes. Figure adapted from (Roughton, Christian et al. 2012).  
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For both systems, a designed ionic liquid was found to have significant energy savings in comparison to 
the experimentally selected ionic liquid. Based on the column simulation results, the ionic liquid 
candidates with the lowest energy requirements were kept and the other candidates were eliminated. 
The ionic liquid flow rates used in the simulation were selected based on minimizing energy 
requirements, resulting in different flow rates for the different ionic liquids. While the experimentally 
selected ionic liquid used lower flow rates, the energy requirements were higher for both azeotropic 
systems when compared to the final design candidates. For acetone-methanol, use of [ompy][triflate] 
provided the lowest energy requirements and reduced energy consumption by 24.5% (1961 kW) 
compared to the experimentally selected ionic liquid [emim][triflate]. As no other design candidate 
remained, [ompy][triflate] was selected as the final design candidate for the acetone-methanol system. 
Energy requirements for the ethanol-water system were lowest when using [mmim][dmp], reducing 
heat duty by 26.5% (739 kW) when compared to the experimentally selected ionic liquid 
[emim][triflate]. As the column using [mmim][dmp] required less energy than the other design 
candidate [mmim][BF4], [mmim][dmp] was chosen as the final design candidate and [mmim][BF4] was 
eliminated from consideration. Both [ompy][triflate] (Papaiconomou, Salminen et al. 2007) and 
[mmim][dmp] (Wang, Wang et al. 2010) have been previously synthesized and studied.  The structures 
of [ompy][triflate] and [mmim][dmp] are shown in Figure 8.12 and Figure 8.13.  
The column energy requirements were closer in value for the ethanol-water system than the acetone-
methanol system, likely influenced by the fact that [mmim][dmp], [mmim][BF4], and [emim][triflate] 
have similar maximum driving force values at the ionic liquid concentrations used. The minimum 
number of stages needed for the separation was found to be less for the methanol-acetone system 
using the designed ionic liquid than found when using the experimentally selected ionic liquid. The 
experimentally selected ionic liquid was able to achieve separation in one less stage than the final ionic 
liquid design candidate for the ethanol-water system, but the reduced capital cost would not offset the 
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larger energy requirement. Due to the energy savings, the entire process including entrainer 
regeneration was simulated only for the systems using the final design candidate entrainers. The energy 
required for air flow into the stripper was neglected in calculation of the total energy requirements for 
the processes. 
 
 
Figure 8.12 1-octyl-4-methylpyridinium trifluoromethane sulfonate ([ompy][triflate]) With a solubility 
parameter value of 21.2 MPa1/2, the ionic liquid is the final design candidate for the acetone-methanol 
azeotrope.  
 
 
Figure 8.13 1,3-dimethylimidazolium dimethylphosphate ([mmim][dmp])  With a solubility parameter 
value of 27.1 MPa1/2, the ionic liquid is the final design candidate for the ethanol-water azeotrope.  
 
The results for the ethanol-water-[mmim][dmp] system were compared to previously published 
simulation results for ethanol-water separation using a conventional entrainer (1,2-ethanediol) and a 
experimentally selected ionic liquid entrainer (1-ethyl-3-methylimidazolium tetrafluoroborate 
[emim][BF4]) (Seiler, Jork et al. 2004). The results for the experimentally selected ionic liquid are 
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compared to the results for the designed ionic liquid candidates in Table 8.5. The separation process was 
the same as used in the current work and the number of stages in the distillation column was set at 28 
for both the conventional and ionic liquid entrainers. Simulations were performed to calculate energy 
requirements at various entrainer concentrations. The optimal energy requirements were 3917 kW for 
the conventional entrainer and 2963 kW for the ionic liquid (Seiler, Jork et al. 2004). Comparison of the 
separation processes shows an energy savings of 28.8% (1127 kW) when using [mmim][dmp] instead of 
the conventional entrainer and an energy savings of 5.8% (173 kW) when using [mmim][dmp] over an 
experimentally selected ionic liquid. Due to inherent error in the UNIFAC-IL model, the calculated excess 
enthalpies may result in some error in the calculated energy requirements. Use of ionic liquids offers an 
alternative to conventional entrainers which may reduce energy requirements when separating 
azeotropic mixtures. By designing the ionic liquid structure to match a solubility parameter target range 
and further screening candidates by minimum concentration needed to break the azeotrope and column 
energy requirements, energy requirements in the resulting separation and entrainer regeneration 
processes are reduced compared to processes using ionic liquids that were not designed or selected 
using a CAMD procedure.  
8.5 PREDICTION OF RELEVANT PROPERTIES FOR IN SITU EXTRACTIVE FERMENTATION 
The data sets used to generate the models for partition coefficient of NDHD in ionic liquid (Kx) and 
toxicity of ionic liquid towards E. coli (lnEC50) were too small to allow descriptor selection through use of 
Mallow’s Cp. Alternatively, models were compared using the based on R
2-Q2 value, with the model 
showing the minimum value being selected. R2-Q2 provides a measure of the difference between the fit 
and the predictive capability. Minimal differences are desired.  
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Figure 8.14 Comparison of correlation coefficient values belong to different model sizes for the 
partition coefficient model (Kx)  
 
For the partition coefficient model, a model size of five showed the smallest R2-Q2 value (0.02) and was 
selected as the final model. The equation for the model is given by Equation 8.1. Four of the five 
descriptors selected describe the cation. All descriptors pass significance testing at a 99% confidence 
level. The model provides an excellent fit to the data and good predictive quality, with R2 = 0.994 and   
Q2 = 0.974.  
         
                                                  
(Equation 8.1) 
A model size of five was also selected for the toxicity model. Again, four of the five descriptors selected 
describe the cation structure. In comparison to the partition coefficient model, the toxicity model shows 
a much poorer fit (R2 = 0.805). The predictive capability of the model is poor (Q2 = 0.090) and thus use of 
the model for molecular design is questionable. The model is given by Equation 8.2. The use of different 
molecular descriptors and/or a non-linear model form are possible directions to pursue for 
improvement of the toxicity model. 
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(Equation 8.2) 
8.6 CAMD RESULTS FOR IN SITU EXTRACTANTS 
Design was limited to the cation and the anion was fixed to tris(perfluoroalkyl)trifluorophosphate (FAP). 
Furthermore, the cation class was limited to imidazolium based ionic liquids. Due to the questionable 
quality of the toxicity correlation, two different design cases were considered: (A) design with only a 
partition coefficient target and (B) design with both a partition coefficient target and a toxicity target. 
Tabu search was used to generate multiple candidates for both design cases. The top candidates for 
both cases A and B are compared in Figure 8.15. 
 
    
Design Case (A)  Design Case (B)  
Objective function  = 5.48x10
-6
  Objective function  = 0.0022  
MW = 206.3 g/mol  MW = 209.6 g/mol  
lnEC
50
 = 2.67 ± 4.09  lnEC
50
 = 3.82 ± 3.84  
K
x
 = 50.1 ± 22.1  K
x
 = 50.7 ± 23.2  
  
Figure 8.15 The best cation candidates for the design cases (A) and (B) For (A) and (B) the target was   
Kx = 50. Additionally, (B) had a target for lnEC50 = 4. Prediction intervals are given for Kx and lnEC50 values. 
The anion was set to FAP. 
  
As seen from the prediction intervals in Figure 8.15, both design cases yield solutions with statistically 
similar property values and of similar size (i.e., molecular weight). However, the large prediction 
intervals for the lnEC50 values further exemplify the poor predictive quality of the model and the 
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corresponding predictions are likely to be unreliable. Of interest is the observation that the inclusion of 
toxicity as a target prevented any polar groups from being included in the alkyl chain of the cation, 
where polar groups are present when only partition coefficient was used as a target. 
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9.0 RESULTS FOR LYOPHILIZED EXCIPIENT DESIGN 
The following section presents the results for property models developed for CAMD of lyophilized 
excipients. Also included are the tuning and design results for the CAMD methods considered. Two main 
approaches were used to design excipients for lyophilized protein formulations: a vitrification approach 
with optimal glass transition temperatures and an overall reduction of aggregation approach to maintain 
%Monomer at 100% following lyophilization. 
 Section 9.1 presents the model results for various glass transition correlations. The molecular design 
results using tabu search are presented in Section 9.2. The experimental measurements observed for 
protein loss following lyophilization are detailed in Section 9.3. Sections 9.4-9.6 present and discuss the 
results for various post-lyophilization protein loss models. The tuning results for both tabu search and a 
genetic algorithm are given in Section 9.7. Finally, Section 9.8 contains the molecular design results 
using the post-lyophilization protein loss models with the tuned stochastic algorithms. Results are 
compared between optimization methods and also between the proteins included in the formulation. 
9.1 GLASS TRANSITION TEMPERATURE PROPERTY MODELS 
The R statistical program (R-Development-Core-Team 2010) was used for linear regression of the 
desired properties to the connectivity indices of the excipients in the training set. The model data was 
obtained from literature (Roos 1993). The carbohydrate excipients used in the model data set were 
monosaccharides (ribose, xylose, fructose, fucose, glucose, and sorbose), disaccharides (lactose, 
lactulose, melibiose, sucrose, and trehalose), oligosaccharides (raffinose), and sugar alcohols (maltitol, 
sorbitol, and xylitol). The leaps package in R (Lumley 2004) was used to conduct an exhaustive search to 
determine which combination of descriptors provided the lowest Cp value for each number of possible 
descriptors that could be used for the QSPR (ranging from one to twelve). A summary of the QSPRs 
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developed in this work is provided in Table 9.1. The individual QSPRs are further detailed in the 
following subsections. 
Table 9.1 Summary of glass transition-related QSPRs developed Figure adapted from (Roughton, Topp 
et al. 2012).  
QSPR Number of Descriptors Selected R2 
Tg 9 0.998 
Tg’ 6 0.994 
Tm’ 7 0.997 
k  9 0.998 
 
9.1.1 QSPR for Glass Transition Temperature of Anhydrous Solute  
The glass transition temperature of the anhydrous solute provides an indication of the stability of the 
carbohydrate excipient during storage conditions.  In addition to being used as a criterion for storage 
stability, Tg is used in the calculation of the excipient concentration in a maximally freeze-concentrated 
matrix. 
The correlation developed for the Tg of carbohydrate excipients is: 
  (  )          
                                                   
                                         
      (Equation 9.1) 
Equation 9.1 provides a good fit for the experimental measurements, providing a coefficient of 
determination (R2) value of 0.998. The predicted Tg values are compared to the experimental values 
using a parity plot in Figure 9.1. 
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Figure 9.1 Comparison of measured experimental values to QSPR predicted values for the glass 
transition temperature of the anhydrous solute (Tg)  The y=x line indicates were predicted = 
experimental. Figure adapted from (Roughton, Topp et al. 2012). 
  
9.1.2 QSPR for Glass Transition Temperature of Maximally Concentrated Solute  
In addition to being used as a criterion for ensuring formation of a maximally freeze-concentrated glass 
matrix, the glass transition temperature of the maximally concentrated solute (Tg’) is used in the 
calculation of the excipient concentration in the glass matrix. 
The correlation developed for the Tg’ of carbohydrate excipients is: 
  
 (  )                                                             
(Equation 9.2) 
Equation 9.2 provides a good fit for the experimental measurements, providing an R2 value of 0.994. The 
predicted Tg’ values are compared to the experimental values using a parity plot in Figure 9.2. 
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Figure 9.2 Comparison of measured experimental values to QSPR predicted values for the glass 
transition temperature of the maximally freeze-concentrated solute (Tg’) The y=x line indicates were 
predicted = experimental. Figure adapted from (Roughton, Topp et al. 2012). 
  
9.1.3 QSPR for the Melting Point of Ice  
The melting point of ice represents the onset of ice formation during the freezing part of the 
lyophilization process. The concentrated solution must be annealed between Tg’ and Tm’ to ensure that 
the resulting freeze-concentrated glass matrix is maximally concentrated. 
The correlation developed for the Tm’ of carbohydrate excipients is given below: 
  
 (  )                                                                 
        
 (Equation 9.3) 
Equation 9.3 provides a good fit for the experimental measurements, providing an R2 value of 0.997. The 
predicted Tm’ values are compared to the experimental values using a parity plot in Figure 9.3. 
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Figure 9.3 Comparison of measured experimental values to QSPR predicted values for the melting 
point of ice (Tm’) The y=x line indicates were predicted = experimental. Figure adapted from (Roughton, 
Topp et al. 2012).  
 
9.1.4 QSPR for Gordon-Taylor Constant  
The Gordon-Taylor constant is used in the calculation of the solute concentration from the Gordon-
Taylor equation. The Gordon-Taylor constant for a compound is usually derived from glass transition 
measurements (Roos 1993). It should be noted that through the descriptor selection method, the same 
connectivity indices were found to provide the best model as those used in the model for glass 
transition temperature of the anhydrous solute. 
The developed correlation for the Gordon-Taylor constant of carbohydrate excipients is given below: 
                                                                    
                 
(Equation 9.4) 
Equation 9.4 provides a good fit for the experimental measurements, providing an R2 value of 0.998. The 
predicted k values are compared to the experimental values using a parity plot in Figure 9.4. 
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Figure 9.4 Comparison of measured experimental values to QSPR predicted values for the Gordon-
Taylor constant (k) The y=x line indicates were predicted = experimental. Figure adapted from 
(Roughton, Topp et al. 2012). 
  
9.2 RESULTS FOR OPTIMAL GLASS FORMER DESIGN 
According to vitrification theory, a protein stabilizing excipient should be able to form a glass during 
lyophilization and subsequent storage of the therapeutic product. The glass transition temperature of 
the maximally freeze-concentrated solute and the melting point of ice for a carbohydrate excipient must 
be high enough to be feasibly reached during the lyophilization process. The protein drug product must 
first be annealed at a temperature between Tg’ and Tm and then reduced below Tg’ to yield a maximally 
freeze-concentrated matrix (Roos 1997).  The melting temperature of ice is higher than the glass 
transition temperature of the maximally concentrated solute. The glass transition temperature of the 
anhydrous solute must be sufficiently high such that the carbohydrate remains a glass during storage of 
the protein drug product. A common heuristic is that the storage temperature of an amorphous drug 
formulation should be 50°C below the anhydrous glass transition temperature (Costantino and Pikal 
2004). For a formulation to be stored at room temperature, a Tg of at least 80°C is desired. This criterion 
is very important, as more than 70% of commercial lyophilized products cannot be stored at room 
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temperature and must be refrigerated to maintain stability, complicating the use of the drugs 
(Costantino and Pikal 2004). All three phase transition temperatures are used along with the Gordon-
Taylor constant to determine the excipient concentration (weight fraction) of a maximally freeze-
concentrated matrix, without protein present. A higher excipient concentration corresponds to lower 
residual water in the matrix, which lowers the mobility of the protein and thus reduces the potential for 
aggregation. No target is placed on the actual value of the Gordon-Taylor constant. The Gordon-Taylor 
constant is calculated only for use in subsequent calculation of the excipient concentration in a 
maximally freeze-concentrated matrix. 
Table 9.2 Property values of candidate carbohydrate excipients designed using tabu search Prediction 
intervals for the properties predicted by the QSPR models were calculated at a 95% level. A lower 
objective function score indicates a better match for the target property values. Table is adapted from 
(Roughton, Topp et al. 2012).  
 Property Candidate 1 Candidate 2 Candidate 3 
Tg 100.9±12.7°C 99.8±15.0°C 90.3 ± 20.6°C 
Tg’ -32.6±6.5°C -33.1±6.7°C -31.7±  5.0°C 
Tm’ -24.8±3.2°C -23.7±3.5°C -24.1 ± 4.1°C 
k 6.76± 0.37 6.73 ± 0.44 6.46 ± 0.61 
Cg’ 0.838 0.838 0.845 
MW  373.3 g/mol 373.3 g/mol 373.3 g/mol 
Obj function 0.00800 0.01367 0.01373 
 
The described molecular design framework was employed using the PD program previously used to 
design various molecules, including dental polymers (Eslick, Ye et al. 2009) and ionic liquids (McLeese, 
Eslick et al. 2010).The results for the three best excipient candidates are given in Table 9.2, determined 
by the solutions with the lowest objective function scores. Seven total candidates were generated. Error 
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was calculated using prediction integrals at a 95% level for the property values predicted using the QSPR 
models. The structures of the proposed carbohydrate excipients are given in Figures 9.5-9.7.  
 
Figure 9.5 Optimal carbohydrate excipient candidate 1 proposed by CAMD using tabu search The 
objective function score is 0.00800. Figure adapted from (Roughton, Topp et al. 2012). 
 
Figure 9.6 Optimal carbohydrate excipient candidate 2 proposed by CAMD using tabu search The 
objective function score is 0.01367. Figure adapted from (Roughton, Topp et al. 2012).  
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Figure 9.7 Optimal carbohydrate excipient candidate 3 proposed by CAMD using tabu serach The 
objective function score is 0.01373. Figure adapted from (Roughton, Topp et al. 2012).  
 
The proposed excipients are similar to disaccharide and oligosaccharide molecular topologies. 
Candidates 1, 2, and 3 are isomers. The property values of the proposed excipients show that the 
computationally designed excipient molecules should stabilize protein formulations. Protein mobility 
should be limited due to the high solute concentration of the maximally freeze-concentrated matrix. The 
values for the glass transition temperature of the maximally freeze-concentrated solute and the melting 
point of ice are high enough that they can be reached during lyophilization. Additionally, the gap in the 
two temperatures is large enough to allow for annealing between the two temperatures, ensuring that 
the maximum solute concentration is reached in the freeze-concentrated matrix. The high glass 
transition temperatures of the anhydrous solute are high enough that drying and long term storage 
conditions will not change the desired glass structure of the protein formulation.  
The prediction intervals show that for all three candidates, all four properties predicted by the QSPR 
models have overlapping prediction intervals. Due to the overlapping prediction intervals, the predicted 
property values of all the candidates are not statistically different; all three candidates are valid 
solutions for the optimization problem. Use of tabu search was able to provide several optimal excipient 
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candidates with statistically similar property values, where a deterministic method would have only 
provided one candidate. The prediction intervals for the glass transition temperature of the anhydrous 
solute were large for all three candidates. The large magnitude of the prediction interval is likely due to 
the target value being close to the upper limit of the property data used to build the correlation. 
One should note that since not all possible properties of importance for an excipient have been 
included, these structures should be considered candidates for protein drug excipients, and not finalized 
designs to be immediately utilized.  Since all of the structures designed in this work are similar to 
disaccharides, it is likely that they can be synthesized.  However, further studies would be required to 
ensure that the excipients themselves exhibit sufficient properties to be used in protein drug 
formulations. 
9.3 EXPERIMENTAL RESULTS FOR POST-LYOPHILIZATION PROTEIN LOSS 
Experimental studies were performed in two rounds. The first round was focused on creating a dataset 
for modeling %Monomer as a function of protein structure. Accordingly, a large amount of proteins 
were considered and fewer excipients. The second round was focused on creating a dataset for 
correlation of %Monomer to excipient structure. Therefore, a large amount of excipients were 
considered with a small set of proteins.  
It is noted here that the experiments for the first round were not performed by the author and were 
instead conducted by Lavanya K. Iyer at Purdue University. The methods and procedures used were the 
same as those used by the author and described in Section 3.0. The results and discussion arising from 
the experiments is included as the data was used to build the corresponding models for %Monomer as a 
function of protein structure. 
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9.3.1 Experimental Results for Data Set Concerning Protein Structure 
For the fifteen proteins and five lyophilized formulations studied here, aggregation varied with protein, 
with formulation and with the analytical method used to assess aggregation (see Table F.1, Appendix F). 
The proteins can be grouped according to aggregation tendency. Five proteins (lysozyme, ovalbumin, 
cytochrome C, α-amylase, BSA) showed high aggregation tendency across the formulation types as 
indicated by low (< 80%) recovery of monomeric protein (%Monomer) by SEC, high aggregation index (> 
100) and/or the presence of high molecular weight bands on SDS-PAGE. Six proteins (RNAse A, α-
chymotrypsinogen, ConA, α-lactoglobulin, SOD, trypsin inhibitor) showed low aggregation tendency 
using these metrics, while the remaining four proteins (myoglobin, DNAse I, catalase, b-lactoglobulin) 
showed intermediate aggregation tendency. Greater than 100% recovery of monomeric protein by SEC 
was observed for some samples and could reflect incomplete separation of aggregate from monomeric 
protein or protein unfolding. While the assignment of proteins to these groups is somewhat arbitrary, it 
is clear that the proteins selected show a range of aggregation propensities on lyophilization. The data 
set is therefore suitable for assessing the effects of protein structure on lyophilization-induced 
aggregation within the parameter space defined by their structural descriptors. Note that, since the 
largest protein in the data set (BSA, 66 kD) is considerably smaller than monoclonal antibodies, these 
and other large proteins are not expected to be well-described by the correlations developed here.    
 
With regard to formulation, those containing buffer, sucrose or glycine all produced aggregates 
following lyophilization for some of the proteins studied (see Table F.1, Appendix F). Compared to these 
excipients, urea formulations produced a greater extent of aggregation for a greater number of proteins, 
as expected for this denaturant (see Table F.1, Appendix F). Formulations containing Gdn HCl showed no 
retention of monomeric protein by SEC for 11 of the 15 proteins, and pellets and/or high molecular 
weight bands on SDS-PAGE for 8 of 15. Because the observed extent of aggregation was very high and 
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relatively insensitive to protein structure in Gdn HCl formulations, this formulation was omitted in 
developing correlations. The correlations thus were developed using the four remaining excipients (i.e., 
buffer, sucrose, glycine or urea). 
 
Of the three methods used to assess aggregation (SDS-PAGE, AI, SEC), only AI and SEC were used 
quantitatively; therefore, only results from these two methods can be used to develop quantitative 
correlations with protein structural descriptors. AI values were not considered quantitatively reliable. 
For example, some formulations for proteins such as concanavalin A, cytochrome-c, β-lactoglobulin and 
trypsin inhibitor showed large AI values but had large errors. In other cases, proteins with low AI values 
showed loss of monomeric protein by SEC and formation of a pellet on SDS-PAGE (e.g., catalase in urea, 
Table F.1, Appendix F). This may be due to the formation of insoluble precipitates that settle out of 
solution and are not detected on UV. Furthermore, RNase, lysozyme α–chymotrypsinogen and many 
other proteins did not show significant differences in AI values across formulations. As a result, 
correlations were developed based on the %Monomer as measured by SEC and AI values were not used 
further.  
9.3.2 Experimental Results for Data Set Concerning Excipient Structure 
SEC chromatographs were collected for BSA and RNAse A with all excipients considered and for -
amylase, ovalbumin and trypsin inhibitor for a subset of carbohydrate excipients. Peak areas were used 
to calculate percent monomer remaining after lyophilization (%Monomer).  Values ranged from 88.2 – 
99.8% for -amylase, 82.6 – 95.9% for BSA, 92.5 – 99.6% for ovalbumin, 81.0 – 102.4% for RNAse A and 
86.5 – 101.2% for trypsin inhibitor. All values that exceeded 100% had standard errors of mean (SEM) 
values that indicated the value was not statistically different than 100%, with the exception of rhamnose 
with trypsin inhibitor (111.1 ± 0.8%). Due to the lack of physical meaning and the extreme difference 
(9.9%) between the value for rhamnose and the next highest formulation, the rhamnose-trypsin 
 
170 
 
inhibitor data point was considered an outlier and excluded from the universal model building data set. 
SEC results are summarized in Table F.2 (see Appendix F). 
The excipients showing the best stabilization were glucose with -amylase (99.8 ± 2.5%), -
methylglucopyranoside with BSA (95.9 ± 0.6%), sorbitol with ovalbumin (99.6 ± 0.4%) and with trypsin 
inhibitor (101.2 ± 2.1%) and psicose with RNAse A (102.4 ± 2.6%).  Maltitol, a sugar alcohol, had low 
stability values for all proteins when compared to other excipient choices: 93.5 ± 0.5% for -amylase, 
85.9 ± 2.3% for BSA, 92.5 ± 0.9% for ovalbumin, 86.6 ± 1.0% for RNAse A and 91.2 ± 0.3% for trypsin 
inhibitor. Raffinose provided poor protection for -amylase (91.3 ± 4.1%) and trypsin inhibitor (86.5 ± 
2.2%).  The sugar alcohol mannitol provided poor protection for BSA (82.6 ± 1.1%), RNAse A (85.3 ± 
1.7%) and trypsin inhibitor (88.9 ± 3.5%). There was no consensus best or worst excipient choice. 
SDS-PAGE results provided qualitative verification of the presence of aggregates following lyophilization 
(see Table F.3, Appendix F). As noted in the previous subsection, use of AI as a quantitative tool was not 
pursued.. The presence of aggregates was halted under reducing conditions for ovalbumin with all 
formulations, suggesting that aggregate formation is due at least in part to formation of disulfide 
bridges. All lyophilized formulations evaluated by pxrd showed that the resulting solid was largely 
amorphous (See Figure F.1, Appendix F).  
9.4 POST-LYOPHILIZATION PROTEIN LOSS MODELS: AS A FUNCTION OF PROTEIN STRUCTURE 
Two methods were used to develop correlations relating protein descriptors to percent monomer 
retained following lyophilization: exhaustive search and forward selection. For both methods, the 
descriptor set used to generate correlations for each formulation was comprised of physical descriptors, 
AGGRESCAN descriptors and PASTA descriptors. The following subsections detail and compare the 
results for each method. 
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9.4.1 Exhaustive Search Method 
The exhaustive search method was performed using all available descriptors for each formulation. Good 
fits, as determined by minimum Cp scores, were obtained with model sizes between eight and twelve 
descriptors (see Table 9.3). The descriptors selected for each formulation are listed in Table 9.3, 
together with statistical measures of goodness-of-fit (R2) and predictive power (Q2 and R2-Q2). 
 
Table 9.3 Descriptors selected using an exhaustive search method with model size selected by 
minimizing Cp score Table adapted from (Roughton, Iyer et al. 2013).  
Formulation 
Model 
Size 
Descriptors Selected 
R
2
 Q
2
 R
2
 - Q
2
 Physical AGGRESCAN PASTA 
Buffer
a
 12 
%-helix, %-
sheet, MW, # S-S, 
# free SH, Tm 
a3vSA, THSA 
Emin, Eavg,  
(E/L)min, Peaks 
1.000 0.999 0.001 
Urea 10 
apolar, pI, # S-S, 
Tm 
TA, Na4vSS 
Eavg, Lavg, 
(E/L)min,  (E/L)avg 
0.998 0.976 0.022 
Sucrose 9 
%-sheet, MW, 
pI, Tm 
a3vSA, NnHS, 
THSA, TA 
Peaks 0.999 0.987 0.012 
Glycine 8 
%-helix, %-
sheet 
NnHS, AATr, 
THSAr, Na4vSS 
Eavg, Peaks 0.982 0.805 0.176 
a
Buffer used in the formulation was potassium phosphate buffer (20 mM, pH 7.4) 
 
In general, the descriptors selected differed from formulation to formulation. Across all formulations, 
each descriptor type was selected with similar frequencies: physical descriptors were selected 16 times, 
AGGRESCAN descriptors were selected 12 times and PASTA descriptors were selected 11 times. No 
single descriptor was selected for all formulations. The most commonly selected descriptors were -
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sheet, Tm, Eavg, and Peaks, which were all selected for three of the four formulations. At least one 
descriptor of each type was selected for each formulation. 
 
The correlations for all four formulations had (R2-Q2) < 0.20 and R2 values close to 1, indicating that they 
provide a reasonable tool for predicting the percent retained monomeric protein after lyophilization 
within each formulation type. The correlation for the buffer formulation had the best fit and best 
predictive power, having the highest R2 and Q2 values and the lowest (R2-Q2) values.  The correlation for 
the glycine formulation provided the poorest fit and lowest Q2 value, and also provided the poorest 
predictive power as indicated by the largest (R2-Q2) value. A summary of the regression for the four 
formulations, together with values of the regression coefficients, is presented in Table 9.4.  
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Table 9.4 Correlation results for all four formulations Descriptors were selected via exhaustive search 
with Cp evaluation. Table adapted from (Roughton, Iyer et al. 2013).  
 
Formulation Descriptor Coefficient Value Standard Error (p-value
a)
 
Buffer
b
 
(Intercept) -0.25 0.48 (0.65) 
% -helix -0.37 0.01 *** 
% -sheet -0.17 0.01 ** 
MW -0.53 0.01 *** 
# S-S -0.88 0.02 *** 
# free SH -13.68 0.11 *** 
Tm -0.50 0.01 
*** 
a3vSA 155.36 2.70 *** 
THSA -0.07 0.03 (0.13) 
Emin -16.25 0.30 
*** 
Eavg 3.27 0.31 
** 
(E/L)min -53.63 0.34 
*** 
Peaks 11.23 0.05 *** 
Urea 
(Intercept) 164.10 13.07 *** 
apolar 4.66E-03 1.57E-04 *** 
pI -7.16 0.80 *** 
# S-S 5.85 0.38 *** 
Tm -2.17 0.09 
*** 
TA -0.32 0.08 * 
Na4vSS 5.13 0.47 *** 
Eavg 12.53 1.64 
** 
Lavg 6.37 0.59 
*** 
(E/L)min -338.10 17.14 
*** 
(E/L)avg 260.90 20.63 
*** 
Sucrose 
(Intercept) 159.17 2.77 *** 
% -sheet 0.69 0.03 *** 
MW -2.84 0.08 *** 
pI -0.84 0.25 * 
Tm 0.62 0.03 
*** 
a3vSA 686.56 17.31 *** 
NnHS -19.03 0.49 *** 
THSA 1.69 0.09 *** 
TA -2.44 0.06 *** 
Peaks 3.89 0.20 *** 
Glycine 
(Intercept) 387.91 19.91 *** 
% -helix -0.65 0.11 *** 
% -sheet -0.53 0.17 * 
NnHS -23.98 1.88 *** 
AATr -2326.82 162.79 *** 
THSAr 2247.68 155.16 *** 
Na4vSS 3.04 0.31 *** 
AvgE 13.64 1.33 *** 
Peaks -3.73 0.60 *** 
a
Significance codes for the p-values are: *** for < 0.001, ** for < 0.01, * for < 0.05 
 b
Buffer used in the formulation was potassium phosphate buffer (20 mM, pH 7.4) 
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9.4.2 Forward Selection Method  
Forward selection was also used to build correlations using all available descriptors. The computational 
package used for forward selection used AIC for descriptor selection; however, AIC yields equivalent 
models to Cp for linear correlations (Wasserman 2004), resulting in no discrepancy between descriptor 
selection between the forward search and exhaustive search methods. Due to the nature of the 
selection method, the final correlations differ in the number of descriptors selected (see Table 9.5). 
Physical descriptors were selected most frequently with this method, accounting for 9 out of the 11 
descriptors selected (see Table 9.5). Only physical descriptors were selected for urea and sucrose 
formulations and four out of the five descriptors selected for the buffer formulation were physical 
descriptors. The most commonly selected descriptor was pI, which was selected first for the buffer and 
sucrose formulations and second for the urea formulation. The early selection of pI indicates that this 
descriptor provides a superior fit to the experimental data for the buffer and sucrose formulations and a 
very good fit for the urea formulation when compared to the other descriptors. 
 
Table 9.5 Descriptors selected using a forward search method with AIC evaluation Numbering 
indicates order in which descriptors were selected. No emphasis indicates physical descriptors and bold 
text indicates AGGRESCAN descriptors. No PASTA descriptors were selected. Table adapted from 
(Roughton, Iyer et al. 2013).  
Formulation 
Descriptors Selected Regression Performance 
1 2 3  5 R
2
 Q
2
 R
2
 - Q
2
 
Buffer
a
 pI Tm %-sheet -helix THSA 0.74 0.16 0.58 
Urea # free SH pI Tm - - 0.54 0.11 0.43 
Sucrose pI %-sheet - - - 0.57 0.19 0.38 
Glycine a3vSA - - - - 0.14 -0.28 0.42 
a
Buffer used in the formulation was potassium phosphate buffer (20 mM, pH 7.4) 
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With forward selection, all of the (R2-Q2) values were large and no correlation provided a good fit to the 
data, as indicated by the low R2 values. The correlation for the buffer formulation had the highest 
number of descriptors and yielded the highest R2 value. However, the predictive power of the 
correlation was unsatisfactory and provided the largest (R2-Q2) value among the four formulations. The 
sucrose formulation provided a slightly higher R2 value than the urea formulation, despite using one less 
descriptor. The correlation for the sucrose formulation had the lowest (R2-Q2) value among the 
correlations generated by forward selection. 
9.4.3 Comparison of methods 
Models generated by exhaustive search were superior to those generated by forward selection, having 
better fits and greater predictive power as indicated by the higher R2, higher Q2 and lower (R2-Q2) values 
(compare Tables 9.3 and 9.5). Forward selection is less computationally expensive when compared to 
exhaustive search. For development with models that involve large sets of possible descriptors, use of 
exhaustive search may be infeasible due to computation requirements. However, the time needed for 
descriptor selection was comparable for both methods using the descriptor set in this model. 
Additionally, the results indicate that use of a forward search is insufficient in developing a predictive 
model with sufficient accuracy. As a result, the forward selection method was not pursued and models 
generated by exhaustive search are emphasized in the results and discussion that follow for the 
%Monomer model as a function of protein structure. Only exhaustive search was used for development 
of the %Monomer model as a function of excipient structure (see Section 9.5). 
9.4.4 Predictive Power of Correlations 
Within a formulation, correlations showed good fits (R2>0.98) and satisfactory predictive power (R2-
Q2<0.2) using the exhaustive search method (see Table 9.3). Parity plots comparing the predicted 
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percentage of monomeric protein to the experimental value are shown in Figure 9.8. Good agreement 
between predicted and actual values is observed for all four formulations, with the greatest deviation 
observed for the glycine formulation. The data for the urea formulation is spread fairly evenly and 
validation resulted in a high Q2 value. For the other formulations, one protein had a substantially lower 
observed and predicted percent monomer values than the other proteins. However, this outlying 
observation resulted in lower Q2 values only for the glycine formulations, as high prediction error was 
found for the outlier when the point was left out during cross-validation. High Q2 values were obtained 
for both the buffer and sucrose formulations, despite the outlier. The results suggest that the 
descriptors selected for the buffer and sucrose formulation are able to account for the structural 
differences in the outlying protein sufficiently, yielding a low prediction error when the protein was left-
out during cross-validation. 
9.4.5 Performance of Individual Descriptor Sets 
The models presented in Tables 9.3-9.5 were generated by pooling all of the available descriptors from 
three descriptor sets: (i) physical descriptors, (ii) AGGRESCAN descriptors, (iii) PASTA descriptors. 
Correlations were also developed for each individual descriptor set in isolation, using the exhaustive 
search method (data not shown). At small model sizes, physical descriptors provided the best fit for the 
buffer, urea and sucrose formulations. The glycine formulation showed similar fits for model sizes of one 
descriptor, regardless of the descriptor set used. At larger model sizes, no single descriptor set could 
provide a fit comparable to that given by pooling all available descriptors.  
 
Overall, physical descriptors performed better across all model sizes than the other individual descriptor 
sets. Thus, while reasonable fits could be obtained using only one descriptor set in isolation (R2≈0.7-0.8; 
data not shown), pooling the descriptors provided better fits (R2≥0.9   Table 9.3). 
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(A)      (B) 
 
      (C)                   (D) 
  
Figure 9.8 Parity plots of experimental percent monomeric protein values (%Monomer) from SEC 
versus predicted %Monomer values Correlations were developed for (A) urea, (B) buffer (potassium 
phosphate 20 mM, pH 7.4), (C) sucrose, and (D) glycine formulations. Figure adapted from (Roughton, 
Iyer et al. 2013).  
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9.4.6 Protein Descriptor Covariance 
The descriptors used in developing the correlations were taken from several different sources without 
regard to possible covariance, either within a given descriptor set or among the pooled descriptors. 
Analysis of covariance was performed to determine which descriptors were correlated strongly with one 
another. Moderate to high covariance (≥|0.7|) was observed for some descriptor pairs ta en from 
different descriptor sets, as expected (see Table 9.6). Within a given descriptor set, AGGRESCAN 
descriptors showed moderate to high covariance (≥|0.7|), as did PASTA descriptors. Some pairs of 
physical descriptors also showed high covariance (e.g., % -helix vs % -sheet). For any given correlation 
developed through multiple linear regression (Tables 9.3 and 9.5), few or no descriptors were selected 
that show moderate to high covariance (≥|0.7|). 
 
9.4.7 Discussion of Model Development Results 
The results presented here demonstrate that, for a given type of formulation, the extent of protein 
aggregation on lyophilization is strongly correlated with both physical and heuristic-based 
computational descriptors of protein structure. The best correlations (see Tables 9.3 and 9.4) were 
achieved using an exhaustive search method and descriptors pooled from the AGGRESCAN and PASTA 
algorithms along with selected physical descriptors (see Tables 4.2 and 4.3, Section 4.1.3). LOOCV 
demonstrated that the resulting correlations were able to provide good predictions of aggregation 
propensity. The results suggest that protein structure determines aggregation propensity during 
lyophilization and can be used for prediction purposes when the formulation components are held 
constant.  
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Table 9.6 Summary of covariance analysis Variable pairs with high degrees of covariance are given. 
Note that |Covariance (X,Y)| = |Covariance(Y,X)|. Table adapted from (Roughton, Iyer et al. 2013).  
  
|          (   )|      |          (   )|      |          (   )|      
(apolar, MW) 
(Lmax, (E/L)avg) 
((E/L)min, (E/L)avg) 
(a3vSA, Emin) 
(a3vSA, Eavg) 
(MW, AAT) 
(AAT, Emin) 
(AAT, Eavg) 
(THSA, Emin) 
(THSA, Eavg) 
(a3vSA, THSA) 
(a3vSA, TA) 
(a3vSA, AATr) 
(TA, AATr) 
(a3vSA, THSAr) 
(NnHS, THSAr) 
(Na4vSS, Emin) 
(Na4vSS, Eavg) 
(Na4vSS, THSA) 
(Na4vSS, TA) 
(Na4vSS, AATr) 
(Na4vSS, THSAr) 
(% -helix, % -sheet) 
(apolar, # free SH) 
(MW, nHS) 
(AAT, nHS) 
(THSA, nHS) 
(Eavg, Emin) 
(Lavg, Lmax) 
(Na4vSS, a3vSA) 
 
Independently, each of the heuristic-based algorithms provided considerably poorer correlations with 
lower predictive power than those built from pooled set of descriptors. The descriptors from both the 
AGGRESCAN and PASTA sets showed high covariance (see Table 9.6). As a result, the amount of 
structural information captured by either method is limited despite the large number of descriptors 
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obtained from both methods. The addition of physical descriptors in the pooled set allows more 
structural features of the protein to be represented and thus provides better fits.  
Descriptors selected varied between formulations and no single protein descriptor could account for the 
extent of aggregation across all formulations. This indicates that, for lyophilized formulations, the 
excipient and its interactions with the protein are important contributors to aggregation. The heuristic-
based algorithms used here do not explicitly include excipient or medium effects. However, the 
heuristic-based algorithms were developed using data from proteins in solution. As both AGGRESCAN 
and PASTA descriptors were frequently selected, the algorithms are shown to be useful in prediction of 
aggregation under lyophilized conditions. 
The most commonly selected descriptors provide insight into the factors contributing to lyophilization-
induced aggregation. In the eight correlations presented in Tables 9.3 and 9.5, pI, % -sheet, and Tm 
were selected five times and were the most commonly selected descriptors. All three have been 
implicated in aggregation induced by colloidal interactions or protein unfolding. The PASTA descriptors 
Peaks and Eavg were selected for three of the four correlations generated by exhaustive search (see 
Table 9.3). Interestingly, the percent monomer increased with increasing Peaks values for the buffer and 
sucrose formulations. While the reason for this is not clear, it may reflect a decrease in the size of each 
aggregation prone region as the number of regions increases. The PASTA descriptor Eavg describes the 
average interaction energies between residue pairings for a given protein, with lower energies indicating 
stronger interactions. As the average energies across all pairings for a protein (Eavg) were more highly 
selected than the pairing resulting in the minimum energy (Emin), the presence of several moderately 
aggregation-prone regions may increase the propensity towards aggregation more than the presence of 
one highly aggregation-prone region. Also, the two descriptors showed a high covariance (0.99), which 
may explain why only one was selected. The descriptors # of free SH and # S-S combined to be selected 
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in four of the eight correlations. The frequent selection of thiol/disulfide related descriptors is not 
surprising, since free thiol groups are reactive and can lead to the formation of disulfide-linked covalent 
aggregates. SDS-PAGE results confirmed that reducible aggregates were observed for proteins 
containing four or more free thiol groups (Table F.1, Appendix F).  
Examination of the descriptors that were not selected is also instructive. Apolar surface area (apolar) 
and fractional apolar surface area (fapolar) were not highly selected. The lack of selection of apolar 
suggests that aggregation during lyophilization is not strongly correlated to total apolar surface area. 
Furthermore, larger percentages of apolar surface area do not appear to affect aggregation as fapolar was 
not chosen for any of the correlations.  
The predictive ability of the correlations is expected to be greatest for proteins whose properties fall 
within the structural space defined by the 15 proteins studied here. Perhaps more importantly, the 
correlations are limited in that the effects of excipients on aggregation are not included quantitatively, 
since the number of excipients tested was small.  
9.5 POST-LYOPHILIZATION PROTEIN LOSS MODELS: AS A FUNCTION OF EXCIPIENT STRUCTURE 
Models were developed to describe %Monomer as a function of excipient structure. During model 
development, several techniques were introduced to further gain insight into the models developed. 
Principle component analysis (PCA) was used to investigate the descriptor space. The impact of using 
chiral connectivity indices versus simple connectivity indices was determined. Finally, K-fold cross-
validation was used in addition to LOOCV to further probe the predictive power of the models presented 
here. 
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9.5.1 Principal Component Analysis and Descriptor Comparison 
Both simple connectivity indices and chiral connectivity indices up to the fifth order were considered for 
use as descriptors for development of the protein-by-protein linear models. PCA was performed using 
the chiral connectivity indices to visualize the descriptor space for the molecules considered (see Figure 
9.9). Two principal components were sufficient to account for 99% of the variance observed in the data 
set, allowing a two dimensional representation of the descriptor space to be sufficient. PCA revealed 
three main clusters of excipient structures roughly correlating with monosaccharides, disaccharides and 
trisaccharides.  
 
Figure 9.9 Principal component analysis of descriptor space for excipients used in study  The “X” 
marker represents N-acetyl-neuraminic acid. Filled in markers represent excipients used for all proteins 
while un-filled markers represent excipients used only with BSA and RNAse A. Descriptors used to 
construct the principal components are connectivity indices up to the fifth order with a chirality 
correction factor of two. 
  
Chirality connectivity indices were able to provide fits with good accuracy (R2 > 0.9) for -amylase, 
ovalbumin and trypsin inhibitor. Simple connectivity indices were unable to provide fits with sufficient 
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accuracy. For BSA and RNAse A, neither class of descriptors was able to yield a model with acceptable 
accuracy. Excipients derived from amino acids were considered for BSA and RNAse A formulations, but 
were not considered for the other proteins.  PCA results suggested that the amino acid based excipients 
were structurally similar to the monosaccharides considered (see Figure 9.9). However, the molecular 
descriptors used do not explicitly account for charge. Amino acids are either charged or zwitterionic at 
the solution conditions used in the study. Separation of the data into two sets (a carbohydrate set and 
amino acid set) provided correlations with increased accuracy when using chiral connectivity indices for 
the carbohydrate data set and when using either type of connectivity indices for the amino acid set (see 
Figure 9.10).  Chiral connectivity indices were used for model development for all carbohydrate data 
sets. As no molecule belonging to the amino acid class contains more than one chiral center and all 
chiral centers are S-configuration, simple connectivity indices were used instead of chiral connectivity 
indices for model development for all amino acid data sets. 
 
Figure 9.10 Comparison of chiral and simple connectivity indices for BSA and RNAse carbohydrate 
models Each point represents the model with the maximum R2 for the given number of descriptors. 
Each model building set contained 20 data points.  
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9.5.2 Correlation and K-Fold Cross-Validation 
With data sets finalized, descriptor selection was used to build linear correlations relating %Monomer to 
excipient structure on a protein-by-protein basis.  Correlations of high accuracy (R2 ≈ 0.99) were 
obtained for all models, indicating that the descriptors considered were able to sufficiently model the 
%Monomer data without over-fitting (See Figures 9.11 and 9.12, Table 9.7). In general, the number of 
descriptors was large compared to the number of data points. Model size is equal to the number of 
descriptors selected plus one as an intercept was used for all models. A model size of 14 was selected 
for the BSA carbohydrate model while a larger model size of 17 was selected for the RNAse A 
carbohydrate model (both datasets contain 20 data points). For the proteins with carbohydrate data 
sets of 12 points, a model size of 8-9 was selected. For the amino acid models, a model size of 4 was 
selected for both BSA and RNAse A (both data sets contain 6 points).  A summary of model parameters is 
given in Table 9.8. 
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Figure 9.11 Parity plots of percent 
monomer remaining after lyophilization as 
a function of carbohydrate excipient choice 
for (A) BSA, (B) RNAse A, (C) -Amylase, (D) 
Ovalbumin and (E) Trypsin Inhibitor 
Predictions were made using the resulting 
correlations from model selection (See 
Table 9.7). Experimental values represent 
the horizontal axis while predicted values 
represent the vertical axis. The y=x line 
indicates a perfect prediction (where 
predicted equals experimental).  
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(A)      (B) 
 
Figure 9.12 Parity plots of percent monomer remaining after lyophilization as a function of amino acid 
excipient choice for (A) BSA and (B) RNAse A Predictions were made using the resulting correlations 
from model selection (See Table 9.7). Experimental values represent the horizontal axis while predicted 
values represent the vertical axis. The y=x line indicates a perfect prediction (where predicted equals 
experimental).  
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minimum fold size of 1 (K=20). Inspection of the PRESS scores for each left-out point showed that the 
prediction for N-acetylneuraminic acid was much poorer than all other predictions and was skewing the 
data towards a lower Q2. The point was excluded from the data set and the data set was again 
correlated to %Monomer values. The resulting model provides a similar R2 value to the original (0.999) 
while reducing the number of descriptors needed by two (see Table 9.7).  Prediction ability is improved 
by increasing the minimum fold size from 1 to 2. The amino acids models had minimum fold sizes of 2, 
accounting for 33% of the data. The carbohydrate models for the proteins with smaller data sets had 
minimum fold sizes between 3 – 4, accounting for 25 – 33% of the data. 
Table 9.7 Comparison of model size (including intercept), R2 and Q2 values for final protein-specific 
models selected Q2 values are given for varying sizes of k-fold cross-validation. The number of folds (K) 
indicates how many sets of left-out data were used for the cross-validation. The size of the fold is the 
value in parenthesis. For example, the BSA and RNAse A datasets with K=20 represents leave-one-out 
cross validation.  
 
    Q2 
Protein Data Set Model Size R2 K=20  
(Fold =1) 
K=10  
(2) 
K=5  
(4) 
K=4 
(5) 
BSA Carbohydrates 14 0.989 0.841 0.715 0.712 <0 
RNAse A Carbohydrates 17 0.999 0.591 <0 - - 
RNAse A Carbohydrates* 15 0.999 0.926 0.826 <0 - 
        
    K=6 
(1) 
K=3 
(2) 
K=2 
(3) 
BSA Amino Acids 4 0.995 0.731 0.812 <0 
RNAse A Amino Acids 4 1.000 0.999 0.995 <0 
        
    K=12 
(1) 
K=6 
(2) 
K=4 
(3) 
K=3 
(4) 
-Amylase Carbohydrates 8 0.995 0.934 0.949 0.752 <0 
Ovalbumin Carbohydrates 9 1.000 0.998 0.932 0.904 <0 
Trypsin Inhibitor Carbohydrates 8 0.996 0.961 0.912 0.708 0.874 
*Data set does not include N-acetyl-neuraminic acid 
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9.5.3 Discussion of Model Development Results 
Development of the protein-by-protein models illustrates that protein stability following lyophilization is 
strongly correlated to excipient choice. The need to separate amino acids from carbohydrates indicates 
that while structurally similar to monosaccharaides on the basis of molecular connectivity (see Figure 
9.9), the structural features of the two molecular classes act in different ways to stabilize the protein. 
Additionally, cross-validation revealed that N-acetyl neuraminic acid was the carbohydrate molecule 
with the largest prediction errors. Structural comparisons show that N-acetyl neuraminic acid is similar 
to disaccharides (see Figure 9.9). The descriptors used do not account for charge, which is present in 
amino acids and N-acetylneuraminic acid at the solution conditions considered. Accounting for charge 
may offer a means to unify the carbohydrate and amino acid models into one model and improve 
prediction for carbohydrate molecules containing charges. The improvement of the carbohydrate 
models through use of chiral connectivity indices (see Figure 9.10) indicates that the three-dimensional 
conformation is an important feature of the excipient in the stabilization of the protein. 
The cross-validation analysis suggests that the maximum amount of data acceptable to leave out was 
33%, which suggests the need to take at least 2/3 of the data experimentally in order to build a reliable 
and predictive model. However, the analysis does not suggest a hard and fast rule when developing 
similar models. Indeed, these numbers could likely be improved by rationally designing the test and 
training set (Golbraikh, Shen et al. 2003) and/or focusing the data set to a more restrictive molecular 
class, such as monosaccharides rather than carbohydrates. 
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9.6 POST-LYOPHILIZATION PROTEIN LOSS MODELS: AS A FUNCTION OF BOTH PROTEIN AND 
EXCIPIENT STRUCTURE 
Chiral connectivity indices and all discussed protein descriptors were used as potential descriptors for 
the universal model. Only data for formulations containing carbohydrate excipients were considered, 
resulting in a data set of 73 %Monomer values. The resulting model required a non-linear form, which 
required differences in model development as compared to the linear models described previously. 
9.6.1 Non-Linear Model Development 
Attempts to build a linear model of sufficient correlative quality were unsuccessful (results not shown). 
Non-linear models were considered to better correlate the descriptors to the %Monomer values. 
Several functional forms were considered, with the best form given by Equation 9.5. 
          (∑    ) (∑    ) 
(Equation 9.5) 
where  represents excipient descriptors,  represents protein descriptors, and a, b, and c are 
adjustable parameters.  All descriptors considered were used initially for model development, with 24 
descriptors accounting for excipient structure and 25 descriptors accounting for protein structure. Given 
the parameters determined for each descriptor, a parameter sensitivity analysis was performed to 
identify the parameters that had no impact on the model prediction. In total 13 descriptors were 
identified as having no impact on the model prediction, with two descriptors accounting for excipient 
structure and 11 descriptors accounting for protein structure (see Table 9.9). The descriptors were 
removed and the model parameters were again determined for the scaling constant (c) and the 
remaining 20 excipient and 6 protein descriptors. After one round of descriptor reduction, the model 
%AAD = 2.58% and reduced chi-squared = 3.23 (see Table 9.10 and Figure 9.13).  
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Table 9.9 List of descriptors considered for non-linear model development Descriptors with no impact 
on model performance (sensitivity ≈ 1) are shaded. Descriptors remaining after two rounds of parameter 
reduction are bolded.  
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Subsequent descriptor reduction guided by sensitivity analysis reduced the number of descriptors to 10, 
with 5 descriptors accounting for the excipient structure and 5 descriptors accounting for the protein 
structure (see Table 9.9). The resulting model is given by Equation 9.6. 
%Monomer = 2.51×10-5  (-2.43χ0 + 6.52χ1 - 3.12χ2 - 94.32ξ1 + 74.04ξ2) (0.029ASA + 19.35%αhelix - 
60.34%βsheet - 71.54MW + 66.38Tm) 
 (Equation 9.6) 
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Table 9.10 Summary statistics of non-protein specific model Model uses the form given by Equation 
9.6. AAD is average absolute deviation and Max AD is the maximum absolute deviation noted.  
 
Statistics 
After First Parameter 
Reduction 
After Second Parameter 
Reduction 
Size of data set 73 73 
Number of parameters 27 11 
Parameters relating to excipient  20 5 
Parameters relating to protien 6 5 
Reduced Chi-squared 3.23 4.45 
AAD 2.58% 3.38% 
Max AD 8.53% 11.83% 
Number of points outside AAD 33 (45%) 33 (45%) 
Number of points outside 2*AAD 8 (11%) 7 (10%) 
 
 
The model performs similarly to the results after the first parameter reduction, with %AAD = 3.38% and 
reduced chi-squared = 4.45 (see Table 9.10 and Figure 9.13). The further reduced model is more 
desirable as there are fewer descriptors needed for calculation, reducing the risk of over-fittting. When 
comparing the models after the first and second rounds of parameter reduction, both models have the 
same number of predicted points that exceed the model %AAD (33 or 45% of the data set). The second 
parameter reduction reduced the number of points that exceeded twice the model %AAD from 8 to 7. 
Predictions that exceeded three times the model %AAD increased from 1 to 2 after the second 
parameter reduction. The resulting model presents sufficient accuracy with reduced risk of over-fitting, 
as evidenced by reduced chi-squared value. The %AAD value of 3.38% observed is of similar value to the 
average experimental standard deviation value of 2.20% observed in %Monomer calculations. Therefore 
the error in the model prediction does not greatly exceed the error that would be encountered in 
experimental measurements.  
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(A)      (B)  
 
Figure 9.13 Parity plots of percent monomer remaining after lyophilization as a function of both 
protein and excipient structure  Predictions were made using results for non-linear model 
development. (A) represents model after first parameter reduction and (B) represents model after 
second parameter reduction. Experimental values represent the horizontal axis while predicted values 
represent the vertical axis. The y=x line indicates a perfect prediction (where predicted equals 
experimental).  
9.6.2 Discussion of Results from Model Development 
Several functional forms for a model describing protein stability following lyophilization as a function of 
excipient choice and protein choice were considered. The final form used is given by Equation 9.6, which 
was motivated by the enthalpic contribution of the Flory-Huggins model, given by Equation 9.7. The 
Flory-Huggins model has been used previously to describe protein-sugar interactions in lyophilized solids 
(Katayama, Carpenter et al. 2009; Wang, Tchessalov et al. 2009). Equation 9.6 emulates the Flory-
Huggins interaction parameter (12) through the multiplication of excipient structural descriptors and 
protein structural descriptors. The success of the Flory-Huggins functional form of the universal model 
suggests that direct protein-excipient interactions may play a significant role in stabilization of the 
protein during lyophilization for the formulations considered. 
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Parameter sensitivity analysis revealed that all of the descriptors obtained or derived from aggregation 
prediction methods had no significant impact on the model prediction (see Table 9.9).  The results 
suggest that AGGRESCAN and PASTA may not be applicable to aggregation induced by the lyophilization 
process or at least are not the strongest predictors of aggregation in lyophilized systems. Both the 
number of disulfide bridges and the number of free thiols had sensitivity values near unity, indicating 
that intermolecular disulfide bond formation was not a primary cause of aggregation for the proteins 
considered. The SDS-PAGE results support this conclusion as only ovalbumin showed reduction of 
aggregate formation under reducing conditions (see Table F.3, Appendix F). The isoelectric point had a 
sensitivity value of one, suggesting that charge-based associations were not driving forces for 
aggregation in the proteins considered. Both %-helix and %-sheet were descriptors that were 
retained in the final model, indicating that secondary structure was an important factor in protein 
stability following lyophilization. The amount of -helix content increased protein stability while the 
amount of -sheet content reduced protein stability. All excipient descriptors retained in the final model 
were chiral connectivity indices of second order or less, suggesting that the short range connectivity 
(bond paths of 2, bonds, and atoms present) was the most important excipient structural feature in 
regards to protein stability.  
The model presented provides predictions for protein stability following lyophilization as a function of 
excipient choice and protein choice. Limitations on the model exist due to the data set used for 
correlation. Only carbohydrates were considered, so extension to other classes of excipients is not 
expected to provide accurate predictions. Additionally, predictions for proteins with structural features 
that do not lie within the range of the proteins considered are not expected to be accurate. The success 
of the model illustrates that such a model development procedure can be applied to other classes of 
proteins and/or excipients for determination of predictive models for a given data set.  
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9.7 STOCHASTIC OPTIMIZATION TUNING RESULTS 
Tuning of both a tabu search and genetic algorithm was performed to determine their suitability for 
CAMD applications. For fair comparison, both methods used the same molecular representation. For 
each parameter considered, 100 runs were performed for varying parameter values while all other 
parameters were kept constant. Average value of the objective function, average time to solution, 
percentage of runs that matched the target property (hit%) and percentage of runs that were within 5% 
of the target property (close%) were the four measures used to guide tuning. Tuning was performed 
through VBA on a PC with Windows 7 32-bit OS, Intel Core i5-2400 CPU @ 3.10 GHz, and 4.00 GB RAM. 
Results for each stochastic optimization method follow. 
9.7.1 Tabu search tuning results 
For tabu search, four parameters were considered for tuning: the maximum number of non-improving 
iterations, the maximum number of neighbors evaluated per iteration, the size of tabu list and the value 
of tabu criterion (see Section 5.4 for more information on parameters). For each parameter value used 
in tuning, 100 trials were conducted. Figures 9.14-9.17 display the tuning results for each of the 
parameters considered. 
The parameter with the most influence on objective function value and percentage of correct or nearly 
correct solutions was the maximum number of non-improving iterations (see Figure 9.14). The result is 
intuitive, as the longer the search is allowed to be performed the more likely that a very good result will 
be found. As the maximum number of non-improving iterations is increased, the time to solution 
increases linearly (R2 = 0.99, Figure 9.14). Consequently, a trade-off exists between solution quality and 
solution efficiency. From tuning, a value of 100 maximum non-improving iterations was chosen as longer 
searches had minimal effects on solution quality while greatly extending time to solution. 
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(A) 
 
(B) 
 
(C) 
 
Figure 9.14 Tuning results for tabu search with varying maximum number of non-improving iterations  
(A) presents the effect of the parameter on average objective value, with error bars representing 
standard deviation from 100 trials. (B) presents the effect of the parameter on average time to solution 
(seconds), with error bars representing standard deviation from 100 trials. (C) displays the percentage  
of 100 trial solutions that hit the desired property target (hit%) or were within 5% of the desired 
property value (close%) for varying parameter values.   
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(C) 
 
Figure 9.15 Tuning results for tabu search with varying maximum number of neighbors considered at 
each iteration (A) presents the effect of the parameter on average objective value, with error bars 
representing standard deviation from 100 trials. (B) presents the effect of the parameter on average 
time to solution (seconds), with error bars representing standard deviation from 100 trials. (C) displays 
the percentage  of 100 trial solutions that hit the desired property target (hit%) or were within 5% of the 
desired property value (close%) for varying parameter values.   
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(B) 
 
(C) 
 
Figure 9.16 Tuning results for tabu search with varying tabu list length of stored solution (A) presents 
the effect of the parameter on average objective value, with error bars representing standard deviation 
from 100 trials. (B) presents the effect of the parameter on average time to solution (seconds), with 
error bars representing standard deviation from 100 trials. (C) displays the percentage  of 100 trial 
solutions that hit the desired property target (hit%) or were within 5% of the desired property value 
(close%) for varying parameter values.   
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(A) 
 
(B) 
 
(C) 
 
Figure 9.17 Tuning results for tabu search with varying tabu criteria (A) presents the effect of the 
parameter on average objective value, with error bars representing standard deviation from 100 trials. 
(B) presents the effect of the parameter on average time to solution (seconds), with error bars 
representing standard deviation from 100 trials. (C) displays the percentage  of 100 trial solutions that 
hit the desired property target (hit%) or were within 5% of the desired property value (close%) for 
varying parameter values. 
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Increasing the maximum number of neighbors evaluated at each iteration and the tabu criterion also 
lead to linear increases in time to solution (see Figure 9.15b and 9.17b). The time effect from increasing 
the number of neighbors considered follows logically as more time is needed for evaluation and tabu 
checks. The effect of increasing the tabu criterion is caused by placing too much restriction on the 
search. As the tabu criterion becomes larger, it is more likely that a neighboring solution will be deemed 
tabu. If too many solutions are declared tabu, the search will require more global moves and become 
more time-consuming. The maximum number of neighbors was chosen to be four, as a discernible 
increase in correct or nearly correct solutions is noted as the parameter changes from three to four (see 
Figure 9.15c). The variability in average objective function value also noticeably decreases as the 
maximum number of neighbors increase from three to four (see Figure 9.15a). Past four neighbors 
considered, no benefit is gained in solution quality. Tabu criterion had no distinguishable effect on 
solution quality and the base value of 0.5 was retained. The length of the tabu list had minimal effect on 
solution quality and no effect on time to solution. The length of the tabu list was set at 15 as that 
parameter value showed reduced variability in average objective function value (see Figure 9.16). 
9.7.2 Genetic Algorithm Tuning Results 
For the genetic algorithm, three parameters were considered for tuning: the maximum number of 
generations, the size of population in each generation and the maximum probability that a member of 
the population will be chosen as a parent (see Section 5.4 for more information on parameters). For 
each parameter value investigate, 100 trials were performed. Figures 9.18-9.20 display the tuning 
results for each of the parameters considered. 
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Figure 9.18 Tuning results for genetic algorithm with varying maximum number of generations (A) 
presents the effect of the parameter on average objective value, with error bars representing standard 
deviation from 100 trials. (B) presents the effect of the parameter on average time to solution (seconds), 
with error bars representing standard deviation from 100 trials. (C) displays the percentage  of 100 trial 
solutions that hit the desired property target (hit%) or were within 5% of the desired property value 
(close%) for varying parameter values.   
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Figure 9.19 Tuning results for genetic algorithm with population size per generation (A) presents the 
effect of the parameter on average objective value, with error bars representing standard deviation 
from 100 trials. (B) presents the effect of the parameter on average time to solution (seconds), with 
error bars representing standard deviation from 100 trials. (C) displays the percentage  of 100 trial 
solutions that hit the desired property target (hit%) or were within 5% of the desired property value 
(close%) for varying parameter values.   
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(A) 
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Figure 9.20 Tuning results for genetic algorithm with varying maximum probability that a member will 
be selected as a parent (A) presents the effect of the parameter on average objective value, with error 
bars representing standard deviation from 100 trials. (B) presents the effect of the parameter on 
average time to solution (seconds), with error bars representing standard deviation from 100 trials. (C) 
displays the percentage  of 100 trial solutions that hit the desired property target (hit%) or were within 
5% of the desired property value (close%) for varying parameter values. 
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the number of solution evaluations that must be performed. The maximum number of generations was 
set at 25 as further increases result in minimal improvements in solution quality (see Figure 9.18a,c). The 
population size was set at 50 to ensure highest solution quality (see Figure 9.19a,c). Varying maximum 
probability that a member will be selected as a parent had no effect on solution quality or time to 
solution (see Figure 20). The base case value of 100 was retained for the probability value. Overall, the 
effectiveness of the genetic algorithm seems to be most dependent on the seed population. A large 
seed population allows for many local minima to be probed, increasing the probability that a good 
solution will be found. The time spent searching (i.e., number of generations) has an effect, but past a 
certain point the search yields no further improvement.  
9.7.3 Comparison of Solution Methods for Test Case 
Following tuning, the final parameter values were determined and are available in Table 9.11. The 
parameter values were used to evaluate 100 trials of the test case (MW = 342 g/mol) for each solution 
method. The objective function values and times to solution over the trials were compared across 
methods.  
Table 9.11 Final tuned values for tabu search and the genetic algorithm The parameter values shown 
were used for the test case comparison and design cases in Section 9.8.  
 
Tabu Search Genetic Algorithm 
Parameter 
Tuned 
Value 
Parameter 
Tuned 
Value 
Maximum non-improving iterations 100 Maximum number of generations 25 
Maximum neighbors evaluated per iteration 4 Population Size 50 
Tabu list length 15 Maximum reproduction probability 100 
Tabu criterion 0.5   
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(A)  
 
(B) 
 
Figure 9.21 Comparison between objective function values obtained for all 100 trial solutions of the 
test case by (A) tabu search and (B) the genetic algorithm 
 
In Figure 9.21, the objective function values for all 100 trials are compared between the tabu search and 
genetic algorithm. It should be noted that the test case had many possible combinations exist which 
satisfy the target value and thus had many opportunities to find a global optimum. The tabu search 
returned a molecule with the target value 81% of the time and returned a molecule within 5% of the 
target value in all trials.  The genetic algorithm had somewhat lower success, returning a molecule with 
the target value 59% of the time. Yet the genetic algorithm still returned a molecule within 5% of the 
target value in all trials. Additionally, the tabu search had several trials that returned much higher 
objective function values when compared to the all of the trials for the genetic algorithm. So while the 
tabu search has a higher probability of returning a correct solution, it also appears to have a higher 
probability of returning a relatively poor solution when compared to the genetic algorithm. 
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The times to solution for all 100 trials are compared between the tabu search and genetic algorithm in 
Figure 9.22. The genetic algorithm had much less variability in time to solution as compared to tabu 
search. The time to solution is also faster on average for the genetic algorithm. Neither observation is 
surprising as the search effectively restarts during tabu search when a new best solution is identified. 
The amount of restarts is random, leading to variability in time to solution. The tuning results suggest 
that tabu search can return results with better objective function values while the genetic algorithm 
returns results with significantly lower time to solution. To further compare the stochastic methods, 
several design cases are considered in the following section. 
(A)  
 
(B) 
 
Figure 9.22 Comparison between times to solution observed for all 100 trial solutions of the test case 
during (A) tabu search and (B) the genetic algorithm 
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9.8 RESULTS FOR OPTIMAL DESIGN OF STABILIZERS FOR LYOPHILIZED PROTEIN FORMULATIONS 
The tuned stochastic optimization methods presented in Section 9.7 were used in CAMD to obtain 
optimal stabilizing excipient candidates for the property models outline in Section 9.5. The models for 
individual proteins were chosen over the universal model given in Section 9.6 as the %Monomer models 
dependent on excipient show superior fit and predictive capability. Therefore the models are good 
examples to illustrate the ability of the CAMD methods to design excipients that optimally match the 
given target value with low prediction error, as evaluated by prediction intervals. Design was limited to 
carbohydrate excipients. Every design case was subjected to 100 trials. Results are compared across 
stochastic optimization methods and also across proteins. 
9.8.1 Comparison of CAMD Results Obtained by Tabu Search and a Genetic Algorithm 
CAMD was used to generate optimal carbohydrate stabilizers for BSA, RNAse A, -amylase, ovalbumin 
and trypsin inhibitor design cases. Solutions were obtained through use of the tuned stochastic 
optimization methods presented in Section 9.7. The best solutions out of 100 runs of both solution 
methods are displayed for each protein in Figures 9.23-9.27. The use of chirality connectivity indices in 
the models allows chiral information to be determined for the solutions, giving an indication of three-
dimensional structure. A summary of the average objective function values and average times to 
solution for all 100 runs is also presented in the figures. 
For all design cases, the best results obtained from tabu search and the genetic algorithm had prediction 
intervals that overlapped the target property value. Therefore, all of the best candidates returned 
displayed predicted property values that were statistically similar to the desired target property value of 
100% monomer remaining after lyophilization. Additionally, for each design case, the prediction 
intervals for the best tabu search solution overlapped with the prediction intervals for the best genetic 
algorithm solution. Despite returning solutions with objective function values that differed up to two 
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orders of magnitudes, both methods returned statistically similar solutions for all design cases. From the 
basis of target property value returned by the best solution, both stochastic methods perform at a 
similarly high level (i.e., both models return solutions that match the target property). 
From case to case, the magnitude of prediction intervals varied. As the size of prediction intervals is 
related to the expected error in the observed property value, solutions with small prediction intervals 
are desired. Considering the best solutions only, tabu search returned solutions with smaller prediction 
intervals for 3 cases (RNAse A, a-amylase and trypsin inhibitor) and the genetic algorithm returned 
solutions with smaller prediction intervals for 2 cases (BSA and ovalbumin). The magnitude also varied 
from case to case. In particular, the ovalbumin design case had solutions with extremely small prediction 
intervals (see Figure 9.26). The magnitude of prediction intervals increases as the descriptors used in the 
prediction diverge from the descriptor values used to build the predictive model. A quick look at the 
best solutions reveals that many of the structures are quite different from the monosaccharaide, 
disaccharaide, trisaccharaide and sugar alcohol structures used in model development.  An exception 
occurs in the ovalbumin design case. The tabu solution is very similar to maltitol and the genetic 
algorithm solution is very similar to galactitol. Maltitol was used in model development and galactitol is 
a stereoisomer of sorbitol and mannitol, both of which were used in model development. As a result, 
the prediction intervals for both ovalbumin solutions are very small. In general, the prediction intervals 
for all design cases are comparable to the average experimental standard deviation of 2.20%. 
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Figure 9.23 Optimal carbohydrate stabilizer candidates for BSA, as determined by (A) tabu search and 
(B) genetic algorithm The objective function value (obj), time to solution in seconds (t), predicted target 
property value (%Monomer), molecular weight (MW), number of hydrogen-bond donors (HBD), number 
of hydrogen-bond acceptors (HBA) and number of rings present (rings) are listed for the top solution. 
Also listed are the average objective function values, average time to solution values and percentage of 
trials with 5% (close%) of target property for 100 trials. Prediction intervals provide the ± interval for the 
objective function value of the best solution. The standard deviation of 100 trials represents the ± 
interval for the average values over 100 trials.  
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Average t = 4.753 ± 1.878 sec 
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Tabu Search (A) 
Objective function  = 1.19x10
-4
 
t = 5.929 sec 
%Monomer = 99.99% ± 3.08% 
MW = 282 g/mol 
HBD = 7 
HBA = 9 
Rings = 1 
Average Obj = 0.00669 ± 0.00917  
Average t = 4.786 ± 1.590 sec 
Close% = 100% 
Genetic Algorithm (B) 
Objective function  = 3.63x10
-5
 
t = 0.265 sec 
%Monomer = 100.00% ± 5.19% 
MW = 344 g/mol 
HBD = 10 
HBA = 11 
Rings = 0 
Average Obj = 0.203 ± 1.005 
Average t = 2.684 ± 3.683 sec 
Close% = 90% 
  
Figure 9.24 Optimal carbohydrate stabilizer candidates for RNAse A, as determined by (A) tabu search 
and (B) genetic algorithm Description of figure values is given in caption for Figure 9.23.  
 
When looking at the quality of solutions over all 100 trials, the tabu search has a better average 
objection function value when compared to the genetic algorithm for all design cases. The objective 
function value has lower variability for the tabu search results compared to the genetic algorithm for all 
design cases, as indicated by the standard deviation values. In addition, the percentage of solutions that 
are within 5% of the target value is 100% for tabu search runs in all design cases while the percentage 
ranges from 90-99% for the genetic algorithm runs. On average, the tabu search can be expected to 
return a solution of higher quality than the genetic algorithm. The results from tuning the test case 
suggest the same conclusion. 
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Tabu Search (A) 
Objective function  = 1.83x10
-5
 
t = 10.187 sec 
%Monomer = 100.00 ± 1.50% 
MW = 240 g/mol 
HBD = 7 
HBA = 8 
Rings = 1 
Average Obj = 0.00153 ± 0.00162 
Average t = 5.240 ± 1.985 sec 
Close% = 100% 
 
Genetic Algorithm (B) 
Objective function  = 3.65x10
-5
 
t = 0.265 sec 
%Monomer = 100.00% ± 1.66% 
MW = 284 g/mol 
HBD = 8 
HBA = 9 
Rings = 1 
Average Obj =0.00536 ± 0.02107 
Average t = 0.384 ± 0.397 sec 
Close% = 99% 
  
Figure 9.25 Optimal carbohydrate stabilizer candidates for -amylase, as determined by (A) tabu 
search and (B) genetic algorithm Description of figure values is given in caption for Figure 9.23.  
 
By method, the times to solution for the best solutions and the average times to solution were 
comparable. Comparing methods, the genetic algorithm is an order of magnitude faster than tabu 
search in determining a solution. The tabu search displays a higher variability in time to solution, as 
indicated by the larger standard deviation values. As noted in the tuning results (see Section 9.7), the 
tabu search effectively restarts when a new best solution is encountered. The number of times this 
occurs is directly proportional to the time to solution. Average time to solution does vary somewhat as 
the design case is varied, which likely indicates that more good solutions exist in the solution space for 
some models as compared to others. If there are higher numbers of good solutions, the probability of 
encountered a good solution is higher and the expected time to solution would be faster. Overall, the 
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results from the design cases agree with the results from the test case that time to solution is faster and 
experiences lower variability with the genetic algorithm as compared to the tabu search. 
 
 
    
 
Tabu Search (A) 
Objective function  = 4.60x10
-5
 
t = 4.982 sec 
%Monomer = 100.00% ± 0.29% 
MW = 342 g/mol 
HBD = 9 
HBA = 11 
Rings = 1 
Average Obj = 0.00186 ± 0.00171 
Average t = 4.930 ± 1.746 sec 
Close% = 100% 
 
Genetic Algorithm (B) 
Objective function  = 3.49x10
-5
 
t = 0.281 sec 
%Monomer = 100.00% ± 0.21% 
MW = 212 g/mol 
HBD = 7 
HBA = 7 
Rings = 0 
Average Obj = 0.0402 ± 0.2923 
Average t = 0.516 ± 0.946 sec 
Close% = 97% 
  
Figure 9.26 Optimal carbohydrate stabilizer candidates for ovalbumin, as determined by (A) tabu 
search and (B) genetic algorithm Description of figure values is given in caption for Figure 9.23.  
 
 
213 
 
   
 
Tabu Search (A) 
Objective function  = 9.98x10
-6
 
t = 5.054 sec 
%Monomer = 100.00 ± 3.42% 
MW = 372 g/mol 
HBD = 10 
HBA = 12 
Rings = 2 
Average Obj = 0.00145 ± 0.00159 
Average t = 5.652 ± 1.924 sec 
Close% = 100% 
 
Genetic Algorithm (B) 
Objective function  = 1.01x10
-4
 
t = 0.390 sec 
%Monomer = 100.00% ± 5.75% 
MW = 330 g/mol 
HBD = 10 
HBA = 10 
Rings = 0 
Average Obj = 0.0231 ± 0.1913 
Average t = 0.430 ± 0.477 sec 
Close% = 99% 
  
Figure 9.27 Optimal carbohydrate stabilizer candidates for trypsin inhibitor, as determined by (A) tabu 
search and (B) genetic algorithm Description of figure values is given in caption for Figure 9.23.  
 
Comparison of the methods demonstrates that tabu search provides solution with higher quality (as 
indicated by the objective function) and the genetic algorithm provides solutions with less computation 
effort (as indicated by the time to solution). It is tempting to select the tabu search method as the better 
stochastic method for CAMD due to higher solution quality, yet the best genetic algorithm solutions are 
statistically comparable to the best tabu search solutions. Additionally, the genetic algorithm on average 
can roughly produce a list of 100 candidates in the time it would take the tabu search to produce a list of 
10 candidates. Therefore, the genetic algorithm is more efficient than the tabu search and equally 
capable of producing high quality results for all design cases. 
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9.8.2 Comparison of CAMD Results as a Function of Protein Included in the Formulation 
A comparison of solutions between each design case (i.e., protein) was performed to determine if 
certain chemical characteristics were preferred by one protein over another. The chemical properties 
used for comparison were molecular weight (MW), number of hydrogen bond donors (HBD), number of 
hydrogen bond acceptors (HBA) and number of rings present (rings). The comparison of average CAMD 
solution properties by protein is given in Figure 9.28. 
Comparison of results indicates that no significant difference in the properties considered exist across 
proteins. The solutions for both stochastic methods average to a monosaccharide (1 ring) with six to 
seven hydrogen bond donors, eight to nine hydrogen bond acceptors and a molecular weight less than 
300 g/mol. The disaccharides sucrose and trehalose are often cited as effective lyoprotectants 
(Schwegman, Hardwick et al. 2005). The average solution property values are lower than the property 
values observed for sucrose and trehalose, which are isomers and have molecular weights of 342 g/mol, 
eight hydrogen bond donors and eleven hydrogen bond donors. Of the best solutions presented in 
Section 9.8.1, only one solution contained two rings (see Figure 9.27a). All other solutions contained 
either one ring or no rings.  
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(A)      (B) 
 
(C)       (D) 
 
Figure 9.28 Comparison across protein models of average chemical information for solutions derived 
by both tabu search and genetic algorithm  The information used for comparison are (A) molecular 
weight (g/mol), (B) number of rings, (C) number of hydrogen bond donors, and (D) number of hydrogen 
bond acceptors. Error bars represent the standard deviation of 100 trials for each case.  
 
The three-dimensional conformation appears to be more important than the chemical properties 
considered for obtaining 100% monomer remaining after lyophilization. By incorporating chiral 
connectivity indices in the %Monomer property models, three-dimensional information is captured. 
Only nine building block groups are used in the determination of all the solutions presented. Yet, the 
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inclusion of chirality information vastly increases the number of possible solutions and is the overriding 
factor in the design of optimal solutions. The models and CAMD results here present the first use of 
chiral connectivity indices in CAMD and the first use of topological descriptors to provide CAMD 
solutions with three-dimensional structural information. It is important to note that the solutions 
provided were not designed using all relevant excipient properties and should therefore not be 
considered final candidates for immediate inclusion in lyophilized protein formulations. However, both 
stochastic methods are able to quickly generate a large list of optimal candidates that can be further 
screened in a post-design phase, which may include any combination of additional property models, 
molecular simulations and experiments that are deemed necessary. The work here provides a starting 
point for the CAMD of excipients with three-dimensional structural information for stabilization of 
lyophilized proteins. 
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10.0 CONCLUSIONS AND FUTURE RECOMMENDATIONS 
The work presented here describes the comprehensive development of CAMD methods with 
applications towards bioengineering, namely the design of ionic liquid media for bioseparations and the 
design of excipients for lyophilized protein formulations. The pre-design approach to CAMD is concerned 
with the determination of systems of interest and the acquisition of data for property of interests. 
Where available, data was collected from literature to build the models developed here. For prediction 
of monomeric protein remaining after lyophilization, the collection of experimental data was required.  
The design phase of CAMD is comprised of two sub-problems. The forward problem is concerned with 
property model development, linking structure to properties of interest. Several approaches novel to 
CAMD were employed to better provide models of sufficient fit and predictive power. Descriptor 
selection was used when applicable to provide models with sufficient fit while avoiding overfitting. 
Exhaustive selection was found to be superior to forward selection when developing models describing 
%Monomer as a function of protein structure. The use of cross-validation has been used previously in 
CAMD (Eslick, Ye et al. 2009), but the approach was furthered here with the use of K-fold validation to 
more significantly probe predictive capability of models describing %Monomer as a function of excipient 
structure. Additionally, the use of Q2 as an indicator of predictive power was illustrated with poor Q2 
values leading to predicted ionic liquid toxicity values with large prediction intervals. Molecular 
descriptors novel to CAMD were used for the models describing %Monomer as a function of excipient 
structure, which provided chirality information to help distinguish between molecules. By using chiral 
connectivity indices, some three-dimensional structural information was captured using only a two-
dimensional molecular representation. 
The reverse problem of the CAMD aims to propose molecular structures that optimally match given 
target property values. Molecular candidates to the ionic liquid and excipient design problems were 
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proposed using a variety of solution approaches. Deterministic methods were used to solve for ionic 
liquid entrainers for separation of azeotropic mixtures. Tabu search, a stochastic method, was used to 
design ionic liquid extractants and excipients with optimal glass forming properties. Novel to the work 
presented here, two stochastic optimization methods (i.e., tabu search and genetic algorithm) were 
tuned for CAMD applications. The stochastic methods were then used to design carbohydrate stabilizers 
for lyophilized protein formulations. Evaluation of the two methods showed that tabu search had longer 
time to solutions but higher solution quality and consistency when compared to the genetic algorithm. 
However when comparing the best solutions from each method, the predicted target values were 
similar as indicated by overlapping prediction intervals. Use of prediction intervals are original to the 
CAMD approaches used here and help to provide a statistical means of comparison between solutions. 
By incorporating chiral connectivity indices in the design of stabilizing excipients, three-dimensional 
structural information for design solutions was provided for the first time in CAMD approaches through 
use of only two-dimensional structural information. 
The post-design of CAMD aims to further screen and establish good candidates for a given application. 
The coupling of product and process design allowed for the design of ionic liquid entrainers and 
azeotropic separation processes with near-optimal performance in terms of energy requirements. Final 
ionic liquid separation process results were shown to require less energy to perform separations than 
systems using entrainers that were not rationally designed. Molecular simulation was investigated as a 
tool to approximate hydrogen-deuterium exchange experiments and gleam information on possible 
protein-excipient interactions. Use of simulation results are likely insufficient to guide design at the 
current state of implementation. A better use of molecular simulation is likely to be as a post-design 
screening tool to further narrow down an excipient candidate list for a given lyophilized protein 
formulation. 
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Moving forward, more property models are needed for the examples considered to better generate a 
list of candidates that would be expected to perform successfully. For example, human toxicity would be 
important for the design of excipients for protein drug formulations. Additionally, several of the design 
solutions are reducing sugars, which would not be acceptable for protein formulations. Rules for group 
addition or improved penalty functions could be employed to prevent reducing sugars from being 
selected as solutions. In several of the design examples, the error in property prediction of %Monomer 
exceeds what would be acceptable from the viewpoint of the biopharmaceutical industry. A multi-
objective optimization problem could be formulated to minimize both differences between target and 
predicted properties along with prediction intervals of predicted properties. Such a problem formulation 
would insure that solutions are returned where confidence in the predicted property values is high. For 
prediction of glass transitions, multiple transitions may occur in a sugar. Improvement to glass transition 
properties could include the prediction of polymorphic systems where multiple transitions would be 
expected to occur. The shift from one-dimensional (e.g., group contribution) and two-dimensional 
descriptors towards three-dimensional or quantum descriptors will likely provide better property 
prediction and more accurate design results in future CAMD applications.  
Tuning of the tabu search and genetic algorithm was performed on a basic level. Future work in tuning 
and increased levels of sophistication in the design algorithms will be useful in improving algorithm 
efficiency and solution quality. For example, mutation rate and crossover rate were randomly selected 
in the genetic algorithm. Further tuning could identify rates that were more useful for CAMD. 
Additionally, the tuning results presented are dependent on the base values of parameters used for 
tuning. It is possible that the base value for a parameter could have such a value that the parameter 
overwhelmed the effects of other parameters. Further investigation into the base parameter values and 
their effect on the final chosen tuned values would be of interest. An especially promising area of 
algorithm development is the parallelization of stochastic optimization methods, which is expected to 
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provide substantial improvements to the computational costs of performing CAMD. As molecular 
complexity increases, the resulting combinatorial search space could warrant the need for vastly reduce 
search times that would be proffered by parallelization. The parallelization of both stochastic solution 
methods would also be of interest from the point of view of a pure scientific curiosity. Combination of 
the design process with a database search offers a promising avenue of future post-design methods. For 
example, a molecule that is design could be used to identify similar molecules in online structure 
databases, such as PubChem. Similarity searches would provide a way to experimentally validate CAMD 
design results without the time and complexity that would result from chemical synthesis of the design 
solutions. Information from experimental validation could be used to further improve property models 
and design methods. Such an integrated experimental-computational CAMD approach would be 
instrumental in the identification of molecule candidates for use in a variety of bioengineering 
applications, including the lyophilized protein formulation design and ionic liquid solvent design cases 
considered here. 
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A. NOMENCLATURE 
 
The meanings of abbreviations and symbols are provided below. Definitions are giving in the order of 
appearance. As much as possible, clarification is also given in the text. 
m, n Size of a set 
i, j ,k Index of a set 
CAMD Computer-aided molecular design 
SAP Spatial aggregation propensity algorithm 
   Glass transition temperature, specifically for an anhydrous solute 
   Gordon-Taylor constant 
   ,   Weight fractions 
  
   Glass transition temperature of the maximally freeze-concentrated solute 
  
   Melting point of ice in the freeze-concentrated solution 
  
   Maximal freeze concentration of solute 
NMR Nuclear magnetic resonance 
GC Group contribution 
Y Response variable 
X, x Dependent variable matrix or array 
 Coefficient vector 
RSS Residual sum of the squares 
 Chemical potential 
    Fugacity coefficient 
    Activity coefficient 
  
   Fugacity at standard conditions 
    Vapor mole fraction 
    Liquid mole fraction 
   Pressure 
  Objective function 
     Property value 
   Representation of molecular structure 
      Adjacency matrix  
    Chemical group 
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    Structural constraint 
   Absorbance 
   Extinction coefficient 
   Concentration 
   Path length 
    Aggregation index 
    Optical density 
          Percent of protein monomer remaining after lyophilization 
SEC Size exclusion chromatography 
SDS-PAGE Sodium-dodecyl-sulfate polyacrylamide gel electrophoresis 
pxrd Powder X-ray diffraction 
 Incident angle 
l Wavelength 
dhkl Characteristic vector defined by crystal geometry 
<I> Intensity 
    Rate constant 
HX-MS Hydrogen-deuterium exchange mass spectroscopy 
 Hildebrand solubility parameter 
Td Thermal decomposition temperature 
Kx Partition Coefficient, specificly for NDHD 
EC50 Half maximal effective concentration 
n Simple connectivity index of n-th order 
n v Valence connectivity index of n-th order 
Ns Number of subgraphs 
i Vertex degree 
i
v Valence vertex degree 
Z Atomic number 
Zv Number of valence electrons 
NH Number of connected hydrogen atoms 
n Average simple connectivity index of n-th order 
n v Average valence connectivity index of n-th order 
a3vSA Sequence average amino acid aggregation propensity  
nHS Number of aggregation hot spots 
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NnHS nHS normalized by number of residues in protein 
AAT Area of aggregation profile above hot spot threshold 
THSA Total area of aggregation profile comprising hot spots 
TA Total area of aggregation profile 
AATr AAT normalized by number of residues in protein 
THSAr THSA normalized by number of residues in protein 
Na4vSS Sliding window average of amino acid propensity values divided by number 
of amino acids in protein 
Emin Minimum energy of PASTA pairings 
Eavg Average energy of PASTA pairings 
Lmax Average amino acid pair length of PASTA pairings 
Lavg Maximum amino acid pair length of PASTA pairings 
(E/L)min Minimum ratio of energy to length of PASTA pairings 
(E/L)avg Average ratio of energy to length of PASTA pairings 
# of Peaks Number of peaks in PASTA aggregation profile 
   Mallow's Cp statistic 
p Number of parameters 
    Variance 
LOOCV Leave-one-out cross-validation 
PRESS Predicted residual sum of the square errors 
Q2 Cross-validation coefficient 
R2 Correlation coefficient 
Sx Sensitivity 
      Percent average absolute deviation 
     Cohesive energy density 
    Molar volume 
       Enthalpy of vaporization 
    Volume fraction 
    Contribution of group 
Rk Group volume parameters 
Qk Surface area parameters 
k Group residual activity coefficient 
m Volume contribution parameter 
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Xm Group fraction parameter 
nm Interaction parameter 
anm Group interaction parameter 
  
    
   Error terms 
 ( )  Binary variable declaring the existence of an alkyl chain 
       ( ) ,       ( ) Binary variables declaring the existence of cation and anion 
   ( )  Fitness of j-th member 
   ⁄   Student’s t-test value 
Dx Location of maximum driving force 
Dy Value of maximum driving force 
N Number of stages 
NF Feed stage location 
SF Scaling factor 
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B. R PROCEDURE FOR MODEL DEVELOPMENT  
 
The following procedure describes the steps used in R to develop linear QSPRs, including descriptor 
selection and cross-validation. The steps needed for calculation of prediction intervals are also given. At 
the end follows an example of code written in R to perform the described tasks. 
1. Open R program 
2. The first time you run the program, you will need to install the leaps package, which is used for 
descriptor selection. Click on Pac ages>Install pac age(s) …  
 
3. Select the CRAN mirror for the download. Choose whichever site you would like and click OK. 
 
 
237 
 
4. From the Packages selection screen, select leaps and click OK 
 
5. After the installation, the leaps package can be used. The package only needs to be installed 
once. To load the leaps pac age, clic  on Pac ages> oad pac age… and then select the leaps 
package 
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6. After the leaps package has loaded, the csv file containing the descriptor information and value 
that is desired to be correlated should be loaded into R. The column headers in the csv file will 
be used by R as names for the variable. Special characters are usually replaced by “X” and spaces 
are replaced by “.”.  To load the csv file, type the following command: 
 
pick a name = read.csv(file.choose()) 
 
The name for the file is chosen by the user.  A “Select file” window will pop up showing the user 
directory. Navigate to the csv file desired and select the file. Click Open. 
 
 
 
7. To attach the column headers to the variable names in R, type the following command 
 
attach(pick a name) 
 
Using whatever name you had chosen in step 6. To check that the file is loaded correctly and to 
see the variable names that R is using, type 
 
pick a name 
 
Again using the name you had chosen in step 6. The csv file data will then display in R. Note the 
variable names for each column, as they will be used to create the correlation later.  
 
 
239 
 
 
 
8. Next, a text file containing only the descriptor values must be loaded into R as a matrix. The 
matrix will be used for the descriptor selection. The number of columns in the text file must be 
inputted. To load the text file, type the following command: 
 
matrix name = matrix(scan(file.choose()),ncol=number of columns in text file,byrow=TRUE) 
 
Where matrix name is chosen by the user and number of columns in text file is entered as a 
number. 
 
9. After the text file has been read, descriptor selection can be performed. Type the following 
command: 
 
leaps(matrix name,correlated variable,method=c(“r ”),nbest=1,strictly.compatible=FALSE) 
 
Where matrix name is the name chosen in step 8 and correlated variable is the name of the 
dependent variable in the correlation being built. Two methods can be used. r2 choses the set of 
descriptors that maximizes the r2 value. Cp chooses the set of descriptors that minimizes the Cp 
value, which is a measure of the lack of fit plus the number of descriptors used. Different values 
for what nbest is equal to can be selected and will determine how many different 
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correlations/models of each size (# of descriptors) will be reported. For example, nbest=3 would 
report the three best models based upon the method chosen for each model size.  
 
The output will display a matrix showing which descriptor was used for each correlation, as 
indicated by TRUE or FALSE. The score given by the method selected will also be displayed. 
 
 
 
10. Select a desired model/correlation for further analysis. Note the descriptors used in the model. 
Build the correlation in R using the following command: 
 
correlation name.lm <- lm(correlated variable~var1+var2 +…+varX) 
 
Where correlation name is selected by the user, correlated variable is the dependent variable, 
and var1 to varX are the descriptors selected using leaps. X denotes the size of the model (# of 
descriptors).  
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11. The correlation information can be retrieved with the following command: 
 
summary(correlation name.lm) 
 
Where correlation name is the same as chosen in step 10. 
 
 
 
12. To evaluate Q2, you must create a csv file containing only the selected descriptors and 
correlated values. The variable names should remain the same to ensure that the correlation 
can be used for cross-validation. 
13. Cross-validation can then be performed using the following command: 
User-definedName.CVlm <- CVlm(csv file name, correlationName.lm, m=number of folds, plotit=TRUE, 
printit = TRUE) 
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14. The predicted and correlation values of each fold are used to calculate Q2 (via excel). 
15. To calculate the prediction intervals for a prediction, the prediction’s descriptors must be 
entered as a new data frame: 
 
Name of new data frame = data.frame(descriptor1 = xxx, descriptor2 = xxx, …) 
 
16. The following command returns the prediction and the lower and upper interval value: 
predict(correlationName.lm, data frame name, interval=”predict”) 
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An example code to complete the following steps is given below: 
TIfields = read.csv(file.choose()) 
attach(TIfields) 
TImatrix = matrix(scan(file.choose()),ncol=10,byrow=TRUE) 
leaps(TImatrix,TI,method=c("Cp"),nbest=1,strictly.compatible=FALSE) 
TI.lm <- lm(TI~cX4 + cX0A + cX1A + cX1v + cX3v + cX2Av + cX5Av) 
summary(TI.lm) 
TI.CVlm <- CVlm(TIfields, TI.lm, m=11, plotit=TRUE, printit = TRUE) 
TItabu = data.frame(cX4 = 13.98383752, cX0A = 0.832184077, 
      cX1A = 0.603651, cX1v = 10.68623644, cX3v = 8.425098614, 
      cX2Av = 0.261058302, cX5Av = 0.057471174) 
TIga = data.frame(cX4 = 7.903364617, cX0A = 0.846240068, 
      cX1A = 0.587963437, cX1v = 8.383716113, cX3v = 5.856908357, 
      cX2Av = 0.260155783, cX5Av = 0.067981002) 
predict(TI.lm, TItabu, interval="predict") 
predict(TI.lm, TIga, interval="predict") 
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C. POLYMER DESIGNER PROCEDURE  
 
To open the Polymer Designer (pd2) executable, open the terminal in the pd2 Folder 
 Then in the terminal, type:  
    ./pd2 
 
In the program, you need to open a database.  Clic  “Open Database” and then select the database you 
want to use.  
 
To fill in the screen with info, clic  on “select columns”. Some useful columns are Info>Name and 
Descriptors> all the various connectivity indices. Then click Add Rows > Search and select the molecules 
you want to be shown. This can be used to calculate connectivity indices. 
 
To add new correlations, you must do the following 
 Close pd2 
 Open >src>tabu>dp_tabu_01.cpp 
 Scroll about ¾ of the way down and edit the correlations. Chii_# is the unweighted connectivity 
index and xi_# is the weighted connectivity index.  
 Edit the cout information so your correlation values will be outputted 
 If you add any new variables, make sure they are declared in this file 
o Then open >src>tabu>dp_tabu_01.hpp and define them there as well 
 Close both the .cpp and .hpp files 
 In the pd2 directory, delete the make file, pd2 executable file and pd2.pro file 
 Then follow the instructions for installing the program found in (Eslick 2009). 
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To run the tabu search: 
 Go to molecules>polymers>browse 
 Select a starting molecule (such as Tabu BisGMA) and click view 
 In the window that opens, go to the Toolbox and click on the graph tab. Then click Algorithm 
Test and select Tabu test. The search results will display in the terminal. 
To view and save a tabu search solution: 
 In pd2, go to Monomers>Browse>View and select anything 
 Go to the graph tab and select “import” then “yes” 
 Select your solution 
 Rearrange the atoms and bonds to better view your solution 
 Then close the molecule window 
 Go to Monomers>Browse>Add and your molecule should appear. Change the name and add a 
description 
 
To change the groups that will be used to build the tabu search solution: 
 Go to molecules>monomers>edit 
 Select a group from 09 to 18 to view. Only these are used by the program as building blocks. 
 In the molecule viewer, you can edit the bond and atoms. An Atomic # = 0 makes the atom a 
connector. Every group must have at least one connector. 
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IONIC LIQUID GROUPS USED IN POLYMER DESIGNER 
 
Cation Groups 
 
 
 
 
 
 
 
Anion Groups 
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EXCIPIENT GROUPS USED IN POLYMER DESIGNER 
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D. CAMD EXCIPIENT DESIGNER SOURCE CODE  
 
The following code is written in VBA and contains all the code used to design carbohydrate excipient 
molecules for optimal %Monomer values. Modular programming was used with modules devoted to the 
following tasks: Running searches and building molecules, calculating descriptors, calculating properties, 
tabu search and genetic algorithm. In addition to the code provided here, data for each group is needed 
in worksheets. Comments are indicated by an apostrophe (').  
CAMD MODULE CODE 
Public n As Long, n_minusrings As Long 
Public m_max As Long 
Public Declare Function GetTickCount Lib "kernel32.dll" () As Long  'Returns time elapsed since startup in 
miliseconds 
 
Sub RunManyCAMD() 
 
Dim i As Long, j As Long, runs As Long 
Dim mol() As Long, mol_size As Long 
Dim Final_Obj As Double 
Dim t As Long 
 
runs = 100 
 
Range("B2:O101").ClearContents 
 
For i = 1 To runs 
    DoEvents    'Prevent not responding message 
    t = GetTickCount 
    Call CAMD(mol, Final_Obj) 
    mol_size = UBound(mol) 
    Cells(1 + i, 2) = i 
    Cells(1 + i, 3) = Final_Obj 
    Cells(1 + i, 4) = GetTickCount - t  'time elapsed while running code(and inserting i and obj values in 
excel - but that is negligible) 
    Cells(1 + i, 5) = MW(mol) 
    Cells(1 + i, 6) = HBD(mol) 
    Cells(1 + i, 7) = HBA(mol) 
    Cells(1 + i, 8) = Rings(mol) 
    For j = 1 To mol_size 
        Cells(1 + i, 8 + j) = mol(j) 
    Next j 
Next i 
End Sub 
 
Sub CAMD(mol() As Long, Final_Obj As Double)      'argument mol() As Long, Final_Obj As Double 
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Dim m As Long, size As Long 
Dim i As Long, j As Long 
'Dim mol() As Long, Final_Obj As Double   'arguments sometimes 
Dim del() As Long, delv() As Long, nH() As Long 
Dim AdjM() As Long, Chi(0 To 5) As Double, ChiV(0 To 5) As Double 
Dim Chi_Avg(0 To 5) As Double, ChiV_Avg(0 To 5) As Double 
 
m_max = 6 'maximum number of groups in molecule 
n = 89 ' number of groups 
n_minusrings = 9    'number of groups that are non-ring groups, also the first groups by order 
 
'Create test solution -- For debugging 
'Call InitialSolution(mol(), m) 
'm = 5 
'ReDim mol(1 To m) 
'mol(1) = 1 
'mol(2) = 37 
'mol(3) = 3 
'mol(4) = 71 
'mol(5) = 1 
 
 
 
'Create adjacency matrix and vectors to store del and delv values 
'Call BuildMolecule(mol(), del(), delv(), nH(), AdjM(), m, size) 
'Call GetConnectivity(del(), delv(), nH(), AdjM(), size, Chi(), ChiV(), Chi_Avg(), ChiV_Avg()) 
'Final_Obj = obj(mol, Chi(), ChiV(), Chi_Avg(), ChiV_Avg()) 
Call RunTabu(mol(), m, del(), delv(), nH(), AdjM(), size, Chi(), ChiV(), Chi_Avg(), ChiV_Avg(), Final_Obj) 
'Call RunGA(mol(), m, del(), delv(), nH(), AdjM(), size, Chi(), ChiV(), Chi_Avg(), ChiV_Avg(), Final_Obj) 
'MsgBox "Best solution was MW = " & MW(mol) 
 
End Sub 
 
 
Sub InitialSolution(mol() As Long, m As Long) 
'Build Random Initial Solution 
 
m = Int((m_max - 1 + 1) * Rnd + 1) ' groups in molecule 
 
ReDim mol(1 To m) 'Vector to store types of groups 
 
'Randomly assign groups in the molecule 
For i = 1 To m 
    If i > 1 Then 
        If mol(i - 1) > n_minusriungs Then  'Make sure that you do not fuse two rings together 
            mol(i) = Int((n_minusrings - 1 + 1) * Rnd + 1)  'Limits groups to non-ring groups 
        Else 
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            mol(i) = Int((n - 1 + 1) * Rnd + 1) 'Entire selection of groups available 
        End If 
    Else 
        mol(i) = Int((n - 1 + 1) * Rnd + 1) 'Entire selection of groups available for first group added 
    End If 
Next i 
 
End Sub 
 
Sub BuildMolecule(mol() As Long, del() As Long, delv() As Long, nH() As Long, AdjM() As Long, m As Long, 
size As Long) 
'Creates adjacency matrix, del and delv values for groups selected 
 
Dim i As Long, j As Long, k As Long, jstart As Long, kstart As Long, jlag As Long 
Dim terminal As Long 
 
'Clear old Adjacency Matrix 
Erase AdjM() 
 
'Always will have two terminals 
size = 2 
 
'Calculate number of non-hydrogen atoms in the molecule 
For i = 1 To m 
    size = size + atoms(mol(i)) 
Next i 
 
'Size adjacency matrix and del/delv vectors to proper size 
ReDim AdjM(1 To size, 1 To size) 
ReDim del(1 To size) 
ReDim delv(1 To size) 
ReDim nH(1 To size) 
 
'Set terminals values for del and delv 
'   This sets both terminals to -OH (hydroxyl) groups 
del(1) = 8 
del(size) = 8 
delv(1) = 6 
delv(size) = 6 
nH(1) = 1 
nH(size) = 1 
 
'Set starting indices 
jstart = 2  'used to store starting node for group being added to molecule 
kstart = jstart 
jlag = 1    'used to store terminal node from previous group added to molecule 
 
For i = 1 To m 
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    AdjM(jlag, jstart) = 1  'Connects starting node from new group with terminal node from previous 
group 
    AdjM(jstart, jlag) = 1 
     
    'Obtains del/delv values and connectivity for group selected by accessing workbook 
    For j = jstart To jstart + atoms(mol(i)) - 1 
        del(j) = Worksheets(Name(mol(i))).Cells(3 + (j - jstart), 2).Value 
        delv(j) = Worksheets(Name(mol(i))).Cells(3 + (j - jstart), 3).Value 
        nH(j) = Worksheets(Name(mol(i))).Cells(3 + (j - jstart), 4).Value 
        For k = kstart To kstart + atoms(mol(i)) - 1 
            AdjM(j, k) = Worksheets(Name(mol(i))).Cells(2 + (j - jstart), 6 + (k - jstart)).Value 
        Next k 
    Next j 
     
    'Finds terminal node for group added and node for next group to be added 
    jlag = terminus(mol(i), jstart) 
    jstart = jstart + atoms(mol(i)) 
    kstart = kstart + atoms(mol(i)) 
     
Next i 
 
AdjM(jlag, size) = 1    'Connects terminal node from new group with terminal 
AdjM(size, jlag) = 1 
 
         
 
 
End Sub 
 
Function atoms(molecule_group As Long) As Long 
'Assigns number of atoms in group selected 
 
Select Case molecule_group 
    Case Is = 1 
        atoms = 1 
    Case 2 To 3 
        atoms = 2 
    Case Is = 4 
        atoms = 1 
    Case Is = 5 
        atoms = 2 
    Case 6 To 9 
        atoms = 5 
    Case 10 To 25 
        atoms = 7 
    Case 26 To 41 
        atoms = 9 
    Case 42 To 57 
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        atoms = 8 
    Case 58 To 89 
        atoms = 9 
End Select 
 
End Function 
 
Function Name(molecule_group As Long) As String 
'Assigns name to group selected 
 
Select Case molecule_group 
    Case Is = 1 
        Name = "Group1" 
    Case Is = 2 
        Name = "Group2a" 
    Case Is = 3 
        Name = "Group2b" 
    Case Is = 4 
        Name = "Group3" 
    Case Is = 5 
        Name = "Group4" 
    Case Is = 6 
        Name = "Group5a" 
    Case Is = 7 
        Name = "Group5b" 
    Case Is = 8 
        Name = "Group5c" 
    Case Is = 9 
        Name = "Group5d" 
    Case Is = 10 
        Name = "Group6a" 
    Case Is = 11 
        Name = "Group6b" 
    Case Is = 12 
        Name = "Group6c" 
    Case Is = 13 
        Name = "Group6d" 
    Case Is = 14 
        Name = "Group6e" 
    Case Is = 15 
        Name = "Group6f" 
    Case Is = 16 
        Name = "Group6g" 
    Case Is = 17 
        Name = "Group6h" 
    Case Is = 18 
        Name = "Group6i" 
    Case Is = 19 
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        Name = "Group6j" 
    Case Is = 20 
        Name = "Group6k" 
    Case Is = 21 
        Name = "Group6l" 
    Case Is = 22 
        Name = "Group6m" 
    Case Is = 23 
        Name = "Group6n" 
    Case Is = 24 
        Name = "Group6o" 
    Case Is = 25 
        Name = "Group6p" 
    Case Is = 26 
        Name = "Group7a" 
    Case Is = 27 
        Name = "Group7b" 
    Case Is = 28 
        Name = "Group7c" 
    Case Is = 29 
        Name = "Group7d" 
    Case Is = 30 
        Name = "Group7e" 
    Case Is = 31 
        Name = "Group7f" 
    Case Is = 32 
        Name = "Group7g" 
    Case Is = 33 
        Name = "Group7h" 
    Case Is = 34 
        Name = "Group7i" 
    Case Is = 35 
        Name = "Group7j" 
    Case Is = 36 
        Name = "Group7k" 
    Case Is = 37 
        Name = "Group7l" 
    Case Is = 38 
        Name = "Group7m" 
    Case Is = 39 
        Name = "Group7n" 
    Case Is = 40 
        Name = "Group7o" 
    Case Is = 41 
        Name = "Group7p" 
    Case Is = 42 
        Name = "Group8a" 
    Case Is = 43 
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        Name = "Group8b" 
    Case Is = 44 
        Name = "Group8c" 
    Case Is = 45 
        Name = "Group8d" 
    Case Is = 46 
        Name = "Group8e" 
    Case Is = 47 
        Name = "Group8f" 
    Case Is = 48 
        Name = "Group8g" 
    Case Is = 49 
        Name = "Group8h" 
    Case Is = 50 
        Name = "Group8i" 
    Case Is = 51 
        Name = "Group8j" 
    Case Is = 52 
        Name = "Group8k" 
    Case Is = 53 
        Name = "Group8l" 
    Case Is = 54 
        Name = "Group8m" 
    Case Is = 55 
        Name = "Group8n" 
    Case Is = 56 
        Name = "Group8o" 
    Case Is = 57 
        Name = "Group8p" 
    Case Is = 58 
        Name = "Group9a" 
    Case Is = 59 
        Name = "Group9b" 
    Case Is = 60 
        Name = "Group9c" 
    Case Is = 61 
        Name = "Group9d" 
    Case Is = 62 
        Name = "Group9e" 
    Case Is = 63 
        Name = "Group9f" 
    Case Is = 64 
        Name = "Group9g" 
    Case Is = 65 
        Name = "Group9h" 
    Case Is = 66 
        Name = "Group9i" 
    Case Is = 67 
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        Name = "Group9j" 
    Case Is = 68 
        Name = "Group9k" 
    Case Is = 69 
        Name = "Group9l" 
    Case Is = 70 
        Name = "Group9m" 
    Case Is = 71 
        Name = "Group9n" 
    Case Is = 72 
        Name = "Group9o" 
    Case Is = 73 
        Name = "Group9p" 
    Case Is = 74 
        Name = "Group9q" 
    Case Is = 75 
        Name = "Group9r" 
    Case Is = 76 
        Name = "Group9s" 
    Case Is = 77 
        Name = "Group9t" 
    Case Is = 78 
        Name = "Group9u" 
    Case Is = 79 
        Name = "Group9v" 
    Case Is = 80 
        Name = "Group9w" 
    Case Is = 81 
        Name = "Group9x" 
    Case Is = 82 
        Name = "Group9y" 
    Case Is = 83 
        Name = "Group9z" 
    Case Is = 84 
        Name = "Group9aa" 
    Case Is = 85 
        Name = "Group9ab" 
    Case Is = 86 
        Name = "Group9ac" 
    Case Is = 87 
        Name = "Group9ad" 
    Case Is = 88 
        Name = "Group9ae" 
    Case Is = 89 
        Name = "Group9af" 
End Select 
 
End Function 
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Function terminus(molecule_group As Long, jstart As Long) As String 
'Finds right hand side terminal atom 
 
Select Case molecule_group 
    Case 1 To 9 
        terminus = jstart 
    Case 10 To 89 
        terminus = jstart + atoms(molecule_group) - 1   'Different atom joins to next group than prior group 
End Select 
 
End Function 
PROPERTY MODULE CODE 
Function MW(mol) As Double 
 
Dim sum As Long, size As Long 
Dim i As Long 
 
m = UBound(mol) 
 
sum = 34 
 
For i = 1 To m 
    Select Case mol(i) 
        Case Is = 1 
            sum = sum + 14 
        Case 2 To 3 
            sum = sum + 30 
        Case Is = 4 
            sum = sum + 16 
        Case Is = 5 
            sum = sum + 28 
        Case 6 To 9 
            sum = sum + 3 * 12 + 2 * 16 + 6 * 1 
        Case 10 To 25 
            sum = sum + 4 * 12 + 3 * 16 + 6 
        Case 26 To 41 
            sum = sum + 5 * 12 + 4 * 16 + 8 
        Case 42 To 57 
            sum = sum + 5 * 12 + 3 * 16 + 8 
        Case 58 To 89 
            sum = sum + 5 * 12 + 4 * 16 + 8 
    End Select 
Next i 
 
MW = sum 
 
 
258 
 
End Function 
Function HBD(mol) As Double 
 
Dim sum As Long, size As Long 
Dim i As Long 
 
m = UBound(mol) 
 
sum = 2 
 
For i = 1 To m 
    Select Case mol(i) 
        Case Is = 1 
            sum = sum + 0 
        Case 2 To 3 
            sum = sum + 1 
        Case Is = 4 
            sum = sum + 0 
        Case Is = 5 
            sum = sum + 0 
        Case 6 To 9 
            sum = sum + 2 
        Case 10 To 25 
            sum = sum + 2 
        Case 26 To 41 
            sum = sum + 3 
        Case 42 To 57 
            sum = sum + 2 
        Case 58 To 89 
            sum = sum + 3 
    End Select 
Next i 
 
HBD = sum 
 
End Function 
Function HBA(mol) As Double 
 
Dim sum As Long, size As Long 
Dim i As Long 
 
m = UBound(mol) 
 
sum = 2 
 
For i = 1 To m 
    Select Case mol(i) 
        Case Is = 1 
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            sum = sum + 0 
        Case 2 To 3 
            sum = sum + 1 
        Case Is = 4 
            sum = sum + 1 
        Case Is = 5 
            sum = sum + 1 
        Case 6 To 9 
            sum = sum + 2 
        Case 10 To 25 
            sum = sum + 3 
        Case 26 To 41 
            sum = sum + 4 
        Case 42 To 57 
            sum = sum + 3 
        Case 58 To 89 
            sum = sum + 4 
    End Select 
Next i 
 
HBA = sum 
 
End Function 
Function Rings(mol) As Double 
 
Dim sum As Long, size As Long 
Dim i As Long 
 
m = UBound(mol) 
 
sum = 0 
 
For i = 1 To m 
    Select Case mol(i) 
        Case Is = 1 
            sum = sum + 0 
        Case 2 To 3 
            sum = sum + 0 
        Case Is = 4 
            sum = sum + 0 
        Case Is = 5 
            sum = sum + 0 
        Case 6 To 9 
            sum = sum + 0 
        Case 10 To 25 
            sum = sum + 1 
        Case 26 To 41 
            sum = sum + 1 
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        Case 42 To 57 
            sum = sum + 1 
        Case 58 To 89 
            sum = sum + 1 
    End Select 
Next i 
 
Rings = sum 
 
End Function 
 
 
Function obj(mol, Chi() As Double, ChiV() As Double, Chi_Avg() As Double, ChiV_Avg() As Double) As 
Double 
 
Dim Prop_MW As Double, Prop_RNA As Double, Prop_BSA As Double, Prop_AA As Double, Prop_Ova As 
Double, Prop_TI As Double 
Dim Target_MW As Double, Target1 As Double, Prop_All As Double 
Dim ASA As Double, ahelix As Double, bsheet As Double, MW_prot As Double, Tm As Double 
'Design Targets 
Target_MW = 342 
Target1 = 1#    '1.64092082073789 
'Target2 = 1#    '-0.99286646595339 
'Protein Properties -- Read from user at later date 
ASA = 4052 
ahelix = 21 
bsheet = 33 
MW_prot = 16.5 
Tm = 62.5 
Penalty = 0 
 
Prop_MW = MW(mol) 
 
Prop_RNA = 12.271 + 0.0637 * Chi(1) + 0.5761 * Chi(3) - 0.1392 * Chi(5) - 18.2244 * Chi_Avg(0) + 3.9332 
* Chi_Avg(2) + _ 
        6.0029 * Chi_Avg(5) + 0.6086 * ChiV(1) - 2.5101 * ChiV(2) + 3.5378 * ChiV(4) - 3.1432 * ChiV(5) + _ 
        36.8323 * ChiV_Avg(2) - 44.3452 * ChiV_Avg(3) - 19.6284 * ChiV_Avg(4) + 13.1564 * ChiV_Avg(5) 
         
Prop_BSA = 5.9445 - 0.279 * Chi(3) - 0.3754 * Chi(5) - 10.0317 * Chi_Avg(0) + 7.5983 * Chi_Avg(1) - 
16.2788 * Chi_Avg(4) + 23.4753 * Chi_Avg(5) + _ 
        0.2149 * ChiV(0) - 0.7594 * ChiV(1) - 0.1974 * ChiV(2) + 2.2207 * ChiV(3) - 0.7265 * ChiV(5) + _ 
        8.4658 * ChiV_Avg(2) - 21.0254 * ChiV_Avg(3) 
         
Prop_AA = 0.6937 - 0.3134 * Chi(3) - 0.1253 * Chi(5) + 1.6912 * Chi_Avg(0) + 5.1275 * Chi_Avg(2) + _ 
        0.8448 * ChiV(3) - 2.3518 * ChiV_Avg(0) - 7.97 * ChiV_Avg(2) 
         
Prop_Ova = 1.1102 - 0.0514 * Chi(2) + 0.5165 * Chi(4) + 1.0148 * Chi_Avg(2) - 7.149 * Chi_Avg(5) - _ 
        1.0949 * ChiV(4) - 0.4271 * ChiV_Avg(0) - 1.4052 * ChiV_Avg(4) + 16.5246 * ChiV_Avg(5) 
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Prop_TI = -6.786 + 0.1362 * Chi(4) + 13.9898 * Chi_Avg(0) - 11.5258 * Chi_Avg(1) + 0.0346 * ChiV(1) - _ 
        0.2911 * ChiV(3) + 16.7938 * ChiV_Avg(2) - 19.2179 * ChiV_Avg(5) 
         
         
Prop_All = 0.0000251 * (-2.43 * Chi(0) + 6.52 * Chi(1) - 3.12 * Chi(2) - 94.32 * Chi_Avg(1) + 74.04 * 
Chi_Avg(2)) * _ 
        (0.029 * ASA + 19.35 * ahelix - 60.34 * bsheet - 71.54 * MW_prot + 66.38 * Tm) 
 
         
'Penalty Function 
For i = 1 To UBound(mol) 
    If mol(1) = 4 Or mol(UBound(mol)) = 4 Then  'Add penalty for O-OH bond 
        Penalty = 1000 
        Exit For 
    End If 
    If i > 1 Then 
        If mol(i - 1) > n_minusrings And mol(i) > n_minusrings Then 'Add penalty if two rings are fused 
together 
            Penalty = 1000 
            Exit For 
        ElseIf mol(i - 1) = 4 And mol(i) = 4 Then   'Add penalty for O-O bond 
            Penalty = 1000 
            Exit For 
        End If 
    End If 
Next i 
    
 
 
obj = Abs(Prop_MW - Target_MW) / Abs(Target_MW) ' + Penalty 
 
End Function 
 
 
 
Function fitness(mol) As Double 
 
Target_MW = 148 
Lower_MW = 0 
Higher_MW = 296 
alpha = 0.001 
 
fitness = Exp(-alpha * (MW(mol) - Target_MW) ^ 2 / (Higher_MW - Lower_MW) ^ 2) 
 
 
End Function 
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Function RNAmonomer(groups As Range) As Double 
 
Dim mol() As Long, m As Long, size As Long, i As Long 
Dim del() As Long, delv() As Long, nH() As Long 
Dim AdjM() As Long, Chi(0 To 5) As Double, ChiV(0 To 5) As Double 
Dim Chi_Avg(0 To 5) As Double, ChiV_Avg(0 To 5) As Double 
 
m = groups.Count 
ReDim mol(1 To m) 
For i = 1 To m 
    mol(i) = groups(i).Value 
Next i 
 
Call BuildMolecule(mol(), del(), delv(), nH(), AdjM(), m, size) 
Call GetConnectivity(del(), delv(), nH(), AdjM(), size, Chi(), ChiV(), Chi_Avg(), ChiV_Avg()) 
 
RNAmonomer = 12.271 + 0.0637 * Chi(1) + 0.5761 * Chi(3) - 0.1392 * Chi(5) - 18.2244 * Chi_Avg(0) + 
3.9332 * Chi_Avg(2) + _ 
        6.0029 * Chi_Avg(5) + 0.6086 * ChiV(1) - 2.5101 * ChiV(2) + 3.5378 * ChiV(4) - 3.1432 * ChiV(5) + _ 
        36.8323 * ChiV_Avg(2) - 44.3452 * ChiV_Avg(3) - 19.6284 * ChiV_Avg(4) + 13.1564 * ChiV_Avg(5) 
 
End Function 
 
Function BSAmonomer(groups As Range) As Double 
 
Dim mol() As Long, m As Long, size As Long, i As Long 
Dim del() As Long, delv() As Long, nH() As Long 
Dim AdjM() As Long, Chi(0 To 5) As Double, ChiV(0 To 5) As Double 
Dim Chi_Avg(0 To 5) As Double, ChiV_Avg(0 To 5) As Double 
 
m = groups.Count 
ReDim mol(1 To m) 
For i = 1 To m 
    mol(i) = groups(i).Value 
Next i 
 
Call BuildMolecule(mol(), del(), delv(), nH(), AdjM(), m, size) 
Call GetConnectivity(del(), delv(), nH(), AdjM(), size, Chi(), ChiV(), Chi_Avg(), ChiV_Avg()) 
 
BSAmonomer = 5.9445 - 0.279 * Chi(3) - 0.3754 * Chi(5) - 10.0317 * Chi_Avg(0) + 7.5983 * Chi_Avg(1) - 
16.2788 * Chi_Avg(4) + 23.4753 * Chi_Avg(5) + _ 
        0.2149 * ChiV(0) - 0.7594 * ChiV(1) - 0.1974 * ChiV(2) + 2.2207 * ChiV(3) - 0.7265 * ChiV(5) + _ 
        8.4658 * ChiV_Avg(2) - 21.0254 * ChiV_Avg(3) 
 
End Function 
 
Function AAmonomer(groups As Range) As Double 
 
 
263 
 
Dim mol() As Long, m As Long, size As Long, i As Long 
Dim del() As Long, delv() As Long, nH() As Long 
Dim AdjM() As Long, Chi(0 To 5) As Double, ChiV(0 To 5) As Double 
Dim Chi_Avg(0 To 5) As Double, ChiV_Avg(0 To 5) As Double 
 
m = groups.Count 
ReDim mol(1 To m) 
For i = 1 To m 
    mol(i) = groups(i).Value 
Next i 
 
Call BuildMolecule(mol(), del(), delv(), nH(), AdjM(), m, size) 
Call GetConnectivity(del(), delv(), nH(), AdjM(), size, Chi(), ChiV(), Chi_Avg(), ChiV_Avg()) 
 
AAmonomer = 0.6937 - 0.3134 * Chi(3) - 0.1253 * Chi(5) + 1.6912 * Chi_Avg(0) + 5.1275 * Chi_Avg(2) + _ 
        0.8448 * ChiV(3) - 2.3518 * ChiV_Avg(0) - 7.97 * ChiV_Avg(2) 
 
End Function 
 
Function OVAmonomer(groups As Range) As Double 
 
Dim mol() As Long, m As Long, size As Long, i As Long 
Dim del() As Long, delv() As Long, nH() As Long 
Dim AdjM() As Long, Chi(0 To 5) As Double, ChiV(0 To 5) As Double 
Dim Chi_Avg(0 To 5) As Double, ChiV_Avg(0 To 5) As Double 
 
m = groups.Count 
ReDim mol(1 To m) 
For i = 1 To m 
    mol(i) = groups(i).Value 
Next i 
 
Call BuildMolecule(mol(), del(), delv(), nH(), AdjM(), m, size) 
Call GetConnectivity(del(), delv(), nH(), AdjM(), size, Chi(), ChiV(), Chi_Avg(), ChiV_Avg()) 
 
OVAmonomer = 1.1102 - 0.0514 * Chi(2) + 0.5165 * Chi(4) + 1.0148 * Chi_Avg(2) - 7.149 * Chi_Avg(5) - _ 
        1.0949 * ChiV(4) - 0.4271 * ChiV_Avg(0) - 1.4052 * ChiV_Avg(4) + 16.5246 * ChiV_Avg(5) 
 
End Function 
 
Function TImonomer(groups As Range) As Double 
 
Dim mol() As Long, m As Long, size As Long, i As Long 
Dim del() As Long, delv() As Long, nH() As Long 
Dim AdjM() As Long, Chi(0 To 5) As Double, ChiV(0 To 5) As Double 
Dim Chi_Avg(0 To 5) As Double, ChiV_Avg(0 To 5) As Double 
 
m = groups.Count 
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ReDim mol(1 To m) 
For i = 1 To m 
    mol(i) = groups(i).Value 
Next i 
 
Call BuildMolecule(mol(), del(), delv(), nH(), AdjM(), m, size) 
Call GetConnectivity(del(), delv(), nH(), AdjM(), size, Chi(), ChiV(), Chi_Avg(), ChiV_Avg()) 
 
TImonomer = -6.786 + 0.1362 * Chi(4) + 13.9898 * Chi_Avg(0) - 11.5258 * Chi_Avg(1) + 0.0346 * ChiV(1) 
- _ 
        0.2911 * ChiV(3) + 16.7938 * ChiV_Avg(2) - 19.2179 * ChiV_Avg(5) 
 
End Function 
 
Sub ReturnCI() 
 
Dim mol() As Long, m As Long, size As Long, i As Long, groups As Range 
Dim del() As Long, delv() As Long, nH() As Long 
Dim AdjM() As Long, Chi(0 To 5) As Double, ChiV(0 To 5) As Double 
Dim Chi_Avg(0 To 5) As Double, ChiV_Avg(0 To 5) As Double 
 
Set groups = Application.InputBox("Select groups", Type:=8) 
m = groups.Count 
ReDim mol(1 To m) 
For i = 1 To m 
    mol(i) = groups(i).Value 
Next i 
 
Call BuildMolecule(mol(), del(), delv(), nH(), AdjM(), m, size) 
Call GetConnectivity(del(), delv(), nH(), AdjM(), size, Chi(), ChiV(), Chi_Avg(), ChiV_Avg()) 
 
For i = 0 To 5 
    ActiveCell.Offset(0, i) = Chi(i) 
    ActiveCell.Offset(1, i) = ChiV(i) 
    ActiveCell.Offset(2, i) = Chi_Avg(i) 
    ActiveCell.Offset(3, i) = ChiV_Avg(i) 
Next i 
 
End Sub 
CONNECTIVITY INDICES CALCULATOR CODE 
Option Explicit 
 
Sub GetConnectivity(del() As Long, delv() As Long, nH() As Long, AdjM() As Long, m As Long, Chi() As 
Double, ChiV() As Double, _ 
                    Chi_Avg() As Double, ChiV_Avg() As Double) 
 
Dim i As Long, j As Long, k As Long, edgecount As Long 
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Dim path2count() As Double, path2sum As Double, p As Long 
Dim path3count() As Double, path3sum As Double, i3 As Long 
Dim path4count() As Double, path4sum As Double, i4 As Long 
Dim path5count() As Double, path5sum As Double, i5 As Long 
Dim av() As Double, avv() As Double, e() As Double, ev() As Double 
 
'Clear old results 
Erase Chi() 
Erase ChiV() 
Erase Chi_Avg() 
Erase ChiV_Avg() 
 
'ReDim all relevant arrays 
 
ReDim av(1 To m)                            'Array for vertex degrees 
ReDim avv(1 To m)                           'Array for valence vertex degrees 
ReDim path2count(1 To m, 1 To m, 1 To m)    'Array for storing existence of 2-length paths 
ReDim path3count(1 To m, 1 To m)    'Array for storing existence of 3-length paths 
ReDim path4count(1 To m, 1 To m)    'Array for storing existence of 4-length paths 
ReDim path5count(1 To m, 1 To m)    'Array for storing existence of 5-length paths 
 
'Calculate valence vertex degrees 
For i = 1 To m 
    avv(i) = (delv(i) - nH(i)) / (del(i) - delv(i) - 1) + AdjM(i, i) 
Next i 
 
'Calculate vertex degrees and X0 and X0v 
For i = 1 To m 
    For j = 1 To m 
        av(i) = AdjM(i, j) + av(i) 
    Next j 
    If av(i) = 0 Then 
        MsgBox "Disconnected Atom", , "Error" 
        Exit Sub 
    End If 
    Chi(0) = Chi(0) + 1 / (av(i) ^ 0.5) 
    ChiV(0) = ChiV(0) + 1 / (avv(i) ^ 0.5) 
Next i 
 
'Count number of edges 
For i = 2 To m 
    For j = 1 To i - 1 
        If AdjM(i, j) > 0 Then edgecount = edgecount + 1 
    Next j 
Next i 
 
'Dimension array to size of number of edges 
ReDim e(1 To edgecount) 
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ReDim ev(1 To edgecount) 
 
'Calculate edge values and X1 and X1v 
k = 1 
For i = 2 To m 
    For j = 1 To i - 1 
        If AdjM(i, j) > 0 Then 
            e(k) = av(i) * av(j) 
            ev(k) = avv(i) * avv(j) 
            Chi(1) = Chi(1) + 1 / (e(k) ^ 0.5) 
            ChiV(1) = ChiV(1) + 1 / (ev(k) ^ 0.5) 
            k = k + 1 
        End If 
    Next j 
Next i 
 
'Records existence of paths of length 2 
For i = 1 To m 
    For j = 1 To m 
        If j <> i Then 
            If AdjM(i, j) > 0 Then 
                For k = 1 To m 
                    If k <> j And k <> i Then 
                        If AdjM(j, k) > 0 Then 
                            If path2count(k, j, i) > 0 Then 
                                path2count(i, j, k) = 0 
                            Else 
                                path2count(i, j, k) = 1 
                            End If 
                        End If 
                    End If 
                Next k 
            End If 
        End If 
    Next j 
Next i 
 
'Calculate X2 and X2v 
For i = 1 To m 
    For j = 1 To m 
        For k = 1 To m 
            path2sum = path2sum + path2count(i, j, k)           'Count the number of paths of length 2 - Mainly 
for debugging purposes 
            If path2count(i, j, k) > 0 Then 
                Chi(2) = Chi(2) + 1 / ((av(i) * av(j) * av(k)) ^ 0.5) 
                ChiV(2) = ChiV(2) + 1 / ((avv(i) * avv(j) * avv(k)) ^ 0.5) 
            End If 
        Next k 
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    Next j 
Next i 
 
'Check for paths of length 3, 4 and 5 
For i = 1 To m 
    For j = 1 To m 
        If j <> i Then 
            If AdjM(i, j) > 0 Then 
                For k = 1 To m 
                    If k <> j And k <> i Then 
                        If AdjM(j, k) > 0 Then 
                            For i3 = 1 To m 
                                If i3 <> k And i3 <> j And i3 <> i Then 
                                    If AdjM(k, i3) > 0 Then 
                                        If path3count(i3, i) > 0 Then 
                                            path3count(i, i3) = 0                                         ' Avoids double counting paths 
                                        Else 
                                            path3count(i, i3) = 1 
                                            path3sum = path3sum + 1 
                                            Chi(3) = Chi(3) + 1 / ((av(i) * av(j) * av(k) * av(i3)) ^ 0.5) 
                                            ChiV(3) = ChiV(3) + 1 / ((avv(i) * avv(j) * avv(k) * avv(i3)) ^ 0.5) 
                                        End If 
                                        For i4 = 1 To m 
                                            If i4 <> i3 And i4 <> k And i4 <> j And i4 <> i Then 
                                                If AdjM(i3, i4) > 0 Then 
                                                    If path4count(i4, i) > 0 Then 
                                                        path4count(i, i4) = 0 
                                                    Else 
                                                        path4count(i, i4) = 1 
                                                        path4sum = path4sum + 1 
                                                        Chi(4) = Chi(4) + 1 / ((av(i) * av(j) * av(k) * av(i3) * av(i4)) ^ 0.5) 
                                                        ChiV(4) = ChiV(4) + 1 / ((avv(i) * avv(j) * avv(k) * avv(i3) * avv(i4)) ^ 0.5) 
                                                    End If 
                                                    For i5 = 1 To m 
                                                        If i5 <> i3 And i5 <> k And i5 <> j And i5 <> i4 And i5 <> i Then   'i5 cannot 
equal i even if there is a five atom ring -- Paths not walks! 
                                                            If AdjM(i4, i5) > 0 Then 
                                                                If path5count(i5, i) > 0 Then 
                                                                    path5count(i, i5) = 0 
                                                                Else 
                                                                    path5count(i, i5) = 1 
                                                                    path5sum = path5sum + 1 
                                                                    Chi(5) = Chi(5) + 1 / ((av(i) * av(j) * av(k) * av(i3) * av(i4) * av(i5)) ^ 
0.5) 
                                                                    ChiV(5) = ChiV(5) + 1 / ((avv(i) * avv(j) * avv(k) * avv(i3) * avv(i4) * 
avv(i5)) ^ 0.5) 
                                                                End If 
                                                            End If 
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                                                        End If 
                                                    Next i5 
                                                End If 
                                            End If 
                                        Next i4 
                                    End If 
                                End If 
                            Next i3 
                        End If 
                    End If 
                Next k 
            End If 
        End If 
    Next j 
Next i 
                                                                                     
                     
'Calculate XAs 
'Molecule guarenteed to have path of length 2, but need to check if any path length > 2 to avoid 
overflow 
Chi_Avg(0) = Chi(0) / m 
Chi_Avg(1) = Chi(1) / edgecount 
Chi_Avg(2) = Chi(2) / path2sum 
If path3sum <> 0 Then 
    Chi_Avg(3) = Chi(3) / path3sum 
Else 
    Chi_Avg(3) = 0 
End If 
If path4sum <> 0 Then 
    Chi_Avg(4) = Chi(4) / path4sum 
Else 
    Chi_Avg(4) = 0 
End If 
If path5sum <> 0 Then 
    Chi_Avg(5) = Chi(5) / path5sum 
Else 
    Chi_Avg(5) = 0 
End If 
 
ChiV_Avg(0) = ChiV(0) / m 
ChiV_Avg(1) = ChiV(1) / edgecount 
ChiV_Avg(2) = ChiV(2) / path2sum 
If path3sum <> 0 Then 
    ChiV_Avg(3) = ChiV(3) / path3sum 
Else 
    ChiV_Avg(3) = 0 
End If 
If path4sum <> 0 Then 
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    ChiV_Avg(4) = ChiV(4) / path4sum 
Else 
    ChiV_Avg(4) = 0 
End If 
If path5sum <> 0 Then 
    ChiV_Avg(5) = ChiV(5) / path5sum 
Else 
    ChiV_Avg(5) = 0 
End If 
 
 
End Sub 
TABU SEARCH CODE 
ption Explicit 
 
Sub RunTabu(mol() As Long, m As Long, del() As Long, delv() As Long, nH() As Long, AdjM() As Long, size 
As Long, _ 
                    Chi() As Double, ChiV() As Double, Chi_Avg() As Double, ChiV_Avg() As Double, Final_Obj As 
Double) 
                     
 
Dim moves As Long, max_moves As Long, TabuCriterion As Double, Stop_Criterion As Double 
Dim imax As Long, List_size As Long, Tabu_list() As Variant, Tabu_count As Long 
Dim Neighbors() As Molecule, p() As Double 
Dim Best_sol() As Long, Current_sol() As Long, Neighbor_sol() As Long 
Dim Best_obj As Double, Current_obj As Double, Neighbor_obj As Double 
Dim Neighbors_Chi(0 To 5) As Double, Neighbors_ChiV(0 To 5) As Double, Neighbors_Chi_Avg(0 To 5) As 
Double, Neighbors_ChiV_Avg(0 To 5) As Double 
Dim Current_Chi(0 To 5) As Double, Current_ChiV(0 To 5) As Double, Current_Chi_Avg(0 To 5) As 
Double, Current_ChiV_Avg(0 To 5) As Double 
Dim Best_Chi(0 To 5) As Double, Best_ChiV(0 To 5) As Double, Best_Chi_Avg(0 To 5) As Double, 
Best_ChiV_Avg(0 To 5) As Double 
Dim i As Long, j As Long, k As Long, iter As Long 
 
imax = 100#  'Max number of non-improving iterations 
List_size = 15#  'Size of tabu list 
ReDim Tabu_list(1 To List_size, 1 To 2) 'Set length of tabu list. 
'1st column is for molecule groups. 2nd column is for Chi0 values used in tabu check. 
max_moves = 4#  'maximum number of moves to create neighbors 
TabuCriterion = 0.2   'Criterion for making solution Tabu 
Stop_Criterion = 0#     'Criterion for objective function being good enough to stop 
 
'Create random initial solution 
Call InitialSolution(mol(), m) 
 
'Initial solution set as best solution and current solution 
Best_sol = mol      'Stores structure 
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Current_sol = mol   'Stores structure 
Call BuildMolecule(mol, del(), delv(), nH(), AdjM(), m, size) 
Call GetConnectivity(del(), delv(), nH(), AdjM(), size, Chi(), ChiV(), Chi_Avg(), ChiV_Avg()) 
For k = 0 To 5 
    Current_Chi(k) = Chi(k) 
    Current_ChiV(k) = ChiV(k) 
    Current_Chi_Avg(k) = Chi_Avg(k) 
    Current_ChiV_Avg(k) = ChiV_Avg(k) 
Next k 
Best_obj = obj(mol, Chi(), ChiV(), Chi_Avg(), ChiV_Avg()) 'Stores objective value 
Tabu_list(1, 1) = mol 'Put initial solution into tabu list 
Tabu_list(1, 2) = Chi(0) 'Stores Chi0 for tabu solution 
 
'Tabu Search 
Do 
 
DoEvents        'Prevent not responding 
 
 
moves = Int((max_moves - 1 + 1) * Rnd + 1) 'Max number of neighbors evaluated 
ReDim Neighbors(1 To moves) 'initialize array for storing neighbors 
ReDim p(1 To moves) 'initialize array for storing objective function values of neighbors 
 
'Create list of neighbors and neighbor properties 
For j = 1 To moves 
    Neighbors(j).mol = Make_Neighbor(Current_sol, m) 
    Call BuildMolecule(Neighbors(j).mol, del(), delv(), nH(), AdjM(), m, size) 
    Call GetConnectivity(del(), delv(), nH(), AdjM(), size, Chi(), ChiV(), Chi_Avg(), ChiV_Avg()) 
    For k = 0 To 5 
        Neighbors(j).Chi(k) = Chi(k) 
        Neighbors(j).ChiV(k) = ChiV(k) 
        Neighbors(j).Chi_Avg(k) = Chi_Avg(k) 
        Neighbors(j).ChiV_Avg(k) = ChiV_Avg(k) 
    Next k 
    p(j) = obj(Neighbors(j).mol(), Chi(), ChiV(), Chi_Avg(), ChiV_Avg()) 
Next j 
 
Neighbor_obj = p(1) 'Arbitrarily sets first neighbor as best objective function value 
 
'Determine best non-tabu neighbor 
For j = 1 To moves 
    Tabu_count = 0  'Initialize 
    If p(j) <= Neighbor_obj Then 'If objective function of neighbor is better than previous best, replace 
        For i = 1 To List_size  'Check against each member of tabu list 
            If Abs(Neighbors(j).Chi(0) - Tabu_list(i, 2)) > TabuCriterion Then 'Tabu Check 
                Tabu_count = 0 'Solution is not Tabu yet... 
            Else 
                Tabu_count = 1 'Solution is Tabu. Quit checking against Tabu List. 
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                Exit For 
            End If 
        Next i 
        If Tabu_count = 0 Then 'Check to see if solution is tabu. If not, assign solution to surrent solution. 
            Neighbor_sol = Neighbors(j).mol 
            Neighbor_obj = p(j) 
            For k = 0 To 5 
                Neighbors_Chi(k) = Neighbors(j).Chi(k) 
                Neighbors_ChiV(k) = Neighbors(j).ChiV(k) 
                Neighbors_Chi_Avg(k) = Neighbors(j).Chi_Avg(k) 
                Neighbors_ChiV_Avg(k) = Neighbors(j).ChiV_Avg(k) 
            Next k 
        ElseIf p(j) <= Best_obj Then 'Override Tabu Criterion if solution is best yet encountered 
            Neighbor_sol = Neighbors(j).mol 
            Neighbor_obj = p(j) 
            For k = 0 To 5 
                Neighbors_Chi(k) = Neighbors(j).Chi(k) 
                Neighbors_ChiV(k) = Neighbors(j).ChiV(k) 
                Neighbors_Chi_Avg(k) = Neighbors(j).Chi_Avg(k) 
                Neighbors_ChiV_Avg(k) = Neighbors(j).ChiV_Avg(k) 
            Next k 
            If p(j) <= Stop_Criterion Then   'Stop search if you have found best possible/allowable solution 
                Neighbor_sol = Best_sol 
                Neighbor_obj = Best_obj 
                Exit Do 
            End If 
        End If 
    End If 
Next j 
 
'Aspirate if all neighbors are Tabu (i.e., no neighbor solution was found) 
If isArrayEmpty(Neighbor_sol) Then 
    Call InitialSolution(mol(), m)  'Randomly generate a new molecule to be pseudo-neighbor 
    Neighbor_sol = mol 
     
    Call BuildMolecule(mol, del(), delv(), nH(), AdjM(), m, size) 
    Call GetConnectivity(del(), delv(), nH(), AdjM(), size, Chi(), ChiV(), Chi_Avg(), ChiV_Avg()) 
    For k = 0 To 5 
        Neighbors_Chi(k) = Chi(k) 
        Neighbors_ChiV(k) = ChiV(k) 
        Neighbors_Chi_Avg(k) = Chi_Avg(k) 
        Neighbors_ChiV_Avg(k) = ChiV_Avg(k) 
    Next k 
    Neighbor_obj = obj(mol, Neighbors_Chi(), Neighbors_ChiV(), Neighbors_Chi_Avg(), 
Neighbors_ChiV_Avg()) 
End If 
 
'Makes best non-tabu neighbor the current solution 
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Current_sol = Neighbor_sol 
Current_obj = Neighbor_obj 
m = UBound(Neighbor_sol) 
For k = 0 To 5 
    Current_Chi(k) = Neighbors_Chi(k) 
    Current_ChiV(k) = Neighbors_ChiV(k) 
    Current_Chi_Avg(k) = Neighbors_Chi_Avg(k) 
    Current_ChiV_Avg(k) = Neighbors_ChiV_Avg(k) 
Next k 
 
Erase Neighbor_sol    'Clears out neighbor solution 
 
'Check current solution against best solution 
If Current_obj < Best_obj Then 
    iter = 0                       'reset count on non-improving iterations 
    Best_obj = Current_obj 
    Best_sol = Current_sol 
    For k = 0 To 5 
        Best_Chi(k) = Current_Chi(k) 
        Best_ChiV(k) = Current_ChiV(k) 
        Best_Chi_Avg(k) = Current_Chi_Avg(k) 
        Best_ChiV_Avg(k) = Current_ChiV_Avg(k) 
    Next k 
Else 
    iter = iter + 1                   'increase count on non-improving iteration 
End If 
 
Call MakeTabuList(Current_sol, Current_Chi(0), Tabu_list(), List_size) 'Add newest solution to tabu list 
     
Loop While iter <= imax 
 
'Records best solution as solution molecule for output 
mol = Best_sol 
m = UBound(mol) 
For k = 0 To 5 
    Chi(k) = Best_Chi(k) 
    ChiV(k) = Best_ChiV(k) 
    Chi_Avg(k) = Best_Chi_Avg(k) 
    ChiV_Avg(k) = Best_ChiV_Avg(k) 
Next k 
Final_Obj = Best_obj 
 
End Sub 
 
Sub MakeTabuList(mol, chi_0, Tabu_list(), List_size As Long) 
'Add new solution to tabu list and delete oldest solution 
 
Dim j As Long 
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For j = List_size To 2 Step -1 
    Tabu_list(j, 1) = Tabu_list(j - 1, 1) 'move all tabu solutions down on the list 
    Tabu_list(j, 2) = Tabu_list(j - 1, 2) 
Next j 
 
Tabu_list(1, 1) = mol 'put newest solution at top of tabu list 
Tabu_list(1, 2) = chi_0 'record Chi0 value for use in future tabu checks 
 
End Sub 
 
Function Swap(mol() As Long, m As Long) 
'Funtion to swap two existing groups 
 
Dim i As Long, j As Long 
Dim old_i As Long, old_j As Long 
 
If m <= 1 Then Exit Function 'exit if molecule is comprised of only one group 
 
' randomly select groups to swap 
i = Int((m - 1 + 1) * Rnd + 1) 
j = Int((m - 1 + 1) * Rnd + 1) 
 
'Stores inital values of i and j 
old_i = mol(i) 
old_j = mol(j) 
 
'Swaps values of i and j 
mol(i) = old_j 
mol(j) = old_i 
 
Swap = mol 'returns new molecule 
 
End Function 
 
Function Insert(mol() As Long, m As Long) 
'Function to insert group into existing molecule 
 
Dim Insertion As Long, old_mol() As Long 
Dim i As Long 
 
If m >= m_max Then Exit Function 
 
ReDim old_mol(1 To m) 'Exits if molecule is at maximum size 
 
'Store old molecule 
For i = 1 To m 
    old_mol(i) = mol(i) 
 
274 
 
Next i 
 
'Grow molecule by one 
m = m + 1 
ReDim mol(1 To m) 
 
Insertion = Int((m - 1 + 1) * Rnd + 1) 'Randomly select insertion point 
 
'Fills in groups prior to insertion 
For i = 1 To Insertion - 1 
    mol(i) = old_mol(i) 
Next i 
 
mol(Insertion) = Int((n - 1 + 1) * Rnd + 1) 'Insert random group at insertion point 
 
'Fills in groups following insertion 
For i = Insertion + 1 To m 
    mol(i) = old_mol(i - 1) 
Next i 
 
Insert = mol 'returns new molecule 
 
End Function 
 
Function Delete(mol() As Long, m As Long) 
'Function to insert group into existing molecule 
 
Dim Deletion As Long, old_mol() As Long 
Dim i As Long 
 
If m <= 1 Then Exit Function 'Exits if molecule only contains one group 
 
ReDim old_mol(1 To m) 
 
'Store old molecule 
For i = 1 To m 
    old_mol(i) = mol(i) 
Next i 
 
'Shrink molecule by one 
m = m - 1 
ReDim mol(1 To m) 
 
Deletion = Int((m - 1 + 1) * Rnd + 1) 'Randomly select deletion point 
 
'Fills in groups prior to deletion 
For i = 1 To Deletion - 1 
    mol(i) = old_mol(i) 
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Next i 
 
'Fills in groups following deletion 
For i = Deletion To m 
    mol(i) = old_mol(i + 1) 
Next i 
 
Delete = mol 'returns new molecule 
 
End Function 
 
Function Mutate(mol() As Long, m As Long) 
 
Dim i As Long 
 
i = Int((m - 1 + 1) * Rnd + 1)  'Randomly select mutation point 
mol(i) = Int((n - 1 + 1) * Rnd + 1) 'Randomly select mutation 
 
Mutate = mol    'returns new molecule 
 
End Function 
 
Function Make_Neighbor(mol() As Long, m As Long) 
'Assigns number of atoms in group selected 
Dim k As Long 
 
If m = 1 Then 
    k = 2   'Make sure you insert to find neighbor if molecule has only one group 
ElseIf m = m_max Then 
    k = 3   'Make sure you delete to find neighbor if molecule has max number of groups 
Else 
    k = Int((4 - 1 + 1) * Rnd + 1) 'Randomly select molecular operator 
End If 
 
Select Case k 
    Case Is = 1 
       Make_Neighbor = Swap(mol, m) 
    Case Is = 2 
       Make_Neighbor = Insert(mol, m) 
    Case Is = 3 
       Make_Neighbor = Delete(mol, m) 
    Case Is = 4 
        Make_Neighbor = Mutate(mol, m) 
End Select 
 
End Function 
 
Public Function isArrayEmpty(parArray As Variant) As Boolean 
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'Returns true if: 
'  - parArray is not an array 
'  - parArray is a dynamic array that has not been initialised (ReDim) 
'  - parArray is a dynamic array has been erased (Erase) 
 
    If IsArray(parArray) = False Then isArrayEmpty = True 
    On Error Resume Next 
    If UBound(parArray) < LBound(parArray) Then 
        isArrayEmpty = True 
        Exit Function 
    Else 
        isArrayEmpty = False 
    End If 
     
End Function 
GENETIC ALGORITHM CODE 
Option Explicit 
 
Sub RunGA(mol() As Long, m As Long, del() As Long, delv() As Long, nH() As Long, AdjM() As Long, size As 
Long, _ 
            Chi() As Double, ChiV() As Double, Chi_Avg() As Double, ChiV_Avg() As Double, Final_Obj As 
Double) 
 
Dim Gen_Max As Long, Pop_Size As Long, Population() As Molecule, p() As Double, Max_Prob As Double 
Dim Best_obj As Double, Best_Member As Long, p_total As Double, Stop_Criterion As Double 
Dim Parents() As Molecule, Parent_selection() As Long, num_parents As Long, prob As Double 
Dim Partner1() As Long, Partner2() As Long 
Dim Parent_1 As Long, Parent_2 As Long, m_1 As Long, m_2 As Long, CX_1 As Long, CX_2 As Long 
Dim i As Long, j As Long, k As Long 
 
 
Gen_Max = 25#  'Maximum numbers of generations 
Pop_Size = 50#  'Population size in each generation 
Max_Prob = 100#   'Maximum probability to sample from for roulette selection 
Stop_Criterion = 100#     'Criterion for objective function being good enough to stop 
ReDim Population(1 To Pop_Size) 'Create array for storing population 
ReDim p(1 To Pop_Size)  'Create array to store fitness values 
i = 0 'Progenitors are zeroth generation 
 
'Seed Population 
For j = 1 To Pop_Size 
    Call InitialSolution(Population(j).mol(), m)    'Randomly generate molecule 
    Call BuildMolecule(Population(j).mol, del(), delv(), nH(), AdjM(), m, size) 
    Call GetConnectivity(del(), delv(), nH(), AdjM(), size, Chi(), ChiV(), Chi_Avg(), ChiV_Avg()) 
    For k = 0 To 5 
        Population(j).Chi(k) = Chi(k) 
        Population(j).ChiV(k) = ChiV(k) 
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        Population(j).Chi_Avg(k) = Chi_Avg(k) 
        Population(j).ChiV_Avg(k) = ChiV_Avg(k) 
    Next k 
Next j 
 
' 
'Genetic Algorithm 
' 
Do 
 
DoEvents    'Suppress not responding 
 
'Calculate Fitness 
If obj(Population(1).mol, Population(1).Chi(), Population(1).ChiV(), Population(1).Chi_Avg(), 
Population(1).ChiV_Avg()) = 0 Then 
    p(1) = 1 / (obj(Population(1).mol, Population(1).Chi(), Population(1).ChiV(), Population(1).Chi_Avg(), 
Population(1).ChiV_Avg()) + 0.001) 
Else 
    p(1) = 1 / obj(Population(1).mol, Chi(), ChiV(), Chi_Avg(), ChiV_Avg()) 'fitness(Population(1).mol) 
End If 
Best_obj = p(1)                 'Set inital member of solution as best member 
Best_Member = 1 
p_total = p(1) 
For j = 2 To Pop_Size 
    If obj(Population(j).mol, Population(j).Chi(), Population(j).ChiV(), Population(j).Chi_Avg(), 
Population(j).ChiV_Avg()) = 0 Then 
        p(j) = 1 / (obj(Population(j).mol, Population(j).Chi(), Population(j).ChiV(), Population(j).Chi_Avg(), 
Population(j).ChiV_Avg()) + 0.001) 
    Else 
        p(j) = 1 / obj(Population(j).mol, Population(j).Chi(), Population(j).ChiV(), Population(j).Chi_Avg(), 
Population(j).ChiV_Avg()) 'fitness(Population(j).mol) 
    End If 
        p_total = p_total + p(j) 
        If p(j) > Best_obj Then     'If current member has better obj than best, replace best with current 
member 
            Best_obj = p(j) 
            Best_Member = j 
        End If 
    Next j 
         
'Termination criteria 
If i >= Gen_Max Or Best_obj > Stop_Criterion Then    'Check if generations have completed or if best 
solution from generation is good enough to stop search 
    mol = Population(Best_Member).mol                'If so, return best solution and exit GA 
    For k = 0 To 5 
        Chi(k) = Population(Best_Member).Chi(k) 
        ChiV(k) = Population(Best_Member).ChiV(k) 
        Chi_Avg(k) = Population(Best_Member).Chi_Avg(k) 
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        ChiV_Avg(k) = Population(Best_Member).ChiV_Avg(k) 
    Next k 
    Final_Obj = obj(mol, Chi(), ChiV(), Chi_Avg(), ChiV_Avg()) 
    Exit Do 
End If 
 
'Select Parents 
num_parents = 0 'no parents selected yet 
Erase Parents() 'erase old parents 
ReDim Parent_selection(1 To Pop_Size)   'Create array for storing parent selection 
k = 1   'counter for number of parents 
For j = 1 To Pop_Size 
    prob = 100 * p(j) / p_total                 'Calculate probability of becoming parent 
    If Int((Max_Prob - 1 + 1) * Rnd + 1) < prob Then 'Roulette selection 
        Parent_selection(j) = 1 
        num_parents = num_parents + 1 
   End If 
Next j 
 
If num_parents = 0 Then     'If no parents selected, randomly choose two members of the population to 
become parents 
    ReDim Parents(1 To 2) 
    Parents(1).mol = Population(Int((Pop_Size - 1 + 1) * Rnd + 1)).mol 
    Parents(2).mol = Population(Int((Pop_Size - 1 + 1) * Rnd + 1)).mol 
Else 
    ReDim Parents(1 To num_parents)    'Dimension array for storing parents 
    k = 1   'counter for number of parents 
    For j = 1 To Pop_Size 
        If Parent_selection(j) = 1 Then 'If memeber is selected as parent, add to parents array 
            Parents(k).mol = Population(j).mol 
            k = k + 1 
        End If 
    Next j 
End If 
    
 
'Reproduction 
For j = 1 To Pop_Size 
    If p(j) >= Best_obj Then    'Elitist Policy 
        Population(j).mol = Population(j).mol 
    Else 
        Erase Partner1 
        Erase Partner2 
        Parent_1 = Int((num_parents - 1 + 1) * Rnd + 1) 
        Parent_2 = Int((num_parents - 1 + 1) * Rnd + 1) 
        m_1 = UBound(Parents(Parent_1).mol) 
        m_2 = UBound(Parents(Parent_2).mol) 
        Partner1 = Parents(Parent_1).mol 
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        Partner2 = Parents(Parent_2).mol 
        Population(j).mol = Make_Offspring(Partner1, Partner2, m_1, m_2, k, CX_1, CX_2) 
        If UBound(Population(j).mol) > m_max Then   'If new member of population is too large, kill off and 
replace with one of its two parents 
            If Int((2 - 1 + 1) * Rnd + 1) = 1 Then 
                Population(j).mol = Partner1 
            Else 
                Population(j).mol = Partner2 
            End If 
        ElseIf k = 5 And j <= (Pop_Size - 1) Then   'If crossover is selected, make sure next offspring is the 
other crossover result 
            j = j + 1 
            Partner1 = Parents(Parent_1).mol 
            Partner2 = Parents(Parent_2).mol 
            m_1 = UBound(Partner1) 
            m_2 = UBound(Partner2) 
            Population(j).mol = Crossover2(Partner1, Partner2, m_1, m_2, CX_1, CX_2) 
        End If 
    End If 
Next j 
 
'Calculate descriptors for next generation 
For j = 1 To Pop_Size 
    m = UBound(Population(j).mol) 
    Call BuildMolecule(Population(j).mol, del(), delv(), nH(), AdjM(), m, size) 
    Call GetConnectivity(del(), delv(), nH(), AdjM(), size, Chi(), ChiV(), Chi_Avg(), ChiV_Avg()) 
    For k = 0 To 5 
        Population(j).Chi(k) = Chi(k) 
        Population(j).ChiV(k) = ChiV(k) 
        Population(j).Chi_Avg(k) = Chi_Avg(k) 
        Population(j).ChiV_Avg(k) = ChiV_Avg(k) 
    Next k 
Next j 
 
 
i = i + 1   'Increase generation 
Erase Parent_selection 
 
Loop 
 
End Sub 
                     
Function Make_Offspring(Partner1() As Long, Partner2() As Long, m1 As Long, m2 As Long, k As Long, 
CX1 As Long, CX2 As Long) 
'Assigns number of atoms in group selected 
 
If m1 = 1 Then 
    k = 2   'Make sure you insert to find neighbor if molecule has only one group 
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ElseIf m1 >= m_max Then 
    k = 3   'Make sure you delete to find neighbor if molecule has max number of groups 
Else 
    k = Int((6 - 1 + 1) * Rnd + 1) 'Randomly select molecular operator 
End If 
 
Select Case k 
    Case Is = 1 
       Make_Offspring = Swap(Partner1, m1) 
    Case Is = 2 
       Make_Offspring = Insert(Partner1, m1) 
    Case Is = 3 
       Make_Offspring = Delete(Partner1, m1) 
    Case Is = 4 
        Make_Offspring = Mutate(Partner1, m1) 
    Case Is = 5 
        Make_Offspring = Crossover1(Partner1, Partner2, m1, m2, CX1, CX2) 
    Case Is = 6 
        Make_Offspring = Blend(Partner1, Partner2, m1, m2) 
End Select 
 
End Function 
 
Function Crossover1(Partner1() As Long, Partner2() As Long, m1 As Long, m2 As Long, CX1 As Long, CX2 
As Long) 
 
Dim i As Long, j As Long, size As Long, mol() As Long 
 
CX1 = Int(((m1 - 1) - 1 + 1) * Rnd + 1) 'Randomly choose crossover points 
CX2 = Int(((m2 - 1) - 1 + 1) * Rnd + 1) 
size = CX1 + (m2 - CX2) 
ReDim mol(1 To size) 
 
For i = 1 To CX1        'Offspring up to CX1 is taken from 1st parent 
    mol(i) = Partner1(i) 
Next i 
 
For j = (CX2 + 1) To m2 'Offspring after CX1 is taken from 2nd parent 
    mol(i) = Partner2(j) 
    i = i + 1 
Next j 
 
Crossover1 = mol 
 
 
End Function 
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Function Crossover2(Partner1() As Long, Partner2() As Long, m1 As Long, m2 As Long, CX1 As Long, CX2 
As Long) 
 
Dim i As Long, j As Long, size As Long, mol() As Long 
 
size = CX2 + (m1 - CX1) 
ReDim mol(1 To size) 
i = 1 
For j = (CX1 + 1) To m1      'Offspring past CX1 is taken from 1st parent 
    mol(i) = Partner1(j) 
    i = i + 1 
Next j 
 
For j = 1 To CX2 'Offspring before CX2 is taken from 2nd parent 
    mol(i) = Partner2(j) 
    i = i + 1 
Next j 
 
Crossover2 = mol 
 
End Function 
 
Function Blend(Partner1() As Long, Partner2() As Long, m1 As Long, m2 As Long) 
'Add two parents together to yield offspring 
 
Dim i As Long, j As Long, size As Long, mol() As Long 
 
size = m1 + m2 
ReDim mol(1 To size) 
 
For i = 1 To m1 
    mol(i) = Partner1(i) 
Next i 
 
For j = 1 To m2 
    mol(i) = Partner2(j) 
    i = i + 1 
Next j 
 
Blend = mol 
 
End Function   
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E. UNIFAC-IL INTERACTION PARAMETERS 
 
Interaction parameters for the UNIFAC-IL model described in Sections 4 and 6 are given. The interaction 
parameters are used in calculation of the activity coefficient for any given binary mixture of interest.  
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F. SUMMARY OF EXPERIMENTAL DATA 
 
Table F.1 summarizes the results obtained by Lavanya K. Iyer at Purdue University and used for model 
development for %Monomer as a function of protein structure (Roughton, Iyer et al. 2013). All other 
figures represent data obtained by the author. 
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Figure F.1 Pxrd results for subset of formulations selected Each panel displays a protein–excipient pair 
selected for analysis. Panels with two X-Ray diffractograms represent formulations that were chosen for 
replication.  
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Table F.2 Experimental SEC results Value in parenthesis indicates standard error of the mean (SEM). 
  
Excipient RNAse A BSA Ovalbumin 
Trypsin 
Inhibitor 
a-Amylase 
Sorbitol 99.3% (1.0%) 91.7% (1.1%) 99.6% (0.4%) 101.2% (2.1%) 98.1% (2.3%) 
Mannitol 85.3% (1.7%) 82.6% (1.1%) 98.8% (0.7%) 88.9% (3.5%) 95.0% (1.2%) 
Maltitol 86.6% (1.0%) 85.9% (2.3%) 92.5% (0.9%) 91.2% (0.3%) 93.5% (0.5%) 
Methyl-
glucamine 
89.3% (0.2%) 94.0% (0.3%) 95.2% (1.1%) 95.5% (0.8%) 97.9% (0.8%) 
Glucose 99.9% (0.5%) 88.8% (0.8%) 98.4% (0.5%) 91.8% (2.1%) 99.8% (2.5%) 
Mannose 85.4% (0.2%) 92.5% (1.4%) 94.8% (0.8%) 94.7% (0.6%) 98.3% (3.6%) 
Methyl-
Glucopyranoside 
89.2% (1.8%) 95.9% (0.6%) 95.3% (0.6%) 96.3% (0.8%) 
88.2% 
(10.0%) 
Xylose 83.0% (1.3%) 90.6% (0.6%) 95.7% (0.6%) 93.0% (0.5%) 94.8% (2.1%) 
Rhamnose 97.0% (1.7%) 85.5% (3.0%) 95.6% (0.1%) 111.1% (0.8%) 92.4% (1.3%) 
Acetyl-
glucosamine 
81.0% (1.7%) 92.8% (0.5%) 94.9% (0.3%) 91.6% (1.0%) 98.7% (1.2%) 
Trehalose 91.5% (0.3%) 89.6% (0.6%) 98.4% (1.1%) 90.4% (0.9%) 92.1% (2.1%) 
Raffinose 92.6% (1.7%) 90.8% (0.4%) 98.1% (0.5%) 86.5% (2.2%) 91.3% (4.1%) 
Psicose 102.4% (2.6%) 95.1% (0.4%)    
Fructose 96.0% (0.4%) 92.3% (1.4%)    
2-deoxy-glucose 97.5% (0.3%) 95.1% (0.7%)    
2-deoxy-ribose 88.5% (0.6%) 93.5% (0.8%)    
Palatinose 98.2% (0.5%) 92.8% (1.6%)    
Melibiose 96.7% (1.9%) 95.1% (0.6%)    
Maltose 95.4% (0.6%) 92.8% (1.3%)    
N-Acetyl-
Neuraminic Acid 
95.5% (0.1%) 94.9% (1.2%)    
Ethyl-glycine 96.9% (0.2%) 92.8% (1.9%)    
n-acetyl-glycine 98.5% (0.4%) 93.1% (2.0%)    
Gly-gly 97.7% (0.6%) 91.6% (0.4%)    
Gly-leu 94.4% (0.6%) 93.4% (0.4%)    
Gly-ser 97.3% (0.9%) 92.5% (0.4%)    
Gly-glu 97.2% (0.6%) 88.6% (0.6%)    
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Table F.3 SDS-PAGE Results under non-reducing and reducing conditions Reducing conditions were not 
used for -amylase as it does not contain cysteine residues. Results for reducing conditions are given in 
parenthesis.  
 
 Excipient RNAse A BSA Ovalbumin Trypsin Inhibitor -Amylase 
Sorbitol 
Dimer + Larger 
Aggregates  
(Dimer) 
Dimer + Larger 
Aggregates (Dimer + 
Larger Aggregates) 
Large Aggregates (None) 
None 
(None) 
Large 
Aggregates 
Mannitol 
Dimer  
(Dimer) 
Dimer + Larger 
Aggregates (Dimer + 
Larger Aggregates) 
Large Aggregates (None) 
None 
(None) 
Large 
Aggregates 
Maltitol 
Dimer  
(Dimer) 
Dimer + Larger 
Aggregates (Dimer + 
Larger Aggregates) 
Large Aggregates (None) 
None 
(None) 
Large 
Aggregates 
Methyl-
glucamine 
Dimer  
(Dimer) 
Dimer + Larger 
Aggregates (Dimer + 
Larger Aggregates) 
Large Aggregates (None) 
None 
(None) 
Large 
Aggregates 
Glucose 
Dimer + Larger 
Aggregates  
(Dimer) 
Dimer + Larger 
Aggregates (Dimer + 
Larger Aggregates) 
Large Aggregates (None) 
None 
(None) 
Large 
Aggregates 
Mannose 
Dimer  
(Dimer) 
Dimer + Larger 
Aggregates (Dimer + 
Larger Aggregates) 
Large Aggregates (None) 
None 
(None) 
Large 
Aggregates 
Methyl-
glucose 
Dimer  
(Dimer) 
Dimer + Larger 
Aggregates (Dimer + 
Larger Aggregates) 
Large Aggregates (None) 
None 
(None) 
Large 
Aggregates 
Xylose 
Dimer  
(Dimer) 
Dimer + Larger 
Aggregates (Dimer + 
Larger Aggregates) 
Large Aggregates (None) 
None 
(None) 
Large 
Aggregates 
Rhamnose 
Dimer + Larger 
Aggregates  
(Dimer) 
Dimer + Larger 
Aggregates (Dimer + 
Larger Aggregates) 
Large Aggregates (None) 
None 
(None) 
Large 
Aggregates 
Acetyl-
glucosamine 
Dimer  
(Dimer) 
Dimer + Larger 
Aggregates (Dimer + 
Larger Aggregates) 
Large Aggregates (None) 
None 
(None) 
Large 
Aggregates 
Trehalose 
Dimer + Larger 
Aggregates  
(Dimer) 
Dimer + Larger 
Aggregates (Dimer + 
Larger Aggregates) 
Large Aggregates (None) 
None 
(None) 
Large 
Aggregates 
Raffinose 
Dimer + Larger 
Aggregates  
(Dimer) 
Dimer + Larger 
Aggregates (Dimer + 
Larger Aggregates) 
Large Aggregates (None) 
None 
(None) 
Large 
Aggregates 
 
 
